| placebo |
placebo |
974 |
2015 |
| Drug |
metformin |
363 |
2015 |
| Drug |
insulin glargine |
180 |
2014 |
| Drug |
sitagliptin |
145 |
2015 |
| Drug |
liraglutide |
128 |
2017 |
| Drug |
glimepiride |
100 |
2014 |
| Drug |
dapagliflozin |
95 |
2010 |
| Drug |
vildagliptin |
93 |
2011 |
| Drug |
pioglitazone |
84 |
2014 |
| Drug |
insulin degludec |
71 |
2010 |
| Drug |
exenatide |
65 |
2014 |
| Drug |
semaglutide |
61 |
2014 |
| Drug |
insulin aspart |
60 |
2011 |
| Drug |
saxagliptin |
54 |
2014 |
| Other |
standard care |
48 |
2018 |
| Drug |
insulin |
47 |
2011 |
| Drug |
rosiglitazone |
45 |
2015 |
| Drug |
linagliptin |
41 |
2014 |
| Drug |
insulin detemir |
38 |
2010 |
| Behavioral |
exercise |
35 |
2010 |
| Drug |
biphasic insulin aspart |
33 |
2011 |
| Drug |
biphasic insulin aspart 30 |
31 |
2011 |
| Other |
control |
30 |
2014 |
| Drug |
dulaglutide |
28 |
2018 |
| Drug |
empagliflozin |
27 |
2017 |
| Drug |
alogliptin |
26 |
2014 |
| Drug |
lixisenatide (ave0010) |
26 |
2010 |
| Drug |
sitagliptin phosphate |
25 |
2010 |
| Drug |
acarbose |
24 |
2014 |
| Drug |
sulfonylurea |
23 |
2010 |
| Behavioral |
diet |
22 |
2014 |
| Drug |
azd1656 |
21 |
2010 |
| Drug |
insulin glulisine |
21 |
2010 |
| Drug |
insulin lispro |
21 |
2011 |
| Drug |
repaglinide |
21 |
2011 |
| Drug |
bi 10773 |
20 |
2010 |
| Drug |
canagliflozin |
20 |
2015 |
| Drug |
ipragliflozin |
20 |
2014 |
| Biological |
albiglutide |
19 |
2009 |
| placebo |
comparator: placebo |
19 |
2010 |
| Drug |
ly2189265 |
19 |
2011 |
| Drug |
saline |
18 |
2020 |
| Drug |
insulin degludec/insulin aspart |
17 |
2009 |
| Drug |
glargine |
16 |
2010 |
| Drug |
insulin degludec/liraglutide |
16 |
2014 |
| Drug |
sotagliflozin (sar439954) |
16 |
2018 |
| Drug |
gliclazide |
15 |
2013 |
| Drug |
insulin nph |
15 |
2008 |
| Drug |
metformin xr |
15 |
2009 |
| Drug |
aleglitazar |
14 |
2010 |
| Drug |
insulin glargine (hoe901) |
14 |
2018 |
| Drug |
metformin hydrochloride |
14 |
2009 |
| Drug |
sitagliptin 100 mg |
14 |
2014 |
| Drug |
glyburide |
13 |
2009 |
| Behavioral |
lifestyle intervention |
13 |
2019 |
| Device |
pen auto-injector |
13 |
2010 |
| Drug |
tirzepatide |
13 |
2017 |
| Drug |
exenatide once weekly |
12 |
2012 |
| Drug |
glipizide |
12 |
2009 |
| Drug |
omarigliptin |
12 |
2013 |
| Drug |
simvastatin |
12 |
2009 |
| Drug |
aspirin |
11 |
2014 |
| Drug |
bexagliflozin |
11 |
2017 |
| Behavioral |
physical activity |
11 |
2018 |
| placebo |
placebo to sitagliptin |
11 |
2010 |
| Drug |
taspoglutide |
11 |
2008 |
| Drug |
vitamin d |
11 |
2020 |
| Drug |
atorvastatin |
10 |
2017 |
| Drug |
ertugliflozin 5 mg |
10 |
2013 |
| Drug |
gsk189075 |
10 |
2008 |
| Drug |
methylprednisolone |
10 |
2012 |
| Drug |
asp1941 |
9 |
2011 |
| Drug |
basal insulin |
9 |
2009 |
| Behavioral |
education |
9 |
2017 |
| Drug |
hms5552 |
9 |
2014 |
| Behavioral |
motivational interviewing |
9 |
2018 |
| placebo |
placebo tablet |
9 |
2012 |
| Drug |
teneligliptin |
9 |
2015 |
| Drug |
voglibose |
9 |
2009 |
| Drug |
clopidogrel |
8 |
2018 |
| Drug |
comparator: pioglitazone |
8 |
2010 |
| Drug |
day |
8 |
2014 |
| Behavioral |
exercise training |
8 |
2018 |
| Drug |
insulin 287 |
8 |
2018 |
| Drug |
insulin glargine (u300) |
8 |
2016 |
| Behavioral |
lifestyle modification |
8 |
2009 |
| Drug |
ly2409021 |
8 |
2014 |
| Drug |
ranolazine |
8 |
2011 |
| Drug |
sulphonylurea |
8 |
2013 |
| Drug |
aliskiren |
7 |
2011 |
| Drug |
ave0010) |
7 |
2018 |
| Drug |
biphasic insulin aspart 50 |
7 |
2013 |
| Behavioral |
caloric restriction |
7 |
2010 |
| Drug |
canagliflozin 300 mg |
7 |
2013 |
| Drug |
ertugliflozin |
7 |
2010 |
| Drug |
gk activator (2) |
7 |
2006 |
| Drug |
hydrochlorothiazide |
7 |
2009 |
| Drug |
insulin glargine/lixisenatide (hoe901/ave0010) |
7 |
2018 |
| Drug |
lixisenatide (hoe901 |
7 |
2018 |
| Drug |
medi0382 |
7 |
2018 |
| Drug |
metformin ir |
7 |
2010 |
| Drug |
nateglinide |
7 |
2011 |
| Drug |
nph insulin |
7 |
2017 |
| Drug |
pf-05175157 |
7 |
2013 |
| placebo |
placebo (semaglutide) |
7 |
2019 |
| placebo |
placebo to omarigliptin |
7 |
2013 |
| Behavioral |
smbg |
7 |
2010 |
| Drug |
valsartan |
7 |
2009 |
| Procedure |
aerobic exercise |
6 |
2017 |
| Drug |
bi 1356 |
6 |
2008 |
| Drug |
biphasic human insulin 30 |
6 |
2011 |
| Drug |
ckd-501 0.5mg |
6 |
2018 |
| Drug |
colesevelam |
6 |
2016 |
| Behavioral |
diabetes education |
6 |
2016 |
| Drug |
gliclazide mr |
6 |
2016 |
| Drug |
lantusâ® |
6 |
2014 |
| Behavioral |
lifestyle therapy |
6 |
2018 |
| placebo |
linagliptin placebo |
6 |
2011 |
| Drug |
ly2605541 |
6 |
2011 |
| Drug |
metoprolol |
6 |
2016 |
| Drug |
mitiglinide |
6 |
2009 |
| placebo |
placebo to ertugliflozin |
6 |
2013 |
| Drug |
rosuvastatin |
6 |
2010 |
| Drug |
technosphere insulin |
6 |
2007 |
| Drug |
warfarin |
6 |
2010 |
| Drug |
ac2993 |
5 |
2013 |
| Drug |
acipimox |
5 |
2009 |
| Drug |
amlodipine |
5 |
2007 |
| Drug |
biphasic human insulin |
5 |
2011 |
| Drug |
canagliflozin 100 mg |
5 |
2013 |
| Drug |
colesevelam hydrochloride |
5 |
2005 |
| Device |
continuous glucose monitoring |
5 |
2010 |
| Drug |
dapagliflozin 10mg |
5 |
2018 |
| Drug |
detemir |
5 |
2013 |
| Drug |
digoxin |
5 |
2010 |
| Drug |
evogliptin |
5 |
2019 |
| Drug |
faster-acting insulin aspart |
5 |
2017 |
| Drug |
gemigliptin |
5 |
2017 |
| Drug |
glibenclamide |
5 |
2014 |
| Drug |
human insulin inhalation powder |
5 |
2007 |
| Drug |
kg |
5 |
2014 |
| Behavioral |
lifestyle |
5 |
2017 |
| Behavioral |
lifestyle counseling |
5 |
2015 |
| Drug |
lixisenatide |
5 |
2013 |
| Drug |
losartan |
5 |
2009 |
| Drug |
ly3209590 |
5 |
2018 |
| Drug |
ly900014 |
5 |
2017 |
| Drug |
miglitol |
5 |
2006 |
| Drug |
mk-0941 |
5 |
2008 |
| Drug |
pf-04991532 |
5 |
2011 |
| placebo |
placebo group |
5 |
2008 |
| placebo |
placebo to metformin |
5 |
2011 |
| Drug |
pramlintide acetate |
5 |
2005 |
| Procedure |
roux-en-y gastric bypass surgery |
5 |
2010 |
| Drug |
sar425899 |
5 |
2018 |
| Drug |
srt2104 |
5 |
2009 |
| Behavioral |
strength training |
5 |
2018 |
| Drug |
topiramate |
5 |
2005 |
| Drug |
70 |
4 |
2008 |
| Drug |
acarbose (glucobay, bayg5421) |
4 |
2009 |
| Drug |
actos |
4 |
2007 |
| Drug |
basal bolus |
4 |
2009 |
| Drug |
bi 10773 high dose |
4 |
2009 |
| Drug |
bi 10773 low dose |
4 |
2009 |
| Drug |
biphasic insulin aspart 70 |
4 |
2012 |
| Biological |
blood sample |
4 |
2014 |
| Drug |
cilostazol |
4 |
2016 |
| Drug |
ckd-387 |
4 |
2018 |
| Behavioral |
coaching |
4 |
2017 |
| placebo |
comparator: placebo (unspecified) |
4 |
2008 |
| Radiation |
ct-scan |
4 |
2017 |
| placebo |
dapagliflozin placebo |
4 |
2010 |
| Drug |
empagliflozin 25 mg |
4 |
2019 |
| Drug |
ertugliflozin 10 mg |
4 |
2013 |
| Drug |
ertugliflozin 15 mg |
4 |
2014 |
| Behavioral |
exercise intervention |
4 |
2009 |
| Drug |
fenofibrate |
4 |
2014 |
| Drug |
glucose |
4 |
2011 |
| Drug |
glucose-dependent insulinotropic polypeptide |
4 |
2011 |
| Behavioral |
health coaching |
4 |
2013 |
| Behavioral |
health education |
4 |
2018 |
| Drug |
lantus |
4 |
2011 |
| Drug |
lispro |
4 |
2010 |
| Other |
low-fat diet |
4 |
2018 |
| placebo |
matching placebo |
4 |
2008 |
| placebo |
matching placebo to sitagliptin |
4 |
2015 |
| Other |
mediterranean diet |
4 |
2018 |
| placebo |
metformin placebo |
4 |
2009 |
| Drug |
midazolam |
4 |
2016 |
| Drug |
muraglitazar |
4 |
2005 |
| Device |
novofineâ® needle 6 mm |
4 |
2009 |
| Diagnostic Test |
oral glucose tolerance test |
4 |
2009 |
| Other |
patient education |
4 |
2018 |
| Drug |
pex168 |
4 |
2013 |
| Drug |
pioglitazone 30 mg |
4 |
2010 |
| placebo |
placebo for saxagliptin |
4 |
2014 |
| placebo |
placebo matching with saxagliptin |
4 |
2012 |
| Drug |
regular human insulin |
4 |
2009 |
| Drug |
regular insulin |
4 |
2010 |
| Behavioral |
resistance exercise |
4 |
2015 |
| Behavioral |
resistance training |
4 |
2010 |
| Dietary Supplement |
resveratrol |
4 |
2014 |
| Drug |
ro4998452 |
4 |
2009 |
| Drug |
rosiglitazone maleate |
4 |
2007 |
| Procedure |
roux-en-y gastric bypass |
4 |
2012 |
| Drug |
sb-509 |
4 |
2010 |
| Drug |
sglt2 inhibitor |
4 |
2015 |
| Drug |
shr3824 |
4 |
2015 |
| Drug |
sildenafil |
4 |
2018 |
| Drug |
sitagliptin 100mg |
4 |
2017 |
| Procedure |
sleeve gastrectomy |
4 |
2016 |
| Other |
supervised exercise training |
4 |
2009 |
| Behavioral |
telehealth |
4 |
2014 |
| Drug |
telmisartan |
4 |
2014 |
| Behavioral |
walking |
4 |
2017 |
| Drug |
xoma 052 |
4 |
2010 |
| Behavioral |
NA |
3 |
2009 |
| Drug |
) metformin hydrochloride |
3 |
2007 |
| Drug |
) simvastatin |
3 |
2007 |
| Drug |
500 mg |
3 |
2010 |
| Behavioral |
active control |
3 |
2011 |
| Other |
aerobic training |
3 |
2010 |
| Drug |
alogliptin/metformin |
3 |
2011 |
| Drug |
alogliptin/pioglitazone |
3 |
2011 |
| Drug |
background therapy |
3 |
2014 |
| placebo |
bi 10773 placebo |
3 |
2013 |
| Drug |
bi10773 |
3 |
2011 |
| Drug |
biguanide |
3 |
2013 |
| Drug |
bosentan |
3 |
2011 |
| Drug |
bydureon |
3 |
2014 |
| Drug |
canagliflozin (ta-7284) |
3 |
2014 |
| Drug |
canagliflozin 50 mg |
3 |
2013 |
| Drug |
canagliflozin, 100 mg |
3 |
2013 |
| Drug |
canagliflozin, 300 mg |
3 |
2013 |
| Behavioral |
carbohydrate-restricted diet |
3 |
2017 |
| Drug |
carvedilol |
3 |
2005 |
| Dietary Supplement |
casein |
3 |
2011 |
| Behavioral |
cbt |
3 |
2014 |
| Drug |
cholecalciferol |
3 |
2011 |
| Drug |
colesevelam hcl |
3 |
2010 |
| placebo |
comparator : placebo (unspecified) |
3 |
2007 |
| Drug |
comparator: sitagliptin |
3 |
2008 |
| Drug |
comparator: sitagliptin phosphate |
3 |
2008 |
| Drug |
diacerein |
3 |
2014 |
| Behavioral |
dietary |
3 |
2017 |
| Other |
dietary intervention |
3 |
2019 |
| Drug |
dpp-4 inhibitor |
3 |
2010 |
| Drug |
dpp-4 inhibitors |
3 |
2014 |
| Drug |
e |
3 |
2017 |
| Diagnostic Test |
echocardiography |
3 |
2012 |
| Drug |
efpeglenatide sar439977 |
3 |
2018 |
| Drug |
empagliflozin 10 mg |
3 |
2018 |
| Drug |
exenatide injection |
3 |
2009 |
| Drug |
exenatide twice daily |
3 |
2009 |
| Behavioral |
exercise program |
3 |
2008 |
| Drug |
ezetimibe |
3 |
2011 |
| Drug |
finerenone (bay94-8862) |
3 |
2015 |
| Device |
flexpenâ® |
3 |
2015 |
| Procedure |
gastric bypass surgery |
3 |
2008 |
| Drug |
gemigliptin 50mg |
3 |
2017 |
| Drug |
glargine insulin |
3 |
2009 |
| Drug |
glimepiride (hoe490) |
3 |
2009 |
| Drug |
glinide |
3 |
2013 |
| Drug |
glucagon |
3 |
2011 |
| Drug |
glucophage |
3 |
2009 |
| Dietary Supplement |
green tea extract |
3 |
2015 |
| Drug |
gsk1292263 |
3 |
2010 |
| Drug |
gsk2330672 |
3 |
2013 |
| Behavioral |
high intensity interval training |
3 |
2015 |
| Drug |
hm11260c |
3 |
2014 |
| Drug |
hoe901-u300 (new formulation of insulin glargine) |
3 |
2011 |
| Other |
home visits |
3 |
2013 |
| Drug |
humalog |
3 |
2014 |
| Drug |
human insulin |
3 |
2010 |
| Drug |
ideglira |
3 |
2019 |
| Drug |
iglarlixi |
3 |
2019 |
| Drug |
insulin glargine hoe901 |
3 |
2014 |
| Drug |
insulin lispro protamine suspension |
3 |
2007 |
| Drug |
insulin peglispro |
3 |
2014 |
| Behavioral |
intervention |
3 |
2020 |
| Behavioral |
intervention group (ig) |
3 |
2009 |
| Drug |
intralipid 20% |
3 |
2008 |
| Drug |
irbesartan |
3 |
2007 |
| Drug |
isis 113715 |
3 |
2007 |
| Drug |
itca 650 |
3 |
2009 |
| Dietary Supplement |
l-arginine |
3 |
2009 |
| Drug |
lantus (insulin glargine) |
3 |
2011 |
| Procedure |
laparoscopic sleeve gastrectomy |
3 |
2016 |
| Drug |
linagliptin 5mg |
3 |
2010 |
| Drug |
lixisenatide ave0010 |
3 |
2013 |
| Drug |
lixisenatide fixed ratio combination |
3 |
2011 |
| Behavioral |
low-carbohydrate diet |
3 |
2016 |
| Behavioral |
low carbohydrate diet |
3 |
2017 |
| Drug |
ly2963016 |
3 |
2014 |
| Dietary Supplement |
maltodextrin |
3 |
2018 |
| placebo |
matching placebo to omarigliptin |
3 |
2012 |
| Drug |
met dr |
3 |
2013 |
| Drug |
metformin (background drug) |
3 |
2011 |
| Drug |
metformin combination tablet |
3 |
2011 |
| Drug |
metformin fdc |
3 |
2011 |
| Drug |
metformin hcl |
3 |
2008 |
| Drug |
metformin/sulfonylurea |
3 |
2012 |
| Drug |
moxifloxacin |
3 |
2011 |
| Other |
no exercise |
3 |
2014 |
| Procedure |
non-surgical periodontal treatment |
3 |
2017 |
| Behavioral |
nutrition |
3 |
2011 |
| Behavioral |
nutrition education |
3 |
2017 |
| Other |
nutritional intervention |
3 |
2013 |
| Dietary Supplement |
olive oil |
3 |
2018 |
| Drug |
olmesartan medoxomil |
3 |
2006 |
| Drug |
opc-262 |
3 |
2010 |
| Other |
oral glucose tolerance test (ogtt) |
3 |
2009 |
| Drug |
oral semaglutide |
3 |
2019 |
| Biological |
pb-119 injection |
3 |
2017 |
| Drug |
pf-06291874 |
3 |
2014 |
| Other |
physical training |
3 |
2018 |
| Drug |
pioglitazone hydrochloride |
3 |
2012 |
| Drug |
pitavastatin |
3 |
2009 |
| placebo |
placebo (high dose) |
3 |
2011 |
| placebo |
placebo (low dose) |
3 |
2011 |
| placebo |
placebo for sitagliptin |
3 |
2017 |
| placebo |
placebo matching with dapagliflozin |
3 |
2012 |
| placebo |
placebo to glimepiride |
3 |
2013 |
| Behavioral |
positive psychology |
3 |
2016 |
| Device |
pump |
3 |
2013 |
| Drug |
ramipril |
3 |
2007 |
| Drug |
repaglinide/metformin combination tablet |
3 |
2011 |
| Drug |
rimonabant (sr141716) |
3 |
2006 |
| Drug |
rivoglitazone hcl |
3 |
2007 |
| Procedure |
root planing |
3 |
2014 |
| Drug |
rosiglitazone/metformin |
3 |
2005 |
| Drug |
salsalate |
3 |
2008 |
| Drug |
saxagliptin 5 mg |
3 |
2012 |
| Drug |
saxagliptin 5mg |
3 |
2014 |
| Procedure |
scaling |
3 |
2014 |
| Drug |
sitagliptin (mk0431) |
3 |
2004 |
| Drug |
sitagliptin 100 mg q.d. |
3 |
2009 |
| Drug |
sitagliptin phosphate ( |
3 |
2007 |
| Drug |
sitagliptin phosphate (/) metformin hydrochloride |
3 |
2007 |
| placebo |
sitagliptin placebo |
3 |
2009 |
| Behavioral |
stress management |
3 |
2012 |
| Drug |
tak-875 |
3 |
2009 |
| Drug |
technosphereâ® insulin inhalation powder |
3 |
2006 |
| Behavioral |
telemonitoring |
3 |
2013 |
| Behavioral |
telephone counseling |
3 |
2012 |
| Drug |
teneli (teneligliptin) |
3 |
2014 |
| Drug |
thiazolidinedione (tzd) |
3 |
2011 |
| Drug |
ticagrelor |
3 |
2014 |
| Drug |
trelagliptin |
3 |
2017 |
| Drug |
vildagliptin / metformin |
3 |
2007 |
| Drug |
vildagliptin 50 mg bid |
3 |
2009 |
| Dietary Supplement |
vitamin c |
3 |
2018 |
| Drug |
1000 mg |
2 |
2010 |
| Drug |
150 mg pf-04991532 |
2 |
2011 |
| Drug |
25 |
2 |
2014 |
| Drug |
30) |
2 |
2016 |
| Drug |
400 mg lx4211 |
2 |
2011 |
| Drug |
5 mg dapagliflozin |
2 |
2017 |
| Device |
8mm x 31g pen needle |
2 |
2009 |
| Behavioral |
a1c results |
2 |
2015 |
| Drug |
acarbose (glucobay odt, bayg5421) |
2 |
2012 |
| Device |
accu-chek smart pix readout device |
2 |
2014 |
| Device |
accu-chek smart pix software |
2 |
2014 |
| Drug |
acetylcholine |
2 |
2018 |
| Behavioral |
active control group (acg) |
2 |
2009 |
| Device |
activity tracker |
2 |
2017 |
| Drug |
actrapid (human insulin) |
2 |
2008 |
| Drug |
advanced medical therapy |
2 |
2014 |
| Other |
aerobic exercise training |
2 |
2010 |
| Drug |
afrezza inhalant product |
2 |
2017 |
| Biological |
albiglutide (gsk716155) |
2 |
2011 |
| Biological |
albiglutide 50 mg |
2 |
2015 |
| Drug |
albiglutide liquid auto-injector |
2 |
2016 |
| placebo |
alogliptin placebo |
2 |
2009 |
| Drug |
alogliptin/glimepiride |
2 |
2011 |
| Drug |
alogliptin/voglibose |
2 |
2010 |
| Drug |
alpha-glucosidase inhibitor |
2 |
2013 |
| Drug |
alpha-glucosidase inhibitors |
2 |
2016 |
| Drug |
amaryl |
2 |
2005 |
| Drug |
aminohippurate sodium inj 20% |
2 |
2018 |
| Drug |
amlexanox |
2 |
2013 |
| Drug |
amlodipine/benazepril |
2 |
2011 |
| Drug |
anagliptin |
2 |
2012 |
| Dietary Supplement |
anthocyanin |
2 |
2014 |
| Drug |
arry-403, glucokinase activator; oral |
2 |
2009 |
| Drug |
asp8232 |
2 |
2014 |
| Drug |
atorvastatin (lipitor) |
2 |
2007 |
| Drug |
avandamet |
2 |
2006 |
| Drug |
ave0010 |
2 |
2018 |
| Drug |
azd4017 |
2 |
2009 |
| Other |
balanced diet high in slowly digestible starch |
2 |
2019 |
| Other |
balanced diet low in slowly digestible starch |
2 |
2019 |
| Procedure |
bariatric surgery |
2 |
2016 |
| Drug |
bay94-8862 |
2 |
2013 |
| Other |
bed rest intervention |
2 |
2018 |
| Drug |
benazepril |
2 |
2011 |
| Drug |
berberine |
2 |
2007 |
| Drug |
best medical management |
2 |
2010 |
| placebo |
bexagliflozin tablets, placebo |
2 |
2017 |
| Drug |
bi 135585 |
2 |
2010 |
| placebo |
bi 1356 placebo |
2 |
2008 |
| Drug |
bi 187004 |
2 |
2013 |
| Drug |
bi 44847 |
2 |
2014 |
| Drug |
biotin (2 mg) |
2 |
2006 |
| Drug |
biphasic human insulin 50 |
2 |
2013 |
| Other |
blood draw |
2 |
2012 |
| Diagnostic Test |
blood test |
2 |
2017 |
| Biological |
bm-mnc |
2 |
2008 |
| Drug |
bms-820132 |
2 |
2011 |
| Drug |
bms-823778 |
2 |
2012 |
| Behavioral |
caipadi |
2 |
2017 |
| Drug |
calcined magnesia |
2 |
2017 |
| Drug |
canagliflozin (jnj-28431754) |
2 |
2009 |
| Drug |
canagliflozin 300mg |
2 |
2011 |
| Drug |
canakinumab |
2 |
2010 |
| Drug |
captopril |
2 |
2012 |
| Drug |
ccx140-b |
2 |
2011 |
| Device |
cgm |
2 |
2018 |
| Drug |
chiglitazar |
2 |
2014 |
| Drug |
cholecystokinin |
2 |
2015 |
| Dietary Supplement |
cinnamon |
2 |
2018 |
| Behavioral |
circuit training |
2 |
2008 |
| Drug |
ckd-395 0.25 |
2 |
2015 |
| Behavioral |
cmt |
2 |
2015 |
| Behavioral |
coached care |
2 |
2010 |
| Dietary Supplement |
cocoa polyphenols |
2 |
2013 |
| Behavioral |
community health worker intervention |
2 |
2014 |
| Drug |
comparator: atorvastatin |
2 |
2005 |
| Drug |
comparator: glimepiride |
2 |
2009 |
| Drug |
comparator: metformin |
2 |
2009 |
| placebo |
comparator: placebo to match sitagliptin 100 mg q.d. |
2 |
2006 |
| placebo |
comparator: placebo to pioglitazone |
2 |
2010 |
| placebo |
comparator: placebo to sitagliptin |
2 |
2010 |
| Dietary Supplement |
conjugated linoleic acid (cla) |
2 |
2010 |
| Device |
continuous glucose monitor |
2 |
2019 |
| Device |
continuous glucose monitor (cgm) |
2 |
2017 |
| Behavioral |
continuous walking |
2 |
2014 |
| Other |
control diet |
2 |
2018 |
| Behavioral |
counseling |
2 |
2016 |
| Drug |
cyclo-z |
2 |
2018 |
| Drug |
cycloset |
2 |
2014 |
| Drug |
d484 |
2 |
2018 |
| Drug |
d635 |
2 |
2019 |
| Drug |
da-1229_01 |
2 |
2014 |
| Drug |
da-1241 |
2 |
2017 |
| Drug |
daily injection of kbp |
2 |
2018 |
| Drug |
dapaglifozin |
2 |
2017 |
| Drug |
dbpr108 |
2 |
2014 |
| Device |
dexcom g6 |
2 |
2020 |
| Drug |
dextrose |
2 |
2017 |
| Behavioral |
diabetes self-management education |
2 |
2016 |
| Other |
diabetes support |
2 |
2008 |
| Other |
diabetes support/education |
2 |
2008 |
| Dietary Supplement |
diamel |
2 |
2018 |
| Drug |
diazoxide |
2 |
2009 |
| Behavioral |
diet a |
2 |
2010 |
| Behavioral |
diet b |
2 |
2010 |
| Behavioral |
diet intervention |
2 |
2011 |
| Procedure |
diet/exercise questionnaire |
2 |
2017 |
| Behavioral |
dietary consulting |
2 |
2015 |
| Dietary Supplement |
dietary intervention-refined rice |
2 |
2013 |
| Dietary Supplement |
dietary intervention-whole grains |
2 |
2013 |
| Dietary Supplement |
dietary intervention-whole grains/legumes |
2 |
2013 |
| Behavioral |
dietary regimen |
2 |
2010 |
| Drug |
dlbs3233 |
2 |
2011 |
| Drug |
dmmet-01 |
2 |
2009 |
| Drug |
doxycycline |
2 |
2012 |
| Drug |
doxycycline group |
2 |
2016 |
| Drug |
dpp-iv inhibitor |
2 |
2005 |
| Drug |
ds-7309 |
2 |
2013 |
| Drug |
ds-8500a |
2 |
2016 |
| Drug |
duvie tab. 0.5mg |
2 |
2016 |
| Drug |
e/m |
2 |
2014 |
| Behavioral |
educational materials |
2 |
2005 |
| Drug |
efpeglenatide (sar439977) |
2 |
2017 |
| Drug |
egt0001442 |
2 |
2011 |
| Drug |
empa |
2 |
2015 |
| Drug |
empagliflozin high dose |
2 |
2014 |
| Drug |
empagliflozin low dose |
2 |
2014 |
| Drug |
enalapril |
2 |
2007 |
| Device |
endobarrier |
2 |
2009 |
| Device |
endobarrier gastrointestinal liner |
2 |
2010 |
| Device |
endobarrier liner |
2 |
2009 |
| Drug |
enteric-coated aspirin caplets |
2 |
2013 |
| Dietary Supplement |
epa |
2 |
2016 |
| Drug |
eplerenone |
2 |
2013 |
| Drug |
ertugliflozin 1 mg |
2 |
2010 |
| Drug |
ertugliflozin 25 mg |
2 |
2010 |
| Other |
euglycaemic clamp |
2 |
2016 |
| Biological |
evolocumab |
2 |
2016 |
| Drug |
ex1000 |
2 |
2008 |
| Drug |
exenatide extended-release |
2 |
2016 |
| Drug |
exenatide lar |
2 |
2018 |
| Drug |
exenatide once weekly suspension |
2 |
2012 |
| Drug |
exenatide/placebo |
2 |
2009 |
| Procedure |
exercise questionnaire |
2 |
2017 |
| Behavioral |
exercise/diet |
2 |
2018 |
| Behavioral |
fams |
2 |
2015 |
| Drug |
fg-3019 |
2 |
2008 |
| Behavioral |
fitbit |
2 |
2015 |
| Drug |
furosemide |
2 |
2007 |
| Biological |
gastric bypass |
2 |
2011 |
| Drug |
gemfibrozil |
2 |
2010 |
| Dietary Supplement |
ginger |
2 |
2014 |
| Drug |
gip |
2 |
2019 |
| Drug |
glimepiride / metformin |
2 |
2010 |
| Drug |
glimepiride 2 mg |
2 |
2019 |
| placebo |
glimepiride placebo |
2 |
2012 |
| Drug |
glipizide 5 mg |
2 |
2016 |
| Drug |
glp-1 analogue |
2 |
2014 |
| Drug |
glp1 receptor agonist |
2 |
2016 |
| Drug |
glucagon-like-peptide-1 |
2 |
2007 |
| Drug |
glucagon-like peptide-1 |
2 |
2017 |
| Dietary Supplement |
glucerna sr |
2 |
2014 |
| Drug |
glucose-dependent insulinotropic polypeptide (gip) |
2 |
2009 |
| Drug |
glucose-dependent insulinotropic polypeptide/xenin-25 |
2 |
2009 |
| Other |
glucose clamp |
2 |
2013 |
| Device |
glucotab system |
2 |
2013 |
| Drug |
glucovance (metformin hcl |
2 |
2002 |
| Drug |
glucovance (metformin hcl/glyburide) |
2 |
2002 |
| Drug |
glyburide) |
2 |
2002 |
| placebo |
gsk1292263 matching placebo |
2 |
2009 |
| Drug |
gsk1362885 |
2 |
2009 |
| Drug |
gsk1614235 |
2 |
2009 |
| Drug |
gsk189075 oral tablets |
2 |
2006 |
| Drug |
gsk376501 |
2 |
2008 |
| Drug |
gsk716155 subcutaneous injections |
2 |
2006 |
| Drug |
gwp42004 |
2 |
2014 |
| Dietary Supplement |
gynostemma pentaphyllum tea |
2 |
2008 |
| Behavioral |
helpline |
2 |
2015 |
| Behavioral |
helpline/a1c results |
2 |
2015 |
| Other |
high fiber |
2 |
2009 |
| Dietary Supplement |
high gi diet |
2 |
2009 |
| Drug |
high metformin |
2 |
2015 |
| Device |
hot |
2 |
2008 |
| Drug |
humalog mix25 |
2 |
2019 |
| Drug |
humalogâ® |
2 |
2015 |
| Drug |
human insulin 30 |
2 |
2007 |
| Drug |
human insulin 30/70 |
2 |
2007 |
| Drug |
hydrochlorothiazide 25 mg |
2 |
2017 |
| Dietary Supplement |
hydrolyzed pine nut oil |
2 |
2017 |
| Behavioral |
hypercaloric diet |
2 |
2015 |
| Procedure |
hyperglycemic clamp |
2 |
2018 |
| Other |
hypoglycaemic clamp |
2 |
2016 |
| Device |
hypoglycemic clamp |
2 |
2012 |
| Drug |
imeglimin |
2 |
2013 |
| Behavioral |
inactivity |
2 |
2014 |
| Behavioral |
information control |
2 |
2017 |
| Drug |
inhaled human insulin |
2 |
2019 |
| Drug |
insulin 338 (gipet i) |
2 |
2015 |
| Drug |
insulin glargine (lantus) |
2 |
2006 |
| Drug |
insulin glargine (u100) |
2 |
2016 |
| Drug |
insulin glargine u100 |
2 |
2019 |
| Drug |
insulin glargine/lixisenatide fixed ratio combination |
2 |
2016 |
| Drug |
insulin glulisine (hmr1964) |
2 |
2018 |
| Drug |
insulin therapy |
2 |
2015 |
| Behavioral |
intensive lifestyle intervention |
2 |
2009 |
| Behavioral |
intensive lifestyle modification |
2 |
2016 |
| Behavioral |
intensive medical management |
2 |
2009 |
| Behavioral |
intermittent fasting |
2 |
2019 |
| Drug |
intermittent insulin therapy |
2 |
2012 |
| Behavioral |
internet co-management module |
2 |
2005 |
| Behavioral |
internet intervention |
2 |
2008 |
| Behavioral |
interval walking |
2 |
2014 |
| Drug |
intranasal insulin |
2 |
2010 |
| Drug |
iohexol inj 300 mg |
2 |
2018 |
| Drug |
iohexol inj 300 mg/ml |
2 |
2018 |
| Drug |
isophane human insulin |
2 |
2012 |
| Drug |
isotonic saline |
2 |
2015 |
| placebo |
itca placebo |
2 |
2011 |
| Drug |
iw-1973 |
2 |
2016 |
| Drug |
januvia tab. 100mg |
2 |
2016 |
| Drug |
jnj-38431055 |
2 |
2009 |
| Drug |
kad-1229 |
2 |
2011 |
| Procedure |
laparoscopic adjustable gastric banding |
2 |
2010 |
| Procedure |
laparoscopic roux-en-y gastric bypass |
2 |
2017 |
| Drug |
laropiprant |
2 |
2014 |
| Drug |
lc15-0444 50mg qd |
2 |
2012 |
| Dietary Supplement |
legumes |
2 |
2013 |
| Drug |
lgd-6972 |
2 |
2013 |
| Behavioral |
lifestyle program |
2 |
2004 |
| Drug |
lik066 |
2 |
2013 |
| Drug |
linagliptin low dose |
2 |
2009 |
| placebo |
liraglutide - placebo |
2 |
2012 |
| Drug |
lisinopril |
2 |
2011 |
| Drug |
lispro insulin |
2 |
2009 |
| Drug |
lobeglitazone |
2 |
2015 |
| Other |
low glycemic index diet |
2 |
2007 |
| Drug |
low metformin |
2 |
2015 |
| Drug |
lx4211 |
2 |
2011 |
| Drug |
ly2405319 |
2 |
2013 |
| Drug |
ly2428757 |
2 |
2009 |
| Drug |
ly2922470 |
2 |
2013 |
| Drug |
m |
2 |
2014 |
| placebo |
matching placebo to glimepiride |
2 |
2012 |
| placebo |
matching placebo to pioglitazone |
2 |
2007 |
| Other |
meal replacement |
2 |
2017 |
| Drug |
meglitinides |
2 |
2016 |
| Biological |
mesenchymal precursor cells (mpcs) |
2 |
2012 |
| Other |
metabolic surgery |
2 |
2017 |
| Drug |
metformin 500mg |
2 |
2012 |
| Drug |
metformin fixed combination |
2 |
2009 |
| Drug |
metformin glycinate |
2 |
2014 |
| Drug |
metformin tablets |
2 |
2006 |
| Drug |
metformin treatment |
2 |
2017 |
| Drug |
metformin/sitagliptin |
2 |
2013 |
| Drug |
metronidazole |
2 |
2017 |
| Drug |
mid metformin |
2 |
2015 |
| Behavioral |
mindfulness |
2 |
2017 |
| Behavioral |
mindfulness based stress reduction |
2 |
2019 |
| Drug |
mk-0431 |
2 |
2009 |
| Drug |
mk-0431/ono-5435 |
2 |
2009 |
| Drug |
mk-0893 |
2 |
2013 |
| Drug |
mk-8521 |
2 |
2014 |
| Drug |
mk0431, sitagliptin phosphate |
2 |
2007 |
| Drug |
mk0653a, ezetimibe ( |
2 |
2007 |
| Drug |
mkc253 inhalation powder |
2 |
2008 |
| Drug |
mlr-1023 |
2 |
2014 |
| Drug |
monorova |
2 |
2018 |
| Drug |
mp-513 |
2 |
2010 |
| Drug |
n-acetylcysteine |
2 |
2011 |
| Drug |
neutral protamine hagedorn insulin |
2 |
2017 |
| Drug |
niacin |
2 |
2019 |
| Procedure |
non-surgical periodontal therapy |
2 |
2014 |
| Procedure |
nonsurgical periodontal treatment |
2 |
2015 |
| Drug |
novomix 30 |
2 |
2020 |
| Drug |
novorapid |
2 |
2017 |
| Drug |
nox-e36 |
2 |
2010 |
| Behavioral |
occupational therapy |
2 |
2018 |
| Drug |
one drop | premium |
2 |
2017 |
| Drug |
ono-5129 |
2 |
2006 |
| Drug |
ono-5435 |
2 |
2009 |
| Drug |
open-label metformin |
2 |
2013 |
| Drug |
oral anti-diabetic drugs |
2 |
2016 |
| Other |
oral nutrition supplement |
2 |
2020 |
| Drug |
orlistat |
2 |
2013 |
| Behavioral |
paleolithic diet |
2 |
2007 |
| Procedure |
panretinal photocoagulation (prp) |
2 |
2020 |
| Drug |
pe0139 injection |
2 |
2013 |
| Drug |
perindopril-indapamide |
2 |
2018 |
| Drug |
pf-00734200 20 mg qd |
2 |
2008 |
| Drug |
pf-04937319 |
2 |
2010 |
| Drug |
pf-05175157/placebo |
2 |
2011 |
| Drug |
pf-05190457 |
2 |
2011 |
| Drug |
pf-05231023 |
2 |
2011 |
| Behavioral |
pharmaceutical care |
2 |
2016 |
| Behavioral |
pharmacist counseling |
2 |
2011 |
| Behavioral |
physical activity program |
2 |
2018 |
| Behavioral |
physiotherapy |
2 |
2010 |
| Drug |
pioglitazone hcl |
2 |
2008 |
| Drug |
pioglitazone/glimepiride |
2 |
2007 |
| Drug |
pl2200 aspirin capsules |
2 |
2013 |
| placebo |
placebo (sitagliptin) |
2 |
2019 |
| placebo |
placebo capsule |
2 |
2009 |
| placebo |
placebo for bexagliflozin |
2 |
2017 |
| placebo |
placebo for dapagliflozin |
2 |
2016 |
| placebo |
placebo for glimepiride |
2 |
2016 |
| placebo |
placebo gel |
2 |
2015 |
| placebo |
placebo infusion |
2 |
2017 |
| placebo |
placebo injection |
2 |
2015 |
| placebo |
placebo matching dapagliflozin |
2 |
2010 |
| placebo |
placebo matching saxagliptin |
2 |
2009 |
| placebo |
placebo of vildagliptin |
2 |
2009 |
| placebo |
placebo sitagliptin |
2 |
2009 |
| placebo |
placebo tablets |
2 |
2005 |
| placebo |
placebo tea |
2 |
2008 |
| placebo |
placebo to alogliptin |
2 |
2011 |
| placebo |
placebo to bi 135585 |
2 |
2010 |
| placebo |
placebo to glargine |
2 |
2017 |
| placebo |
placebo to glipizide |
2 |
2012 |
| placebo |
placebo treatment |
2 |
2017 |
| Drug |
placebo/metformin |
2 |
2009 |
| Drug |
placebo/placebo |
2 |
2016 |
| placebo |
placebo; oral |
2 |
2009 |
| Dietary Supplement |
plain yogurt drink |
2 |
2010 |
| Drug |
pn2034 |
2 |
2005 |
| Dietary Supplement |
pomegranate juice |
2 |
2015 |
| Behavioral |
positive psychology / motivational interviewing |
2 |
2017 |
| Drug |
premixed insulin |
2 |
2010 |
| Drug |
probenecid |
2 |
2018 |
| Dietary Supplement |
probiotics |
2 |
2013 |
| Other |
progressive resistance training |
2 |
2009 |
| Drug |
ras-antagonist |
2 |
2016 |
| Other |
raw corn starch |
2 |
2018 |
| Behavioral |
reach |
2 |
2015 |
| Behavioral |
reach / fams |
2 |
2015 |
| Other |
refined olive oil |
2 |
2019 |
| Procedure |
renal biopsy |
2 |
2018 |
| Drug |
rex-001 |
2 |
2017 |
| Drug |
ro5095932 |
2 |
2009 |
| Drug |
roflumilast |
2 |
2010 |
| Drug |
rosuvamibe |
2 |
2018 |
| Drug |
routine care |
2 |
2010 |
| Procedure |
roux-en-y gastric bypass (rygb) |
2 |
2014 |
| Drug |
ruboxistaurin mesylate |
2 |
2002 |
| Drug |
saline infusion |
2 |
2018 |
| Device |
scaling/root planing |
2 |
2014 |
| Drug |
semaglutide (administered by dv3396 pen) |
2 |
2019 |
| Drug |
semaglutide (administered by pds290 pen) |
2 |
2019 |
| Drug |
semaglutide 0.5 mg |
2 |
2017 |
| Drug |
semaglutide 1.0 mg |
2 |
2017 |
| Drug |
semaglutide, 0.5 mg |
2 |
2018 |
| Drug |
semaglutide, 1.0 mg |
2 |
2018 |
| Drug |
sevelamer |
2 |
2015 |
| Other |
sham |
2 |
2017 |
| Behavioral |
shared decision making |
2 |
2014 |
| Drug |
simvastatin 20 mg |
2 |
2007 |
| Device |
smbg group |
2 |
2010 |
| Behavioral |
smoking cessation |
2 |
2005 |
| Drug |
standard-of-care treatment |
2 |
2019 |
| Other |
standardized living protocol |
2 |
2014 |
| Drug |
statin (simvastatin) |
2 |
2007 |
| Behavioral |
strength training/nutrition |
2 |
2011 |
| Dietary Supplement |
sucrose |
2 |
2019 |
| Drug |
sulfonylureas (su) |
2 |
2011 |
| Procedure |
surgery |
2 |
2011 |
| Drug |
ta-7284-high |
2 |
2009 |
| Drug |
ta-7284-low |
2 |
2009 |
| Drug |
ta-7284 high |
2 |
2011 |
| Drug |
ta-7284 low |
2 |
2011 |
| Drug |
tadalafil |
2 |
2013 |
| placebo |
technosphere placebo |
2 |
2007 |
| Behavioral |
telemedical coaching |
2 |
2018 |
| Drug |
teneli |
2 |
2009 |
| Drug |
teneligliptin 20 mg |
2 |
2009 |
| Drug |
teneligliptin 20mg |
2 |
2016 |
| Drug |
testosterone |
2 |
2012 |
| Behavioral |
text messages |
2 |
2018 |
| Drug |
thiazolidinediones |
2 |
2016 |
| placebo |
ticagrelor placebo |
2 |
2014 |
| Behavioral |
training |
2 |
2017 |
| Behavioral |
treatment as usual |
2 |
2018 |
| Behavioral |
trf |
2 |
2018 |
| Drug |
tzd |
2 |
2013 |
| Behavioral |
vedic medicine |
2 |
2003 |
| Procedure |
vertical sleeve gastrectomy |
2 |
2012 |
| Drug |
vi-0521 |
2 |
2007 |
| Drug |
victozaâ® |
2 |
2012 |
| Drug |
vildagliptin (laf237) |
2 |
2013 |
| Dietary Supplement |
vinegar |
2 |
2014 |
| Behavioral |
water |
2 |
2018 |
| Other |
wb-011 |
2 |
2019 |
| Dietary Supplement |
wheat bran |
2 |
2012 |
| Dietary Supplement |
wheat flour |
2 |
2018 |
| Dietary Supplement |
whey |
2 |
2011 |
| Dietary Supplement |
white rice |
2 |
2018 |
| Drug |
xenin-25 |
2 |
2009 |
| Dietary Supplement |
yellow pea fiber |
2 |
2010 |
| Dietary Supplement |
yellow pea protein |
2 |
2010 |
| Behavioral |
yoga |
2 |
2015 |
| Behavioral |
’diabetes education |
1 |
2006 |
| Behavioral |
‘diabetes education / management’ |
1 |
2006 |
| Behavioral |
’ohana (family) support lifestyle intervention |
1 |
2000 |
| Dietary Supplement |
- omegaven |
1 |
2009 |
| Drug |
- sulfonylurea] |
1 |
2016 |
| Drug |
“usual care” |
1 |
2010 |
| Other |
#1 nutritional ingredient |
1 |
2011 |
| Other |
#1 nutritional ingredient /fiber |
1 |
2011 |
| Other |
#2 nutritional ingredient |
1 |
2011 |
| Other |
#2 nutritional ingredient / fiber |
1 |
2011 |
| Other |
#3 nutritional ingredient |
1 |
2011 |
| Other |
#3 nutritional ingredient / fiber |
1 |
2011 |
| Drug |
) hydrochlorothiazide (hyzaar) |
1 |
2007 |
| Drug |
) laropiprant |
1 |
2008 |
| Drug |
[18f]fluorbetaox |
1 |
2012 |
| Drug |
[68ga] ga-do3a-vs-cys40-exendin-4 (glp-1 receptor tracer) |
1 |
2017 |
| Drug |
[68ga] ga-do3a-vs-cys40-tuna-2 (glucagon receptor tracer) |
1 |
2017 |
| Other |
[7,7,8,8-2h]-palmitate |
1 |
2016 |
| Drug |
0.1 mg gsk2330672 |
1 |
2011 |
| Drug |
0.25 units |
1 |
2009 |
| Drug |
0.25 units/kg daily insulin |
1 |
2009 |
| Drug |
0.3 mg gsk2330672 |
1 |
2011 |
| Drug |
0.5 units |
1 |
2009 |
| Drug |
0.5 units/kg daily insulin |
1 |
2009 |
| Drug |
0.5g srt2104 |
1 |
2009 |
| Drug |
0.9 % nacl |
1 |
2012 |
| Other |
0.9% saline solution |
1 |
2008 |
| Drug |
0.9% sodium chloride |
1 |
2011 |
| Drug |
1- insulin glargine qhs |
1 |
2008 |
| Dietary Supplement |
1 gram of white korean ginseng |
1 |
2012 |
| Drug |
1 mg gsk2330672 |
1 |
2011 |
| Drug |
1. berberine hydrochloride tablets ; 2. promets probiotics powder |
1 |
2016 |
| placebo |
1. berberine hydrochloride tablets; 2. probiotics placebo powder |
1 |
2016 |
| placebo |
1. berberine placebo tablets ; 2. promets probiotics powder |
1 |
2016 |
| placebo |
1. berberine placebo tablets; 2. probiotics placebo powder |
1 |
2016 |
| Drug |
1.5 mg |
1 |
2008 |
| Drug |
1.5 mg/2.0 mg cjc-1134-pc |
1 |
2008 |
| Behavioral |
10-week exercise programme based on aerobic interval |
1 |
2019 |
| Behavioral |
10-week exercise programme based on aerobic interval/resistance training |
1 |
2019 |
| Drug |
10 mg dapagliflozin |
1 |
2017 |
| Drug |
10 mg dapagliflozin / 1000 mg metformin xr tablet |
1 |
2017 |
| Drug |
10 mg gsk2330672 |
1 |
2011 |
| Drug |
10 mg mk-0941 dfc (fasted) |
1 |
2007 |
| Drug |
10 mg mk-0941 oct (after meal) |
1 |
2007 |
| Drug |
10 mg mk-0941 oct (before meal) |
1 |
2007 |
| Drug |
10 mg mk-0941 oct (fasted) |
1 |
2007 |
| Drug |
10 mg qd (n=22) |
1 |
2017 |
| Drug |
10% arginine hydrochloride-r-gene 10 |
1 |
2012 |
| Other |
10% protein) |
1 |
2015 |
| Drug |
100 mg pb1023 |
1 |
2012 |
| Drug |
100 mg pf-05231023 |
1 |
2012 |
| Drug |
100 mg sitagliptin |
1 |
2013 |
| Drug |
100 mg sp2086 |
1 |
2013 |
| Other |
100% probiotic |
1 |
2017 |
| Drug |
1000 mg (ttd) |
1 |
2006 |
| Drug |
1000 mg b.i.d. |
1 |
2005 |
| Drug |
1000 mg metformin |
1 |
2011 |
| Drug |
1000 mg metformin xr |
1 |
2017 |
| Drug |
1000 mg metformin xr fdc |
1 |
2017 |
| Drug |
1000 mg metformin xr fdc tablet |
1 |
2017 |
| Drug |
1000 mg metformin xr tablet |
1 |
2017 |
| Drug |
1000(metformin)mg 1t |
1 |
2015 |
| Other |
10004rf |
1 |
2011 |
| Drug |
1000mg |
1 |
2015 |
| Drug |
1000mg (diabex) |
1 |
2009 |
| Drug |
10mg atorvastatin |
1 |
2011 |
| Drug |
10mg atorvastatin fdc |
1 |
2011 |
| Drug |
10mg ds-8500a tablet |
1 |
2014 |
| Drug |
10mg tzp-102 |
1 |
2011 |
| Radiation |
111in-exendin 4 spect |
1 |
2015 |
| Radiation |
111in-exendin 4 spect/ct |
1 |
2015 |
| Other |
12-week resistance training |
1 |
2017 |
| Device |
12 lead holter |
1 |
2013 |
| Drug |
12.5 mg) |
1 |
2005 |
| Drug |
12.5mg) |
1 |
2005 |
| Device |
12.7mm x 29g pen needle |
1 |
2010 |
| Other |
1200 kcal diet |
1 |
2014 |
| Other |
123i-metaiodobenzylguanidine-single-photon emission computed tomography scan |
1 |
2014 |
| Behavioral |
12h fasting |
1 |
2019 |
| Dietary Supplement |
13c inulin |
1 |
2013 |
| Drug |
14^c-labeled ertugliflozin for iv use |
1 |
2015 |
| Drug |
14^c-labeled ertugliflozin for oral use |
1 |
2015 |
| Drug |
14c-microtracer |
1 |
2019 |
| Diagnostic Test |
15 breaths per minute |
1 |
2017 |
| Drug |
150 mg pf-05231023 |
1 |
2012 |
| Drug |
1500 mg (ttd) |
1 |
2006 |
| Other |
18f- fluorodeoxyglucose-positron emission tomography computed tomography scan |
1 |
2014 |
| Other |
18f- fluorodeoxyglucose-positron emission tomography computed tomography scan/123i-metaiodobenzylguanidine-single-photon emission computed tomography scan |
1 |
2014 |
| Drug |
18f-av-133 |
1 |
2012 |
| Radiation |
18f-fdg pet |
1 |
2015 |
| Radiation |
18f-fdg pet/ct |
1 |
2015 |
| Drug |
18f-mk6240 injection |
1 |
2017 |
| Other |
19 injections |
1 |
2012 |
| Drug |
1mg glimepiride |
1 |
2011 |
| Drug |
1mg glimepiride/10mg atorvastatin fdc |
1 |
2011 |
| Drug |
1mg glimepiride/20mg atorvastatin fdc |
1 |
2011 |
| Drug |
2 - insulin glargine qam |
1 |
2008 |
| Drug |
2 capsules of allopurinol 150 mg daily for 3 month |
1 |
2015 |
| Drug |
2 capsules of lactose daily for 3 month |
1 |
2015 |
| Diagnostic Test |
2 hour glucose tolerance test using 75g glucose drink |
1 |
2019 |
| Drug |
2 hours humulin r 100 iu |
1 |
2019 |
| Drug |
2 hours humulin r 100 iu/ml pit |
1 |
2019 |
| Drug |
2.0 mg cjc-1134-pc |
1 |
2008 |
| Drug |
2.5 mg onglyzaâ® (saxagliptin) tablet |
1 |
2017 |
| Drug |
2.5 mg saxagliptin |
1 |
2017 |
| Drug |
2.5 mg saxagliptin / 5 mg dapagliflozin / 1000 mg metformin xr fdc tablet |
1 |
2017 |
| Drug |
2.5 mg saxagliptin / 5 mg dapagliflozin / 850 mg metformin xr fdc tablet |
1 |
2017 |
| Drug |
2.5 mg saxagliptin tablet |
1 |
2017 |
| Dietary Supplement |
20 g whey protein |
1 |
2015 |
| Drug |
20% dextrose |
1 |
2016 |
| Drug |
200 mg lx4211 |
1 |
2011 |
| Drug |
200 mg sp2086 |
1 |
2013 |
| Drug |
2000 mg (ttd) |
1 |
2006 |
| Drug |
20mg atorvastatin |
1 |
2011 |
| Drug |
20mg atorvastatin fdc |
1 |
2011 |
| Drug |
20mg tzp-102 |
1 |
2011 |
| Procedure |
24-hour continuous glucose monitoring (at select sites) |
1 |
2005 |
| Other |
24-hour intervention with closed-loop strategy |
1 |
2015 |
| Other |
24-hour intervention with multiple daily injections |
1 |
2015 |
| Drug |
25 % insulin lispro injection |
1 |
2011 |
| Drug |
25 at 0.6 u |
1 |
2017 |
| Drug |
25 at 0.8 u |
1 |
2017 |
| Drug |
25 at 1.0 u |
1 |
2017 |
| Drug |
25 mg pf-04991532 |
1 |
2011 |
| Drug |
25 mg pf-05231023 |
1 |
2012 |
| Other |
25% reduction of basal insulin dose |
1 |
2017 |
| Drug |
25(oh) vitamin d |
1 |
2012 |
| Drug |
250 mg |
1 |
2013 |
| Drug |
250 mg srt2104 suspension |
1 |
2009 |
| Device |
28 g lancet |
1 |
2018 |
| Device |
28g |
1 |
2008 |
| Drug |
2mg |
1 |
2008 |
| Drug |
2mg glimepiride |
1 |
2011 |
| Drug |
2mg glimepiride/10mg atorvastatin fdc |
1 |
2011 |
| Drug |
2mg glimepiride/20mg atorvastatin fdc |
1 |
2011 |
| Drug |
2s, 4r ketoconazole (dio-902) |
1 |
2006 |
| Behavioral |
3-month exercise training |
1 |
2006 |
| Behavioral |
3-month exercise training/diet education |
1 |
2006 |
| Drug |
3 - nph insulin qhs |
1 |
2008 |
| Other |
3 day cho-free diet |
1 |
2011 |
| Other |
3 day fast |
1 |
2011 |
| Dietary Supplement |
3 grams of wheat bran control |
1 |
2012 |
| Dietary Supplement |
3 grams of white korean ginseng |
1 |
2012 |
| Drug |
3 hours humulin r 100 iu |
1 |
2019 |
| Drug |
3 hours humulin r 100 iu/ml pit |
1 |
2019 |
| Drug |
3 mg gsk2330672 |
1 |
2011 |
| Drug |
3) |
1 |
2006 |
| Other |
3:1 ratio ketogenic diet |
1 |
2018 |
| Device |
30 g lancet |
1 |
2018 |
| Drug |
30 mg gsk2330672 |
1 |
2011 |
| Behavioral |
30 minutes outdoors |
1 |
2018 |
| Other |
30% animal, 70% plant proteins in diet |
1 |
2017 |
| Drug |
30% insulin aspart injection (rdna origin) |
1 |
2006 |
| Drug |
300 mg lx4211 (150 mg tablets) |
1 |
2010 |
| Drug |
300 mg lx4211 (50 mg tablets) |
1 |
2010 |
| Drug |
300 mg lx4211 (liquid) |
1 |
2010 |
| Drug |
300 mg pf-04991532 |
1 |
2011 |
| Device |
33 g lancet |
1 |
2018 |
| Device |
33g |
1 |
2008 |
| Device |
33g lancets (relion) |
1 |
2020 |
| Behavioral |
36h fasting |
1 |
2019 |
| Drug |
3mg |
1 |
2008 |
| Drug |
3mg glimepiride |
1 |
2011 |
| Drug |
3mg glimepiride/10mg atorvastatin fdc |
1 |
2011 |
| Drug |
3mg glimepiride/20mg atorvastatin fdc |
1 |
2011 |
| Drug |
4 mg |
1 |
2008 |
| Device |
4 mm x 32g pen needle |
1 |
2010 |
| Drug |
450 mg pf-04991532 |
1 |
2011 |
| Behavioral |
47 min moderate intensity training |
1 |
2013 |
| Drug |
4mg glimepiride |
1 |
2011 |
| Drug |
4mg glimepiride/10mg atorvastatin fdc |
1 |
2011 |
| Drug |
4mg glimepiride/20mg atorvastatin fdc |
1 |
2011 |
| Device |
4mm x 32g pen needle |
1 |
2009 |
| Drug |
5-ala-sfc |
1 |
2015 |
| Other |
5-hour bedtime |
1 |
2008 |
| Drug |
5 mg |
1 |
2010 |
| Drug |
5 mg dapagliflozin / 1000 mg metformin xr fdc |
1 |
2017 |
| Drug |
5 mg dapagliflozin / 1000 mg metformin xr tablet |
1 |
2017 |
| Drug |
5 mg dapagliflozin / 850 mg metformin xr fdc |
1 |
2017 |
| Drug |
5 mg forxigaâ® (dapagliflozin) tablet |
1 |
2017 |
| Drug |
5 mg qd (n=22) |
1 |
2017 |
| Drug |
5 mg saxagliptin |
1 |
2017 |
| Other |
5.5-hour bedtime |
1 |
2008 |
| Drug |
50 |
1 |
2009 |
| Drug |
50 mg pb1023 |
1 |
2012 |
| Drug |
50 mg pf-05231023 |
1 |
2012 |
| Drug |
50 mg sp2086 |
1 |
2013 |
| Other |
50% animal, 50% plant proteins in diet |
1 |
2017 |
| Drug |
50% glargine dose on discharge |
1 |
2013 |
| Drug |
500 mg (ttd) |
1 |
2006 |
| Drug |
500 mg glucophage xrâ® |
1 |
2017 |
| Drug |
500 mg metformin |
1 |
2010 |
| Drug |
500 mg tablet |
1 |
2010 |
| Drug |
500mg |
1 |
2016 |
| Dietary Supplement |
500mg of korean red ginseng |
1 |
2012 |
| Drug |
500mg, astrazeneca) |
1 |
2019 |
| Device |
5mm x 31g pen needle |
1 |
2009 |
| Behavioral |
6-week online diabetes self-management educational program |
1 |
2006 |
| Dietary Supplement |
6 grams of white korean ginseng |
1 |
2012 |
| Behavioral |
6 meals |
1 |
2011 |
| Behavioral |
6 meals/day followed by 2 meals/day |
1 |
2011 |
| Drug |
60 mcg |
1 |
2015 |
| Drug |
60 mg gsk2330672 |
1 |
2011 |
| Device |
640g insulin pump |
1 |
2014 |
| Radiation |
68ga-nodaga-exendin-4 pet |
1 |
2017 |
| Radiation |
68ga-nodaga-exendin-4 pet/ct |
1 |
2017 |
| Drug |
70 mg pb1023 |
1 |
2012 |
| Other |
70% animal, 30% plant proteins in diet |
1 |
2017 |
| Drug |
70% insulin aspart protamine suspension |
1 |
2006 |
| Drug |
70% insulin aspart protamine suspension/30% insulin aspart injection (rdna origin) |
1 |
2006 |
| Drug |
75 mg lx4211 |
1 |
2011 |
| Drug |
75 mg pf-04991532 |
1 |
2011 |
| Drug |
75% insulin lispro protamine suspension |
1 |
2011 |
| Drug |
75% insulin lispro protamine suspension/25 % insulin lispro injection |
1 |
2011 |
| Drug |
750 mg pf-04991532 |
1 |
2011 |
| Drug |
750mg |
1 |
2015 |
| Other |
75g glucose beverage (glucola, trutol, |
1 |
2019 |
| Other |
75g glucose beverage (glucola, trutol,/similar brand) |
1 |
2019 |
| Drug |
75mg ds-8500a tablet |
1 |
2014 |
| Procedure |
8-point glucose diary (to assess pre- |
1 |
2005 |
| Procedure |
8-point glucose diary (to assess pre-/post prandial glucoses) |
1 |
2005 |
| Behavioral |
8 weeks individualized training program |
1 |
2005 |
| Other |
8.5-hour bedtime |
1 |
2008 |
| Other |
8.5-hour bedtimes |
1 |
2008 |
| Drug |
80% glargine |
1 |
2013 |
| Drug |
850 mg metformin |
1 |
2010 |
| Drug |
850 mg metformin xr fdc |
1 |
2017 |
| Drug |
850 mg metformin xr fdc tablet |
1 |
2017 |
| Drug |
850 mg tablet |
1 |
2010 |
| Dietary Supplement |
a |
1 |
2006 |
| Behavioral |
a 12-week moderate-intensity exercise training |
1 |
2017 |
| Behavioral |
a canola oil enriched mediterranean diet |
1 |
2014 |
| Behavioral |
a chinese menu plan for type 2 diabetes |
1 |
2014 |
| Behavioral |
a high wheat fiber diet |
1 |
2014 |
| Other |
a mail letter, a phone call |
1 |
2019 |
| Other |
a mail letter, a phone call/a phone call/mailed letter |
1 |
2019 |
| Other |
a meal (730kcal, 50%carbohydrate, of which 38% was starch, 40% fat, |
1 |
2015 |
| Other |
a meal (730kcal, 50%carbohydrate, of which 38% was starch, 40% fat,/10% protein) |
1 |
2015 |
| Other |
a phone call |
1 |
2019 |
| Dietary Supplement |
a staple food of comparable energy containing a small amount of dietary fiber |
1 |
2019 |
| Dietary Supplement |
a staple food of comparable energy containing a small amount of dietary fiber/with a comparable energy maltodextrin / lifestyle guidance |
1 |
2019 |
| Drug |
a statin |
1 |
2012 |
| Device |
a videotelephone, tandberg e20, |
1 |
2014 |
| Behavioral |
a ymca wellness coach |
1 |
2014 |
| Drug |
a: bi 10773 |
1 |
2010 |
| Drug |
a: bi 10773 / metformin tablet |
1 |
2010 |
| Device |
abbott sensor based glucose monitoring system |
1 |
2014 |
| Procedure |
abdominal fat biopsy |
1 |
2019 |
| Procedure |
abdominal subcutaneous biopsies |
1 |
2017 |
| Procedure |
abdominal subcutaneous biopsies/blood test |
1 |
2017 |
| Procedure |
abdominal surgery |
1 |
2011 |
| Device |
abo-glyc |
1 |
2018 |
| placebo |
abo-glyc placebo |
1 |
2018 |
| Behavioral |
aboriginal youth mentorship program |
1 |
2013 |
| Drug |
abt-614 |
1 |
2011 |
| Drug |
ac-201, 25mg |
1 |
2011 |
| Drug |
ac-201, 50mg |
1 |
2011 |
| Drug |
ac-201, 75mg |
1 |
2011 |
| Drug |
ac2993 10.0 mcg |
1 |
2002 |
| Drug |
ac2993 2.5 mcg |
1 |
2002 |
| Drug |
ac2993 5.0 mcg |
1 |
2002 |
| Drug |
ac2993 7.5 mcg |
1 |
2002 |
| Drug |
acarbose / vildagliptin |
1 |
2009 |
| Drug |
acarbose 50 mg |
1 |
2009 |
| Drug |
acarbose/metformin fdc (bay81-9783) |
1 |
2012 |
| Drug |
acarbose/metformin fdc(bay81-9783) |
1 |
2019 |
| Device |
acc |
1 |
2008 |
| Device |
acc/28g |
1 |
2008 |
| Behavioral |
acceptance |
1 |
2011 |
| Behavioral |
acceptance/commitment therapy |
1 |
2011 |
| Behavioral |
access to online patient portal |
1 |
2005 |
| Other |
access to the online portal |
1 |
2018 |
| Device |
accu-chek 360â° view blood glucose analysis tool |
1 |
2008 |
| Device |
accu-chek aviva glucose meter |
1 |
2008 |
| Device |
accu-chek aviva meter |
1 |
2008 |
| Device |
accu-chek flexlink |
1 |
2014 |
| Device |
accu-chek flexlink plus |
1 |
2014 |
| Device |
accu-chek integra glucometer |
1 |
2010 |
| Device |
accu-chek softclix lancing device (roche) |
1 |
2020 |
| Device |
accu-chekâ® insight insulin pump |
1 |
2014 |
| Behavioral |
accumulated exercise |
1 |
2015 |
| Drug |
ace inhibitors, angiotensin receptor blockers, beta blockers, calcium channel blockers |
1 |
2000 |
| Drug |
acetaminophen (paracetamol) |
1 |
2014 |
| Other |
acetate |
1 |
2013 |
| Other |
acetate/placebo infusion |
1 |
2013 |
| Drug |
acetyl-l-carnitine |
1 |
2009 |
| Drug |
acetyl-l-carnitine/statin (simvastatin) |
1 |
2009 |
| Drug |
acetylsalicylic acid |
1 |
2017 |
| Behavioral |
achievement |
1 |
2015 |
| Other |
action plans |
1 |
2009 |
| Behavioral |
activate (idea) |
1 |
2008 |
| Device |
active cpap therapy |
1 |
2010 |
| Device |
active extracorporeal shock wave |
1 |
2020 |
| Other |
active joint range-of-motion exercises |
1 |
2019 |
| Other |
active joint range-of-motion exercises/isometric contraction exercises |
1 |
2019 |
| Other |
active product |
1 |
2019 |
| Device |
active stress handling |
1 |
2018 |
| Behavioral |
active titration algorithm |
1 |
2011 |
| Behavioral |
activities education program (leap-ahead) |
1 |
2008 |
| Other |
activity |
1 |
2014 |
| Other |
activity monitor |
1 |
2018 |
| Drug |
actrapid |
1 |
2007 |
| Drug |
actrapid insulin |
1 |
2010 |
| Drug |
actrapid insulin/gloucose |
1 |
2010 |
| Procedure |
acupuncture |
1 |
2019 |
| Behavioral |
acute aerobic-resistance exercise |
1 |
2009 |
| Behavioral |
acute aerobic exercise |
1 |
2009 |
| Behavioral |
acute dietary protocols |
1 |
2020 |
| Behavioral |
acute dietary protocols/lifestyle modification |
1 |
2020 |
| Other |
acute exercise |
1 |
2018 |
| Other |
acute in vivo induced hyperinsulinemia |
1 |
2013 |
| Device |
acute muscle exercise by nmes |
1 |
2015 |
| Drug |
acz885 |
1 |
2009 |
| Dietary Supplement |
ad lib diet |
1 |
2009 |
| Behavioral |
ad libitum health diet |
1 |
2013 |
| Other |
ada- based diet |
1 |
2018 |
| Other |
ada ( american diabetes association) recommended diet |
1 |
2007 |
| Dietary Supplement |
ada diet |
1 |
2017 |
| Drug |
add glimepiride |
1 |
2010 |
| Drug |
add vildagliptin |
1 |
2010 |
| Other |
additional support by chw |
1 |
2008 |
| Behavioral |
address other drug related problems |
1 |
2019 |
| Drug |
adenosine |
1 |
2009 |
| Behavioral |
adherence |
1 |
2019 |
| Behavioral |
adherence counseling |
1 |
2017 |
| Behavioral |
adherence intervention |
1 |
2010 |
| Drug |
administration of sitagliptin |
1 |
2007 |
| Other |
adoption of a vegan diet |
1 |
2017 |
| Other |
adr-1 |
1 |
2014 |
| Other |
adult enteral formula |
1 |
2007 |
| Behavioral |
advise |
1 |
2015 |
| Dietary Supplement |
adzuki bean |
1 |
2016 |
| Behavioral |
aerobic |
1 |
2005 |
| Other |
aerobic exercise group |
1 |
2019 |
| Behavioral |
aerobic exercise/strength exercise |
1 |
2006 |
| Other |
aerobic exercises according to circadian rhythym |
1 |
2020 |
| Behavioral |
aerobic/resistance exercise |
1 |
2005 |
| Drug |
afrezza |
1 |
2017 |
| Drug |
afrezza/one drop | premium |
1 |
2017 |
| Other |
age measurement |
1 |
2016 |
| Dietary Supplement |
aged garlic extract (age) |
1 |
2019 |
| Drug |
agiocur pregranules |
1 |
2018 |
| Drug |
albiglutide (gsk716155)/exenatide |
1 |
2007 |
| Biological |
albiglutide / insulin glargine |
1 |
2009 |
| Biological |
albiglutide 30 mg |
1 |
2015 |
| Drug |
albiglutide 30 mg weekly |
1 |
2012 |
| Drug |
albiglutide 50 mg weekly |
1 |
2012 |
| placebo |
albiglutide liquid auto-injector matching placebo |
1 |
2016 |
| Drug |
albiglutide lyophilized dcc pen injector |
1 |
2016 |
| placebo |
albiglutide matching placebo |
1 |
2015 |
| Biological |
albiglutide uptitration |
1 |
2009 |
| Drug |
alcohol |
1 |
2005 |
| Other |
alcohol consumption |
1 |
2012 |
| Behavioral |
alcohol: 25 gday (white wine) |
1 |
2006 |
| Drug |
aleglitazar/metformin |
1 |
2012 |
| Dietary Supplement |
alginate beverage |
1 |
2010 |
| Other |
algorithm-based diet |
1 |
2018 |
| Drug |
alirocumab |
1 |
2017 |
| Procedure |
allergy tests |
1 |
2011 |
| Drug |
allisartan isoproxil |
1 |
2017 |
| placebo |
allisartan isoproxil placebo |
1 |
2017 |
| Drug |
allopurinol |
1 |
2018 |
| Dietary Supplement |
almased |
1 |
2012 |
| Dietary Supplement |
almased meal replacement powder |
1 |
2012 |
| Dietary Supplement |
almond |
1 |
2014 |
| Other |
almond butter |
1 |
2019 |
| Other |
almond diet first, then ncep diet |
1 |
2012 |
| Dietary Supplement |
almonds |
1 |
2010 |
| Drug |
aloe vera |
1 |
2015 |
| Drug |
alogliptin / pioglitazone |
1 |
2014 |
| Drug |
alogliptin benzoate |
1 |
2016 |
| Drug |
alpha-gi |
1 |
2013 |
| Drug |
alpha-glucosidase inhibitor (a-gi) |
1 |
2011 |
| Behavioral |
alpha-methyl-4-deoxy-4-[(18)f]fluoro-d-glucopyranoside |
1 |
2018 |
| Drug |
alpha glucosidase inhibitor |
1 |
2010 |
| Drug |
alpha lipoic acid |
1 |
2007 |
| Dietary Supplement |
alphalact-albumin |
1 |
2009 |
| Drug |
amantadine |
1 |
2011 |
| Behavioral |
american diabetes association diet |
1 |
2012 |
| Other |
american diabetes association guidelines |
1 |
2012 |
| Dietary Supplement |
american ginseng |
1 |
2016 |
| Drug |
amiloride |
1 |
2014 |
| Dietary Supplement |
amino acid |
1 |
2014 |
| Dietary Supplement |
amino acid/chromium-picolinate containing drink |
1 |
2014 |
| Drug |
amlodiopine |
1 |
2011 |
| Drug |
amlodipine 5mg |
1 |
2017 |
| placebo |
amlodipine placebo |
1 |
2017 |
| Drug |
amlodipine, hydralazine, terazosin |
1 |
2014 |
| Drug |
amlodipine, hydralazine, terazosin/hydrochlorothiazide |
1 |
2014 |
| Drug |
anakinra prefilled syringe |
1 |
2020 |
| Biological |
analysis of arterial compliance |
1 |
2018 |
| Biological |
analysis of vasomotor endothelial function |
1 |
2018 |
| Other |
analysis telomere |
1 |
2012 |
| Behavioral |
ancillary therapy |
1 |
2007 |
| Drug |
androgel (testosterone gel) |
1 |
2005 |
| Drug |
androxal |
1 |
2010 |
| Procedure |
angiographic transplantation of stem cells |
1 |
2008 |
| Procedure |
angioplasty, transluminal, percutaneous coronary, other catheter-based interventions |
1 |
2000 |
| Behavioral |
anti-diabetic drugs |
1 |
2009 |
| Behavioral |
anti-diabetic drugs/behavioral suggestions |
1 |
2009 |
| Drug |
anti-diabetic medications |
1 |
2006 |
| Drug |
anti-diabetics |
1 |
2019 |
| Drug |
anti-hyperglycemic agents |
1 |
1999 |
| Drug |
anti-hypertensive agents |
1 |
1999 |
| Dietary Supplement |
anti-oxidant |
1 |
2012 |
| Dietary Supplement |
anti-oxidant/micronutrient |
1 |
2012 |
| Drug |
antidiabetic background therapy |
1 |
2013 |
| Dietary Supplement |
antidiabetic herbal tea |
1 |
2019 |
| Drug |
antihyperglycemic agent(s) |
1 |
2010 |
| Drug |
antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ed using metformin, sulfonylurea and |
1 |
2009 |
| Drug |
antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ed using metformin, sulfonylurea and/or insulin |
1 |
2009 |
| Drug |
any angiotensin receptor blockers |
1 |
2011 |
| Drug |
apdt |
1 |
2011 |
| Drug |
apdt / doxycycline placebo |
1 |
2011 |
| Drug |
apidra (insulin glulisine) |
1 |
2009 |
| Drug |
apidraâ® [insulin glulisine]) |
1 |
2007 |
| Behavioral |
app-technology for healthy eating habits |
1 |
2018 |
| Behavioral |
app-technology to increase physical activity |
1 |
2017 |
| Behavioral |
apple watch |
1 |
2016 |
| Other |
appropriate drug use |
1 |
2012 |
| Drug |
aprepitant |
1 |
2014 |
| Other |
aquatic exercise |
1 |
2013 |
| Drug |
ar-c165395xx |
1 |
2015 |
| Behavioral |
art therapy - pre |
1 |
2016 |
| Behavioral |
art therapy - pre/post test measures |
1 |
2016 |
| Biological |
arterial pressure measurement |
1 |
2018 |
| Device |
artificial saliva spray (as) |
1 |
2018 |
| Drug |
ascorbic acid (vitamin c) |
1 |
2008 |
| Behavioral |
asmart |
1 |
2012 |
| Drug |
aspart 30 |
1 |
2015 |
| Drug |
aspart insulin |
1 |
2017 |
| Drug |
aspart insulin before meals |
1 |
2007 |
| Drug |
aspart insulin/lipro insulin |
1 |
2017 |
| placebo |
aspirin placebo |
1 |
2014 |
| Device |
assessment of burden of chronic conditions (abcc)-tool |
1 |
2019 |
| Behavioral |
assessment of physiological stress |
1 |
2018 |
| Behavioral |
assessment of physiological stress/sleep pattern |
1 |
2018 |
| Behavioral |
assignment of a lay patient partner |
1 |
2009 |
| Other |
associated comorbidities in primary care |
1 |
2019 |
| Other |
at stable dose |
1 |
2016 |
| Drug |
atazanavir |
1 |
2008 |
| Drug |
atazanavir / placebo |
1 |
2008 |
| Drug |
atenolol |
1 |
2007 |
| Drug |
atl-962 |
1 |
2005 |
| Drug |
atorvastatin (atrostatâ®, delta pharmaceutical industries, cairo, egypt) tablets. |
1 |
2018 |
| Drug |
atorvastatin/omega-3 fatty acids |
1 |
2005 |
| Behavioral |
attention-meetings (ag) |
1 |
2016 |
| Behavioral |
attention control |
1 |
2005 |
| Behavioral |
audio brochure |
1 |
2014 |
| Behavioral |
augmented diabetes patient education |
1 |
2009 |
| Biological |
autologous adipose-derived mesenchymal stem |
1 |
2019 |
| Biological |
autologous adipose-derived mesenchymal stem/stromal cells (msc) higher dose |
1 |
2019 |
| Biological |
autologous adipose-derived mesenchymal stem/stromal cells (msc) lower dose |
1 |
2019 |
| Biological |
autologous stem cells |
1 |
2013 |
| Device |
automated bolus calculator |
1 |
2016 |
| Behavioral |
automated telephone intervention vs. usual care |
1 |
2008 |
| Drug |
automatic system guided treatment |
1 |
2018 |
| Drug |
avandamet 2 mg |
1 |
2006 |
| Drug |
avandamet 2 mg/500 mg (ttd) |
1 |
2006 |
| Drug |
avandamet 4 mg |
1 |
2006 |
| Drug |
avandamet 4 mg/1000 mg (ttd) |
1 |
2006 |
| Drug |
avandamet 6 mg |
1 |
2006 |
| Drug |
avandamet 6 mg/1500 mg (ttd) |
1 |
2006 |
| Drug |
avandamet 8 mg |
1 |
2006 |
| Drug |
avandamet 8 mg/ 2000 mg (ttd) |
1 |
2006 |
| Drug |
avandia |
1 |
2005 |
| Drug |
avandia/amaryl |
1 |
2005 |
| Drug |
ave2268 |
1 |
2006 |
| Device |
aviva expert blood glucose meter |
1 |
2011 |
| Device |
aviva nano blood glucose meter |
1 |
2011 |
| Drug |
azd1722 |
1 |
2013 |
| Drug |
azd5658 |
1 |
2010 |
| Drug |
azd6370 |
1 |
2008 |
| Drug |
azd7687 |
1 |
2010 |
| Drug |
azd8329 |
1 |
2010 |
| Drug |
azd8601 |
1 |
2016 |
| Drug |
azd8601/placebo |
1 |
2016 |
| Drug |
azd8601/placebo (sad) |
1 |
2016 |
| Drug |
azd9668 |
1 |
2015 |
| Drug |
azilsartan |
1 |
2014 |
| Drug |
azilsartan medoxomil |
1 |
2015 |
| Dietary Supplement |
b |
1 |
2006 |
| Drug |
b - exenatide 10 mcg twice daily |
1 |
2004 |
| Drug |
b: bi 10773 tablet |
1 |
2010 |
| Drug |
b: bi 10773 tablet/metformin tablet |
1 |
2010 |
| Biological |
background insulin |
1 |
2013 |
| Drug |
background therapy: oral anti-diabetic drug (metformin, pioglitazone, sglt2 inhibitor) |
1 |
2016 |
| Other |
bagueutte cheese gourmet (crocodille) |
1 |
2012 |
| Other |
bake beans in tomato sauce, low gi |
1 |
2019 |
| Other |
bake beans in tomato sauce, reduced sugar |
1 |
2019 |
| Drug |
baker’s yeast (bio chromium) |
1 |
2005 |
| Drug |
balaglitazone |
1 |
2007 |
| Other |
barberry juice |
1 |
2017 |
| Drug |
bardoxolone methyl (amorphous dispersion) |
1 |
2010 |
| Drug |
bardoxolone methyl (rta 402) |
1 |
2008 |
| Procedure |
bariatric surgery, either gastric bypass surgery |
1 |
2012 |
| Procedure |
bariatric surgery, either gastric bypass surgery/sleeve gastrectomy |
1 |
2012 |
| Procedure |
bariatric surgery: bilio-pancreatic diversion |
1 |
2009 |
| Procedure |
bariatric surgery: gastric bypass |
1 |
2009 |
| Drug |
basal insulin (lantusâ® [insulin glargine], |
1 |
2007 |
| Drug |
basal insulin (lantusâ® [insulin glargine],/levemirâ® [insulin detemir]) |
1 |
2007 |
| Drug |
basal insulin analog |
1 |
2017 |
| Drug |
basal insulin basaglar |
1 |
2018 |
| Drug |
basal insulin basaglar/lantus / gliclazide mr |
1 |
2018 |
| Drug |
basal insulin glargine |
1 |
2018 |
| Drug |
basal insulin glargine/lixisenatide |
1 |
2018 |
| Drug |
basal insulin only |
1 |
2014 |
| Device |
basal insulin titration application |
1 |
2017 |
| Drug |
basal insulin/bolus insulin |
1 |
2014 |
| Drug |
basal insulin/exenatide |
1 |
2014 |
| Drug |
basal plus |
1 |
2009 |
| Drug |
basalin to lantus |
1 |
2018 |
| Behavioral |
basic carbohydrate counting |
1 |
2018 |
| Behavioral |
basic needs navigation |
1 |
2019 |
| Procedure |
bastric bypass |
1 |
2012 |
| Drug |
bay 94-8862 |
1 |
2013 |
| Drug |
bayer acarbose |
1 |
2011 |
| Device |
bd |
1 |
2008 |
| Device |
bd diabetes care application (for mobile devices) |
1 |
2019 |
| Device |
bd diabetes care application (for mobile devices)/use of bd nano pen needle |
1 |
2019 |
| Device |
bd/33g |
1 |
2008 |
| Dietary Supplement |
beetroot |
1 |
2014 |
| Drug |
beetroot juice (beet-it stamina shot) |
1 |
2013 |
| Drug |
beetroot juice (beet-it stamina shot)/exercise training |
1 |
2013 |
| Combination Product |
behavior intervention of downhill exercise |
1 |
2019 |
| Combination Product |
behavior intervention of uphill exercise |
1 |
2019 |
| Other |
behavioral |
1 |
2019 |
| Behavioral |
behavioral activation |
1 |
2010 |
| Behavioral |
behavioral change communication to promote physical activity |
1 |
2008 |
| Behavioral |
behavioral group weight loss intervention |
1 |
2001 |
| Other |
behavioral health consult |
1 |
2019 |
| Behavioral |
behavioral hlth nurse |
1 |
2015 |
| Combination Product |
behavioral intervention of downhill exercise |
1 |
2019 |
| Combination Product |
behavioral intervention of sedentary no-exercise trial |
1 |
2019 |
| Behavioral |
behavioral lifestyle intervention |
1 |
2020 |
| Combination Product |
behavioral modification |
1 |
2018 |
| Behavioral |
behavioral motivation |
1 |
2014 |
| Behavioral |
behavioral skills |
1 |
2009 |
| Other |
behavioral smoking cessation intervention |
1 |
2018 |
| Behavioral |
behavioral suggestions |
1 |
2009 |
| Behavioral |
behavioral weight loss |
1 |
2014 |
| Behavioral |
behavioral weight loss with digital tools |
1 |
2018 |
| Behavioral |
behavioral weight loss/exercise |
1 |
2014 |
| Behavioral |
behavioral: fitness tracker |
1 |
2016 |
| Behavioral |
behaviour counseling from a registered kinesiologist |
1 |
2014 |
| Behavioral |
behavioural change programme |
1 |
2010 |
| Behavioral |
behvarioal lifestyle modification |
1 |
2015 |
| Drug |
beinaglutide |
1 |
2019 |
| Drug |
bempedoic acid |
1 |
2018 |
| Drug |
bempedoic acid / ezetimibe fdc oral tablet |
1 |
2018 |
| Other |
beneflax - 38% secoisolariciresinol diglucoside (sdg) |
1 |
2012 |
| Dietary Supplement |
benfotiamine |
1 |
2016 |
| Drug |
benfotiamine 1050mg, 3 days |
1 |
2007 |
| Behavioral |
best possible self |
1 |
2018 |
| Other |
beta-blocker none |
1 |
2016 |
| Drug |
beta-blocker up-to maximal dosages |
1 |
2016 |
| Drug |
beta-hydroxy-butyrate |
1 |
2018 |
| Dietary Supplement |
betaine (trimethyglycine) |
1 |
2017 |
| Drug |
bethanechol (100 mg) |
1 |
2011 |
| Drug |
bethanechol (25 mg) |
1 |
2011 |
| Drug |
bethanechol (50 mg) |
1 |
2011 |
| Other |
beverage only |
1 |
2011 |
| Behavioral |
bewell24 smartphone app |
1 |
2017 |
| Drug |
bexagliflozin tablets |
1 |
2015 |
| Drug |
bexagliflozin tablets, 20 mg |
1 |
2017 |
| Drug |
bezafibrate |
1 |
2007 |
| Drug |
bezafibrate / diflunisal |
1 |
2007 |
| Drug |
bezafibrate / placebo |
1 |
2007 |
| Drug |
bfkb8488a |
1 |
2017 |
| Behavioral |
bfst for teens with type 2 diabetes |
1 |
2015 |
| Other |
bg star meter (conventional) internet blood glucose reporting |
1 |
2013 |
| Device |
bgstar lancing device (sanofi aventis) |
1 |
2020 |
| Device |
bgstar ultra-thin 33g lancets (sanofi aventis) |
1 |
2020 |
| Drug |
bi 10773 / bi 1356 |
1 |
2013 |
| Drug |
bi 10773 / bi 1356 placebo |
1 |
2013 |
| placebo |
bi 10773 low dose placebo |
1 |
2011 |
| Drug |
bi 10773 medium dose |
1 |
2007 |
| Drug |
bi 10773 open label |
1 |
2010 |
| Drug |
bi 1356 / metformin |
1 |
2008 |
| Drug |
bi 1356 bs - single rising dose |
1 |
2014 |
| Drug |
bi 1356 bs, high dose |
1 |
2014 |
| Drug |
bi 1356 bs, low dose |
1 |
2014 |
| Drug |
bi 1356 bs, medium dose |
1 |
2014 |
| Drug |
bi 1356 dose 1 once daily |
1 |
2006 |
| Drug |
bi 1356 dose 2 once daily |
1 |
2006 |
| Drug |
bi 1356 dose 3 once daily |
1 |
2006 |
| Drug |
bi 456906 |
1 |
2019 |
| Drug |
bi1356 high dose |
1 |
2011 |
| Drug |
bi1356 low dose |
1 |
2011 |
| Drug |
biasp 30 |
1 |
2013 |
| Drug |
bid (n=22) |
1 |
2017 |
| Dietary Supplement |
bifidobacterium animalis a6 |
1 |
2020 |
| Drug |
biguanide (bg) |
1 |
2012 |
| Drug |
biguanides (bg) |
1 |
2011 |
| Drug |
biguanides, thiazolidinediones |
1 |
2000 |
| Dietary Supplement |
bilberry capsule first, then control cap |
1 |
2010 |
| Procedure |
biliopancreatic diversion with duodenal switch |
1 |
2016 |
| Procedure |
billroth ii reconstruction after subtotal gastrectomy |
1 |
2020 |
| Drug |
biochaperone combo |
1 |
2015 |
| Drug |
biochaperone insulin lispro |
1 |
2015 |
| Drug |
biochaperoneâ® combo |
1 |
2016 |
| Drug |
biochaperoneâ® combo 75 |
1 |
2017 |
| Drug |
biochaperoneâ® combo 75/25 at 0.6 u/kg |
1 |
2017 |
| Drug |
biochaperoneâ® combo 75/25 at 0.8 u/kg |
1 |
2017 |
| Drug |
biochaperoneâ® combo 75/25 at 1.0 u/kg |
1 |
2017 |
| Drug |
biod-531 |
1 |
2014 |
| Other |
biodex strength testing |
1 |
2018 |
| Other |
biogenetic explanation |
1 |
2019 |
| Other |
biogenetic explanation/endocrinologist intensive managment |
1 |
2019 |
| Other |
biok |
1 |
2017 |
| Other |
biok/ 100% probiotic |
1 |
2017 |
| Dietary Supplement |
biomebliss |
1 |
2019 |
| Device |
bionic pancreas |
1 |
2018 |
| Drug |
biosynthetic human insulin injection |
1 |
2008 |
| Drug |
biphasic remogliflozin etabonate |
1 |
2015 |
| Other |
biscuit 1 control |
1 |
2019 |
| Other |
biscuit 2 test |
1 |
2019 |
| Drug |
bisoprolol |
1 |
2010 |
| Dietary Supplement |
bitter melon juice (100 ml) |
1 |
2020 |
| Other |
bkr-013 |
1 |
2017 |
| Other |
bkr-013/placebo |
1 |
2017 |
| Dietary Supplement |
black seed oil |
1 |
2019 |
| Dietary Supplement |
black tea extract |
1 |
2009 |
| Drug |
blinded fenofibrate |
1 |
1999 |
| Drug |
blinded fenofibrate/placebo/simvastatin |
1 |
1999 |
| Other |
blood-flow restriction resistance training |
1 |
2019 |
| Diagnostic Test |
blood glucose |
1 |
2017 |
| Device |
blood glucose meter |
1 |
2018 |
| Device |
blood glucose meter with test stripes |
1 |
2018 |
| Device |
blood glucose monitoring system |
1 |
2015 |
| Diagnostic Test |
blood glucose/blood pressure testing |
1 |
2017 |
| Drug |
blood pressure lowering therapy |
1 |
2006 |
| Diagnostic Test |
blood pressure testing |
1 |
2017 |
| Other |
blueberry |
1 |
2017 |
| Other |
blueberry drink |
1 |
2017 |
| Other |
blueberry tea |
1 |
2015 |
| Other |
blueberry/pizza |
1 |
2017 |
| Drug |
bm-mnc/hot |
1 |
2008 |
| Biological |
bm-mnc/uc-msc |
1 |
2019 |
| Other |
bmmct |
1 |
2012 |
| Drug |
bms-512148 |
1 |
2005 |
| Drug |
bms-686117 |
1 |
2007 |
| Drug |
bms-770767 |
1 |
2010 |
| Drug |
bms-816336 |
1 |
2009 |
| Drug |
bms-903452 |
1 |
2010 |
| Biological |
bms-986036 |
1 |
2014 |
| Drug |
bolus insulin |
1 |
2014 |
| Device |
bolus insulin patch (calibra finesse) |
1 |
2015 |
| Other |
bone biopsies |
1 |
2016 |
| Other |
boost glucose control (a) |
1 |
2016 |
| Other |
boost glucose control (b) |
1 |
2016 |
| Other |
boost original |
1 |
2016 |
| Device |
bowl |
1 |
2005 |
| Dietary Supplement |
bpl-1 probiotic capsules |
1 |
2019 |
| Procedure |
brachial artery reactivity testing |
1 |
2004 |
| Drug |
bradykinin |
1 |
2011 |
| Drug |
brain natriuretic peptide |
1 |
2011 |
| Biological |
bran oil |
1 |
2018 |
| Other |
breakfast |
1 |
2011 |
| Behavioral |
breaking prolonged sitting |
1 |
2018 |
| Behavioral |
breath meter |
1 |
2016 |
| Drug |
brevicon |
1 |
2007 |
| Behavioral |
brief alcohol intervention |
1 |
2009 |
| Behavioral |
brief cbt |
1 |
2014 |
| Behavioral |
brief intervention |
1 |
2013 |
| Behavioral |
brief lifestyle program |
1 |
2018 |
| Behavioral |
brief mindfulness intervention |
1 |
2018 |
| Behavioral |
brief motivational interview |
1 |
2019 |
| Drug |
brl 49653c |
1 |
2012 |
| Drug |
bromocriptine mesylate |
1 |
2014 |
| Drug |
bti320 |
1 |
2018 |
| Behavioral |
budgeting, purchasing |
1 |
2018 |
| Behavioral |
budgeting, purchasing/cooking educational intervention |
1 |
2018 |
| Drug |
bumetanide |
1 |
2009 |
| Drug |
bupropion |
1 |
2008 |
| Drug |
bupropion sr 360 mg |
1 |
2007 |
| Behavioral |
burst physical activity |
1 |
2017 |
| Other |
butter |
1 |
2020 |
| Other |
butter based breakfast |
1 |
2018 |
| Drug |
byetta |
1 |
2007 |
| Drug |
byetta (exenatide) |
1 |
2009 |
| Drug |
byetta, exenatide |
1 |
2008 |
| Drug |
byk324677 |
1 |
2011 |
| Drug |
bym338 10 mg |
1 |
2016 |
| Drug |
bym338 10 mg/kg |
1 |
2016 |
| Drug |
c - exenatide 10 mcg once daily |
1 |
2004 |
| Drug |
c mandibular anesthesia |
1 |
2015 |
| Drug |
c maxillary anesthesia |
1 |
2015 |
| Behavioral |
c) |
1 |
2013 |
| Drug |
c: bi 10773 |
1 |
2010 |
| Drug |
c: bi 10773 / metformin tablet |
1 |
2010 |
| Dietary Supplement |
c18:0 |
1 |
2016 |
| Dietary Supplement |
caffeine |
1 |
2016 |
| Behavioral |
caffeine abstinence |
1 |
2009 |
| Drug |
caffeine administration |
1 |
2007 |
| Dietary Supplement |
caffeine/chlorogenic acid |
1 |
2016 |
| Drug |
calcinaned magnesia |
1 |
2017 |
| Dietary Supplement |
calcium |
1 |
2015 |
| placebo |
calcium-placebo |
1 |
2007 |
| Drug |
calcium carbonate 400 mg orally twice daily |
1 |
2007 |
| Drug |
calcium dobesilate |
1 |
2017 |
| Behavioral |
calcium intake |
1 |
2007 |
| Drug |
calcium polycarbophil |
1 |
2010 |
| Other |
calisthenics exercises |
1 |
2018 |
| Behavioral |
calm-d intervention |
1 |
2012 |
| Dietary Supplement |
calori restricted diet |
1 |
2017 |
| Behavioral |
calorie controlled diabetic diet for the control patients |
1 |
2007 |
| Behavioral |
calorie restriction (25%) |
1 |
2013 |
| Device |
camaps hx closed-loop |
1 |
2019 |
| Dietary Supplement |
camel milk |
1 |
2020 |
| Dietary Supplement |
camel milk containing bifidobacterium animalis a6 |
1 |
2020 |
| Drug |
canagliflozin - sglt2i |
1 |
2016 |
| Drug |
canagliflozin (jnj-28431754) 100 mg |
1 |
2009 |
| Drug |
canagliflozin (jnj-28431754) 300 mg |
1 |
2009 |
| Drug |
canagliflozin 100mg |
1 |
2011 |
| Drug |
canagliflozin 150 mg |
1 |
2011 |
| Drug |
canagliflozin 150mg |
1 |
2011 |
| Drug |
canagliflozin 300mg/canagliflozin 150mg |
1 |
2011 |
| Drug |
canagliflozin 300mg/placebo |
1 |
2011 |
| Drug |
canaglifozin |
1 |
2019 |
| Drug |
candesartan cilexetil |
1 |
2014 |
| placebo |
candesartan cilexetil placebo |
1 |
2014 |
| Behavioral |
capability |
1 |
2019 |
| placebo |
carbohydrate placebo |
1 |
2011 |
| Drug |
carbon-14 radio-labeled srt2104 |
1 |
2009 |
| Diagnostic Test |
cardiac magnetic resonance |
1 |
2017 |
| Procedure |
cardiac mri |
1 |
2018 |
| Device |
cardiac resynchronization therapy defibrillator device |
1 |
2017 |
| Other |
cardiac rmi |
1 |
2012 |
| Behavioral |
cardiorespiratory exercise |
1 |
2018 |
| Other |
cardiovascular exercise training |
1 |
2018 |
| Behavioral |
caresmarts mobile health diabetes program |
1 |
2016 |
| Dietary Supplement |
carrageenan |
1 |
2015 |
| Dietary Supplement |
carrot |
1 |
2011 |
| Behavioral |
case manager counseling |
1 |
2010 |
| Behavioral |
casm |
1 |
2009 |
| Behavioral |
casm / |
1 |
2009 |
| Dietary Supplement |
cassia cinnamon |
1 |
2019 |
| Drug |
cat 1004 |
1 |
2012 |
| Behavioral |
cboc’s undergo half-day joint-clinics via teleconference |
1 |
2005 |
| Behavioral |
cbt-ad intervention |
1 |
2017 |
| Behavioral |
cbt classes |
1 |
2013 |
| Behavioral |
cbt/cmt |
1 |
2016 |
| Drug |
cck (kinevac) |
1 |
2015 |
| Behavioral |
cd-rom |
1 |
2009 |
| Dietary Supplement |
cd diet |
1 |
2019 |
| Behavioral |
cde |
1 |
2019 |
| Behavioral |
cde training |
1 |
2016 |
| Behavioral |
cdsmp |
1 |
2010 |
| Behavioral |
cellular application treating diabetes using breathing technique |
1 |
2016 |
| Drug |
cellulosum mycrocryst |
1 |
2009 |
| Drug |
cenicriviroc 150 mg |
1 |
2014 |
| Drug |
centella asiatica extract |
1 |
2019 |
| Drug |
cerave |
1 |
2009 |
| Behavioral |
cereal breakfast |
1 |
2017 |
| Behavioral |
cereal breakfast with high saturated fat |
1 |
2017 |
| Device |
cgm continuous glucose monitoring |
1 |
2013 |
| Device |
cgm group |
1 |
2010 |
| Other |
cgms |
1 |
2013 |
| Other |
cgms gold |
1 |
2013 |
| Device |
cgms with an insulin pump using rapid acting insulin |
1 |
2009 |
| Other |
change of time of administration |
1 |
2010 |
| Procedure |
changing hemoglobin concentration |
1 |
2005 |
| Other |
chap-p sessions |
1 |
2018 |
| Drug |
charcoal |
1 |
2019 |
| Other |
chemically interesterified palm olein (iv56) |
1 |
2013 |
| Drug |
chenodeoxycholic acid |
1 |
2012 |
| Drug |
chenodeoxycholic acid 1250 mg |
1 |
2012 |
| Other |
chica type 2 diabetes module |
1 |
2013 |
| Dietary Supplement |
chinese-canadian specific cooking classes |
1 |
2016 |
| Behavioral |
chinese coping skills training |
1 |
2009 |
| Behavioral |
chinese square dancing group |
1 |
2019 |
| Dietary Supplement |
chlorella vulgaris |
1 |
2018 |
| Dietary Supplement |
chlorogenic acid |
1 |
2016 |
| Dietary Supplement |
chlorogenic acid (cga) enriched coffee |
1 |
2015 |
| Other |
chocolate spread based breakfast |
1 |
2018 |
| Dietary Supplement |
cholecalciferol (euro-pharm international, canada) |
1 |
2018 |
| Drug |
cholecalciferol (vitamin d) |
1 |
2006 |
| Drug |
choline alfoscerate |
1 |
2017 |
| Drug |
chonline alphoscerate |
1 |
2017 |
| Behavioral |
chpe |
1 |
2011 |
| Dietary Supplement |
chromium-picolinate containing drink |
1 |
2014 |
| Drug |
chromium picolinate |
1 |
2006 |
| Drug |
chromium picolinate (600 mcg cr |
1 |
2006 |
| Drug |
chromium picolinate (600 mcg cr) |
1 |
2006 |
| Drug |
chromium picolinate (600 mcg cr) / biotin (2 mg) |
1 |
2006 |
| Drug |
chromium picolinate (600 mcg cr/3) / biotin (2 mg) |
1 |
2006 |
| placebo |
chromium picolinate 1000 mcg daily vs placebo |
1 |
2006 |
| Behavioral |
chronic disease management web-based software |
1 |
2008 |
| Behavioral |
chronic disease self-management workshop |
1 |
2010 |
| Other |
chronologically scheduled snacking with 40-30-30 products |
1 |
2010 |
| Behavioral |
chw diabetes education: tailored web site |
1 |
2011 |
| Other |
chw intervention |
1 |
2014 |
| Behavioral |
chws |
1 |
2014 |
| Behavioral |
chws/mobile health care application |
1 |
2014 |
| Drug |
ciclosporin |
1 |
2018 |
| Drug |
cilostazol/probucol |
1 |
2009 |
| Other |
cinnamomum cassia |
1 |
2018 |
| Dietary Supplement |
cinnamomum zeylanicum |
1 |
2019 |
| Dietary Supplement |
cinnamon 2g per day for 12 weeks |
1 |
2009 |
| Drug |
cinnamon/placebo 500 mg capsule twice daily |
1 |
2005 |
| Behavioral |
circadian misalignment |
1 |
2015 |
| Drug |
circadin |
1 |
2008 |
| Behavioral |
circuit resistance training (crt) |
1 |
2018 |
| Behavioral |
circuit training / motivational interviewing |
1 |
2008 |
| Behavioral |
circuit training/nutrition |
1 |
2008 |
| Drug |
cjc-1134-pc |
1 |
2008 |
| Drug |
ckd-370 |
1 |
2019 |
| Drug |
ckd-380 10mg tab. |
1 |
2018 |
| Drug |
ckd-395 0.25/500mg |
1 |
2016 |
| Drug |
ckd-395 0.25/750mg |
1 |
2015 |
| Drug |
ckd-395 0.5 |
1 |
2015 |
| Drug |
ckd-395 0.5(lobeglitazone) |
1 |
2015 |
| Drug |
ckd-395 0.5(lobeglitazone)/1000(metformin)mg 1t |
1 |
2015 |
| Drug |
ckd-395 0.5/1000mg |
1 |
2015 |
| Drug |
ckd-501 |
1 |
2011 |
| Drug |
ckd-501 1mg |
1 |
2009 |
| Drug |
ckd-501 2mg |
1 |
2009 |
| Drug |
ckd-501 amlodipine |
1 |
2011 |
| Drug |
ckd-501, ketoconazole |
1 |
2011 |
| Other |
classical resistance training |
1 |
2019 |
| Other |
clinical |
1 |
2013 |
| Other |
clinical evaluation |
1 |
2019 |
| Other |
clinical treatment |
1 |
2013 |
| Drug |
clonidine |
1 |
2007 |
| Drug |
clopidogrel active metabolite |
1 |
2018 |
| Device |
cloud-based continuous glucose monitoring |
1 |
2020 |
| Drug |
cm3.1-ac100 |
1 |
2010 |
| Device |
cmr |
1 |
2013 |
| Dietary Supplement |
cnt 2000 american ginseng extract |
1 |
2016 |
| Drug |
cnt0 3649 30 mcg |
1 |
2014 |
| Drug |
cnt0 3649 30 mcg/kg |
1 |
2014 |
| Drug |
cnto 3649 10 mcg |
1 |
2014 |
| Drug |
cnto 3649 10 mcg/kg |
1 |
2014 |
| Drug |
cnto 3649 100 mcg |
1 |
2014 |
| Drug |
cnto 3649 100 mcg/kg |
1 |
2014 |
| Drug |
cnto 3649 300 mcg |
1 |
2014 |
| Drug |
cnto 3649 300 mcg/kg |
1 |
2014 |
| Drug |
cnto 3649 iv (healthy participants) |
1 |
2009 |
| Drug |
cnto 3649 sc (diabetic patients) |
1 |
2009 |
| Drug |
cnto 3649 sc (healthy participants) |
1 |
2009 |
| Drug |
co-administration of 50 mg sitagliptin |
1 |
2010 |
| Drug |
co-administration of 50 mg sitagliptin/500 mg metformin |
1 |
2010 |
| Drug |
co-administration of 50 mg sitagliptin/850 mg metformin |
1 |
2010 |
| Drug |
co-administration of saxagliptin |
1 |
2009 |
| Drug |
co-administration of saxagliptin/metformin ir, fasted |
1 |
2009 |
| Drug |
co-administration of saxagliptin/metformin ir, fed |
1 |
2009 |
| Behavioral |
coaching (cth |
1 |
2013 |
| Behavioral |
coaching strategy |
1 |
2015 |
| Dietary Supplement |
cocarnit |
1 |
2019 |
| Dietary Supplement |
cocoa |
1 |
2012 |
| Other |
cocoa butter |
1 |
2019 |
| Other |
cocoa butter oleogel |
1 |
2019 |
| Dietary Supplement |
cod |
1 |
2009 |
| Behavioral |
cod protein ncep-diet |
1 |
2006 |
| Behavioral |
cognitive-behavioral life-style counseling |
1 |
2006 |
| Behavioral |
cognitive-behavioral therapy group |
1 |
2017 |
| Behavioral |
cognitive behavior therapy (cbt) |
1 |
2011 |
| Behavioral |
cognitive behavioral-based therapy |
1 |
2013 |
| Behavioral |
cognitive behavioral therapy -based weight loss program |
1 |
2012 |
| Behavioral |
cognitive behavioral therapy (cbt) |
1 |
2019 |
| Behavioral |
cognitive behavioral therapy for insomnia |
1 |
2018 |
| Behavioral |
cognitive behavioral training |
1 |
2010 |
| Drug |
cohort a: ormd-0801 |
1 |
2018 |
| Drug |
cohort b: ormd-0801 |
1 |
2018 |
| Drug |
colchicine 0.25 mg |
1 |
2017 |
| Drug |
colchicine 0.5 mg |
1 |
2017 |
| Drug |
colchicine 0.5mg |
1 |
2014 |
| Drug |
colchicine 0.5mg/d |
1 |
2014 |
| Other |
cold water exercise |
1 |
2015 |
| Drug |
colesevelam 3750 mg |
1 |
2012 |
| Drug |
colesevelam 3750 mg / chenodeoxycholic acid 1250 mg |
1 |
2012 |
| placebo |
colesevelam matching placebo |
1 |
2005 |
| placebo |
colesevelam placebo |
1 |
2007 |
| Drug |
colesevelam tablets |
1 |
2007 |
| Behavioral |
collaborative care |
1 |
2018 |
| Behavioral |
collaborative education |
1 |
2012 |
| Behavioral |
collaborative social incentive |
1 |
2016 |
| Drug |
colonoscopy preparation using polyethylene glycol |
1 |
2017 |
| Other |
combination of imos |
1 |
2018 |
| Other |
combination of imos/xtendâ® sucromalt |
1 |
2018 |
| Behavioral |
combination of monthly food vouchers |
1 |
2019 |
| Drug |
combination of pioglitazone |
1 |
2018 |
| Drug |
combination of pioglitazone/metformin tablets |
1 |
2018 |
| Device |
combination pulsatile stendo3 |
1 |
2014 |
| Drug |
combined antioxidant therapy |
1 |
2013 |
| Behavioral |
combined digital |
1 |
2017 |
| Behavioral |
combined digital/face-to-face lifestyle intervention group |
1 |
2017 |
| Behavioral |
combined intervention |
1 |
2009 |
| Drug |
combined lifestyle intervention |
1 |
2005 |
| Drug |
combined lifestyle intervention/optimisation of pharmacological treatment |
1 |
2005 |
| Other |
combined training |
1 |
2015 |
| Behavioral |
commitment therapy |
1 |
2011 |
| Behavioral |
communal coping intervention |
1 |
2019 |
| Behavioral |
community health worker (chw) |
1 |
2014 |
| Behavioral |
community health worker diabetes education: print media |
1 |
2011 |
| Behavioral |
community health worker home visits |
1 |
2009 |
| Behavioral |
community health worker team |
1 |
2001 |
| Other |
community pharmacist-involved collaborative care |
1 |
2018 |
| Behavioral |
community pharmacist-led diabetes education program |
1 |
2012 |
| Behavioral |
community resources |
1 |
2000 |
| Behavioral |
commuting with electrically assisted bicycles |
1 |
2017 |
| Behavioral |
companion support |
1 |
2016 |
| Drug |
comparator : ezetimibe ( |
1 |
2007 |
| Drug |
comparator : ezetimibe (/) simvastatin / duration of treatment: 30 weeks |
1 |
2007 |
| Drug |
comparator : placebo (unspecified) / duration of treatment: 12 weeks |
1 |
2006 |
| Drug |
comparator : ramipril |
1 |
2007 |
| Drug |
comparator : ramipril /duration of treatment : 8 weeks |
1 |
2007 |
| Drug |
comparator: antidiabetic standard of care |
1 |
2009 |
| Drug |
comparator: atorvastatin / duration of treatment: 6 weeks |
1 |
2007 |
| Behavioral |
comparator: diet |
1 |
2007 |
| Drug |
comparator: er niacin |
1 |
2008 |
| Drug |
comparator: er niacin ( |
1 |
2008 |
| Drug |
comparator: er niacin (/) laropiprant |
1 |
2008 |
| Drug |
comparator: glipizide |
1 |
2004 |
| Drug |
comparator: laropiprant |
1 |
2008 |
| Drug |
comparator: metformin 1000 mg b.i.d. |
1 |
2005 |
| Drug |
comparator: metformin 500 mg b.i.d. |
1 |
2005 |
| Drug |
comparator: metformin hydrochloride |
1 |
2007 |
| Drug |
comparator: mk0431 100 mg q.d. (q.d. = once daily) |
1 |
2005 |
| Drug |
comparator: mk0431 50 mg b.i.d. (b.i.d. = twice daily) |
1 |
2005 |
| Drug |
comparator: open-label mk0431 |
1 |
2005 |
| Drug |
comparator: open-label mk0431/metformin 50/1000 mg b.i.d. |
1 |
2005 |
| Behavioral |
comparator: physical activity |
1 |
2007 |
| placebo |
comparator: placebo (phase a) |
1 |
2005 |
| Drug |
comparator: placebo (phase a)/metformin (phase b) |
1 |
2005 |
| Drug |
comparator: placebo (unspecified) / duration of treatment: 21 weeks |
1 |
2007 |
| placebo |
comparator: placebo metformin |
1 |
2009 |
| placebo |
comparator: placebo sitagliptin |
1 |
2009 |
| Drug |
comparator: placebo to match sitagliptin 100 mg q.d./metformin ≥ 1500 mg/day |
1 |
2006 |
| Drug |
comparator: placebo to match sitagliptin 100 mg q.d./pioglitazone 30 mg q.d. |
1 |
2006 |
| Drug |
comparator: rosiglitazone |
1 |
2007 |
| Drug |
comparator: sitagliptin 100 mg |
1 |
2004 |
| Drug |
comparator: sitagliptin 200 mg |
1 |
2004 |
| Drug |
comparator: sitagliptin phosphate (mk0431) |
1 |
2006 |
| Drug |
comparator: sitagliptin phosphate (sitagliptin) |
1 |
2007 |
| Drug |
comparator: sitagliptin phosphate monohydrate form |
1 |
2009 |
| Drug |
comparator: sulfonylurea |
1 |
2010 |
| Drug |
comparator: voglibose |
1 |
2006 |
| Other |
comparing 3 versus 6 meals in type 2 diabetes patients |
1 |
2019 |
| Other |
comparison |
1 |
2007 |
| Behavioral |
competitive social incentive |
1 |
2016 |
| Other |
comprehensive care protocol in new diagnosis of type 2 diabetes mellitus |
1 |
2019 |
| Other |
comprehensive care protocol in new diagnosis of type 2 diabetes mellitus/associated comorbidities in primary care |
1 |
2019 |
| Behavioral |
comprehensive intervention (disease management program) |
1 |
2009 |
| Other |
computer-assisted decision support |
1 |
2012 |
| Behavioral |
computer automated self-management |
1 |
2008 |
| Behavioral |
computer automated self-management (casm) |
1 |
2008 |
| Behavioral |
computer automated self-management/problem solving therapy (caps) |
1 |
2008 |
| Procedure |
computerised support to the diabetes type ii patients |
1 |
2012 |
| Other |
computerized cognitive training |
1 |
2012 |
| Drug |
conjugated bile acids sodium |
1 |
2016 |
| Behavioral |
connected health |
1 |
2015 |
| Behavioral |
connection to health |
1 |
2013 |
| Behavioral |
connection to health (cth) |
1 |
2016 |
| Behavioral |
connection to health interactive behavior change technology |
1 |
2013 |
| Behavioral |
connection to health/coaching (cth/c) |
1 |
2013 |
| Drug |
conservative glycemic control |
1 |
2009 |
| Other |
consultation by telephone |
1 |
2013 |
| Behavioral |
consultation with endocrinologist |
1 |
2005 |
| Behavioral |
consumption of dietary portfolio |
1 |
2007 |
| Other |
continued daily lifestyle |
1 |
2012 |
| Behavioral |
continuous bg feedback |
1 |
2016 |
| Device |
continuous glucose monitoring (cgm) |
1 |
2019 |
| Device |
continuous glucose monitoring sensor |
1 |
2019 |
| Device |
continuous glucose monitoring system |
1 |
2019 |
| Device |
continuous glucose monitoring system(cgms) |
1 |
2017 |
| Device |
continuous glucose monitoring system. |
1 |
2015 |
| Other |
continuous glucose monitoring with treatment algorithm |
1 |
2012 |
| Drug |
continuous metformin |
1 |
2012 |
| Other |
continuous moderate intensity exercise |
1 |
2013 |
| Device |
continuous positive airway pressure |
1 |
2012 |
| Device |
continuous positive airway pressure (cpap) |
1 |
2008 |
| Device |
contour nextone |
1 |
2020 |
| Drug |
control - high carbohydrate, high glycemic index foods |
1 |
2005 |
| Behavioral |
control arm (usual care |
1 |
2009 |
| Behavioral |
control arm (usual care/standard care arm) |
1 |
2009 |
| Dietary Supplement |
control beverage |
1 |
2010 |
| Other |
control breakfast |
1 |
2013 |
| Dietary Supplement |
control capsule first then bilberry cap |
1 |
2010 |
| Dietary Supplement |
control fat (sunflower oil) |
1 |
2008 |
| Other |
control games |
1 |
2012 |
| Other |
control group traditional primary care |
1 |
2016 |
| Other |
control noodle |
1 |
2019 |
| Behavioral |
control or |
1 |
2014 |
| Behavioral |
control phase; exercise phase |
1 |
2009 |
| Behavioral |
control thinking |
1 |
2018 |
| Dietary Supplement |
control tomato soup |
1 |
2010 |
| Behavioral |
control; no exercise training |
1 |
2013 |
| Other |
conventional antidiabetic treatment |
1 |
2006 |
| Other |
conventional care |
1 |
2015 |
| Dietary Supplement |
conventional coffee |
1 |
2015 |
| Behavioral |
conventional diet education |
1 |
2020 |
| Drug |
conventional interferon alfa |
1 |
2013 |
| Behavioral |
conventional lifestyle program |
1 |
2018 |
| Drug |
conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules |
1 |
2012 |
| Procedure |
conventional periodontal treatment |
1 |
2013 |
| Procedure |
conventional roux-en-y reconstruction after subtotal gastrectomy |
1 |
2020 |
| Behavioral |
cookbooks |
1 |
2016 |
| Behavioral |
cooking educational intervention |
1 |
2018 |
| Behavioral |
cookingmatters |
1 |
2018 |
| Drug |
coptis chinensis, astragalus mambranesceus, lonicera japonica (traditional chinese treatment) |
1 |
2008 |
| Drug |
coq10 |
1 |
2008 |
| Procedure |
coronary artery bypass |
1 |
2000 |
| Dietary Supplement |
cosmos caudatus |
1 |
2014 |
| Drug |
cotadutide |
1 |
2019 |
| Combination Product |
cotadutide multidose pen injection |
1 |
2019 |
| Behavioral |
counseling from diabetes educator |
1 |
2005 |
| Behavioral |
counseling from dietician |
1 |
2005 |
| Other |
counseling pa |
1 |
2017 |
| Behavioral |
counselling to increase knowledge |
1 |
2019 |
| Behavioral |
counselling to increase motivation |
1 |
2019 |
| Other |
cous-cous sandwich |
1 |
2012 |
| Behavioral |
covert v overt nutrition labeling |
1 |
2005 |
| Dietary Supplement |
cow milk |
1 |
2020 |
| Other |
cracked whole wheat porridge |
1 |
2018 |
| Dietary Supplement |
cranberry |
1 |
2008 |
| Drug |
crchum-mt cocktail |
1 |
2014 |
| Drug |
creatine monohydrate |
1 |
2017 |
| Dietary Supplement |
crhp diet |
1 |
2019 |
| Dietary Supplement |
crocin |
1 |
2019 |
| Drug |
cs-3150 |
1 |
2016 |
| Drug |
cs-917 |
1 |
2006 |
| Drug |
cs02 tablet |
1 |
2017 |
| Drug |
cs02 tablet/placebo tablet |
1 |
2017 |
| Drug |
csii |
1 |
2011 |
| Drug |
csii, metformin, pioglitazone |
1 |
2011 |
| Drug |
csii, sitagliptin |
1 |
2011 |
| Behavioral |
cst |
1 |
2012 |
| Drug |
ctp-499 |
1 |
2011 |
| Behavioral |
culturally tailored diabetes education |
1 |
2010 |
| Behavioral |
culturally tailored food |
1 |
2019 |
| Behavioral |
culturally tailored food/diet advice |
1 |
2019 |
| Dietary Supplement |
curcumin |
1 |
2015 |
| Behavioral |
current ct program |
1 |
2016 |
| Behavioral |
current ict program (acc-ict) |
1 |
2009 |
| Other |
custom designed exercises |
1 |
2018 |
| Biological |
cvx-096 |
1 |
2009 |
| Drug |
cwp-0403 100mg |
1 |
2009 |
| Drug |
cwp-0403 50mg |
1 |
2009 |
| Other |
cycling |
1 |
2012 |
| Drug |
cyclosporin |
1 |
2006 |
| Drug |
cyt013-il1bqb |
1 |
2009 |
| Device |
cytal wound matrix 1-layer |
1 |
2018 |
| Drug |
d |
1 |
2014 |
| Device |
d-nav |
1 |
2015 |
| Drug |
d-tagatose |
1 |
2009 |
| Drug |
d308 10mg tab. |
1 |
2018 |
| Drug |
d308, ckd-501 |
1 |
2018 |
| Drug |
d745 |
1 |
2019 |
| Drug |
da-1229 |
1 |
2013 |
| Drug |
da-1229 / metformin |
1 |
2013 |
| Drug |
da-1229_01 fast |
1 |
2014 |
| Drug |
da-1229_01 fed |
1 |
2014 |
| Drug |
daclatasvir |
1 |
2018 |
| Dietary Supplement |
daidzein |
1 |
2009 |
| Drug |
daily dpp-4 inhibitor |
1 |
2017 |
| Other |
daily enteral nutritional product and |
1 |
2007 |
| Other |
daily enteral nutritional product and/or behavioral changes |
1 |
2007 |
| Drug |
daily injection of kbp/placebo for 12 weeks as add-on to metformin |
1 |
2017 |
| Drug |
daily injection of kbp/placebo for up to 28 days |
1 |
2018 |
| Drug |
daily oad (metformin and |
1 |
2013 |
| Drug |
daily oad (metformin and/or sulfonylurea) |
1 |
2013 |
| Behavioral |
daily physical activity, pedometer |
1 |
2009 |
| Behavioral |
daily physical activity, pedometer/counseling |
1 |
2009 |
| Device |
daily workout sequence with nmes in one week |
1 |
2015 |
| Drug |
dapagliflozin (forxiga) |
1 |
2016 |
| Drug |
dapagliflozin / glimepiride |
1 |
2007 |
| Drug |
dapagliflozin / glucophage tablet fasted |
1 |
2012 |
| Drug |
dapagliflozin / glucophage tablet fed |
1 |
2012 |
| Drug |
dapagliflozin 10 mg oral tablet [farxiga] |
1 |
2019 |
| Drug |
dapagliflozin 10mg qd |
1 |
2016 |
| placebo |
dapagliflozin 10mg then placebo oral tablet |
1 |
2017 |
| Drug |
dapagliflozin 5 mg |
1 |
2014 |
| Drug |
dapagliflozin fdc |
1 |
2014 |
| placebo |
dapagliflozin matching placebo |
1 |
2009 |
| Drug |
dapagliflozin, farxiga |
1 |
2015 |
| Drug |
dapagliflozin/metformin |
1 |
2019 |
| Drug |
dapagliflozin/metformin ir fdc tablet fasted |
1 |
2012 |
| Drug |
dapagliflozin/metformin ir fdc tablet fed |
1 |
2012 |
| Drug |
dapagliflozine 10 mg once daily tablet treatment |
1 |
2016 |
| Drug |
darapladib |
1 |
2014 |
| Device |
dario blood glucose monitoring system |
1 |
2019 |
| Behavioral |
day followed by 2 meals |
1 |
2011 |
| Behavioral |
day) |
1 |
2011 |
| Dietary Supplement |
dbcare |
1 |
2007 |
| placebo |
dbpr108 tablet(100mg), placebo matching dbpr108 tablet(50mg) |
1 |
2019 |
| placebo |
dbpr108 tablet(100mg), placebo matching dbpr108 tablet(50mg), placebo matching dbpr108 tablet(100mg) |
1 |
2019 |
| placebo |
dbpr108 tablet(50mg), placebo matching dbpr108 tablet(100mg) |
1 |
2019 |
| Behavioral |
dbs at the end of the main meal |
1 |
2015 |
| Behavioral |
dbs at the end of the main meal / diet |
1 |
2015 |
| Drug |
dcb-dm101 |
1 |
2016 |
| Behavioral |
ddr |
1 |
2009 |
| Other |
de assessment |
1 |
2016 |
| Procedure |
dead sea water |
1 |
2012 |
| Device |
decision aid statin choice |
1 |
2005 |
| Behavioral |
default - use of online grocery shopping platform with default shopping carts |
1 |
2019 |
| Drug |
delapril, delapril-manidipine fixed combination |
1 |
2005 |
| Behavioral |
delayed cbt |
1 |
2008 |
| Other |
delayed non-surgical periodontal therapy |
1 |
2009 |
| Drug |
den 15 mg |
1 |
2005 |
| Drug |
den 2.5 mg |
1 |
2005 |
| Drug |
den 30 mg |
1 |
2005 |
| Drug |
den 45 mg |
1 |
2005 |
| Drug |
den 7.5 mg |
1 |
2005 |
| Drug |
denosumab 60 mg |
1 |
2018 |
| Drug |
denosumab 60 mg/ml [prolia] |
1 |
2018 |
| Procedure |
dental cleaning |
1 |
2016 |
| Procedure |
dental extractions |
1 |
2010 |
| Device |
dental implant |
1 |
2010 |
| Device |
dental implant/modified dental implant |
1 |
2010 |
| Procedure |
dental prophylaxis |
1 |
2015 |
| Diagnostic Test |
dermal electrochemical conductance (dec) |
1 |
2018 |
| Biological |
dermgen |
1 |
2014 |
| Drug |
detemir / aspart insulin before meals |
1 |
2007 |
| Drug |
detemir insulin |
1 |
2018 |
| Drug |
detemir insulin, aspart insulin, metformin |
1 |
2009 |
| Device |
dexcom cgm |
1 |
2010 |
| Device |
dexcom g4 platinum |
1 |
2015 |
| Device |
dexcom g6 cgm system |
1 |
2018 |
| Device |
dexcom g6 rt-cgm |
1 |
2018 |
| Drug |
dextromethorphan |
1 |
2013 |
| Drug |
dextromethorphan hydrobromide |
1 |
2011 |
| Dietary Supplement |
dha capsules of 2 g |
1 |
2016 |
| Behavioral |
diabempic |
1 |
2020 |
| Other |
diabetes care programme |
1 |
2020 |
| Behavioral |
diabetes care self-management mobile health application |
1 |
2020 |
| Behavioral |
diabetes education only |
1 |
2019 |
| Behavioral |
diabetes education/combination of monthly food vouchers/stock boxes |
1 |
2019 |
| Behavioral |
diabetes education/monthly food vouchers |
1 |
2019 |
| Behavioral |
diabetes education/monthly stock boxes |
1 |
2019 |
| Other |
diabetes educational classes |
1 |
2016 |
| Behavioral |
diabetes empowerment scale |
1 |
2005 |
| Behavioral |
diabetes health coach support |
1 |
2014 |
| Behavioral |
diabetes knowledge |
1 |
2009 |
| Behavioral |
diabetes knowledge/information |
1 |
2009 |
| Other |
diabetes management |
1 |
2010 |
| Other |
diabetes management instructions |
1 |
2019 |
| Behavioral |
diabetes management package (dmp) |
1 |
2019 |
| Other |
diabetes management team |
1 |
2009 |
| Behavioral |
diabetes map intervention |
1 |
2015 |
| Other |
diabetes meal plan with experimental diabetes-specific nutritional shake, diabetes specific cereal, |
1 |
2008 |
| Other |
diabetes meal plan with experimental diabetes-specific nutritional shake, diabetes specific cereal,/diabetes specific snack bars. |
1 |
2008 |
| Other |
diabetes medication choice cards |
1 |
2011 |
| Other |
diabetes medication choice decision aid |
1 |
2013 |
| Other |
diabetes medication management |
1 |
2014 |
| Drug |
diabetes mellitus type 2 de-escalation treatment (det) |
1 |
2019 |
| Behavioral |
diabetes peer counseling |
1 |
2011 |
| Other |
diabetes program |
1 |
2017 |
| Behavioral |
diabetes pueblo |
1 |
2019 |
| Other |
diabetes risk assessment service in norwegian community pharmacies |
1 |
2019 |
| Behavioral |
diabetes self-management consultant |
1 |
2005 |
| Behavioral |
diabetes self-management program |
1 |
2017 |
| Behavioral |
diabetes self management program |
1 |
2008 |
| Other |
diabetes specific enteral product |
1 |
2007 |
| Other |
diabetes specific experimental nutritional product (medical food) |
1 |
2008 |
| Other |
diabetes specific feeding product |
1 |
2007 |
| Other |
diabetes specific snack bars. |
1 |
2008 |
| Behavioral |
diabetes survival skills self-management education |
1 |
2009 |
| Other |
diabetes transitions tool kit |
1 |
2011 |
| Drug |
diabetes treatment |
1 |
2008 |
| Behavioral |
diabetic conversation map |
1 |
2018 |
| Drug |
diabex) |
1 |
2009 |
| Dietary Supplement |
diacylglycerol oil |
1 |
2013 |
| Device |
diagoneâ„¢ |
1 |
2017 |
| Drug |
diamicron |
1 |
2005 |
| Drug |
diamicron/glucophage |
1 |
2005 |
| Device |
diamond system |
1 |
2012 |
| Dietary Supplement |
diasipâ® nutricia advanced |
1 |
2019 |
| Behavioral |
diet- |
1 |
2006 |
| Behavioral |
diet-/exercise intervention |
1 |
2006 |
| Behavioral |
diet-appropriate foods |
1 |
2016 |
| Behavioral |
diet-appropriate foods/cookbooks |
1 |
2016 |
| Other |
diet-only. |
1 |
2005 |
| Behavioral |
diet (anti-inflammatory |
1 |
2006 |
| Behavioral |
diet (anti-inflammatory/standard diabetic diet) |
1 |
2006 |
| Behavioral |
diet (traditional, moderate energy restriction) |
1 |
2003 |
| Behavioral |
diet / lifestyle counseling |
1 |
2009 |
| Behavioral |
diet advice |
1 |
2019 |
| Behavioral |
diet beverage |
1 |
2018 |
| Behavioral |
diet education |
1 |
2006 |
| Behavioral |
diet education based on cgms data |
1 |
2020 |
| Other |
diet hp |
1 |
2018 |
| Behavioral |
diet intervention/structured exercise training program |
1 |
2010 |
| Other |
diet lp |
1 |
2018 |
| Dietary Supplement |
diet oil |
1 |
2011 |
| Other |
diet therapy |
1 |
2016 |
| Other |
diet/exercise |
1 |
2012 |
| Other |
diet/lifestyle |
1 |
2012 |
| Behavioral |
diet/lifestyle counseling |
1 |
2017 |
| Behavioral |
diet/lifestyle program |
1 |
2017 |
| Other |
diet/physical activity program |
1 |
2016 |
| Behavioral |
diet: carbohydrate days. (name: oatmeal.) |
1 |
2006 |
| Behavioral |
dietary consult |
1 |
2015 |
| Behavioral |
dietary consulting/advise |
1 |
2015 |
| Other |
dietary counseling |
1 |
2008 |
| Combination Product |
dietary intervention of eating two meals |
1 |
2019 |
| Combination Product |
dietary intervention of exercise after the meal |
1 |
2019 |
| Combination Product |
dietary intervention of exercise before the meal |
1 |
2019 |
| Combination Product |
dietary intervention of uphill exercise |
1 |
2019 |
| Behavioral |
dietary ketosis: regulator of obesity |
1 |
2017 |
| Behavioral |
dietary ketosis: regulator of obesity/metabolic syndrome |
1 |
2017 |
| Behavioral |
dietary modification |
1 |
2018 |
| Dietary Supplement |
dietary portfolio |
1 |
2018 |
| Behavioral |
dietary prescription |
1 |
2019 |
| Behavioral |
dietary therapy |
1 |
2005 |
| Behavioral |
dietary tracking |
1 |
2017 |
| Dietary Supplement |
dietary, herbal |
1 |
2015 |
| Behavioral |
dietary/lifestyle modification counseling |
1 |
2006 |
| Drug |
diflunisal |
1 |
2007 |
| Behavioral |
digital health partnership program |
1 |
2017 |
| Device |
digital integrated healthcare platform |
1 |
2019 |
| Behavioral |
digital lifestyle intervention group |
1 |
2017 |
| Biological |
digoxin/albiglutide |
1 |
2010 |
| Drug |
dihydromyricetin |
1 |
2018 |
| Behavioral |
dimini lifestyle intervention |
1 |
2018 |
| Drug |
dipeptidyl peptidase-4 inhibitors |
1 |
2018 |
| Drug |
dipeptidyl peptidase-iv (dpp-iv) inhibitors |
1 |
2016 |
| Drug |
dipeptidyl peptidase 4 inhibitor |
1 |
2019 |
| Drug |
dipeptidyl peptidase iv inhibitors |
1 |
2009 |
| Behavioral |
direct |
1 |
2017 |
| Other |
discharge order set (dos) |
1 |
2018 |
| Behavioral |
discrete bg feedback |
1 |
2016 |
| Behavioral |
disease management plus |
1 |
2008 |
| Other |
dl |
1 |
2015 |
| Drug |
dlbs-32 |
1 |
2009 |
| Drug |
dlbs1033 |
1 |
2013 |
| Drug |
dm |
1 |
2017 |
| Behavioral |
dm-standard |
1 |
2008 |
| Drug |
dm/htn medications as needed |
1 |
2017 |
| Drug |
dm199 |
1 |
2013 |
| Procedure |
dmr procedure |
1 |
2016 |
| Device |
dmr procedure (fractyl) |
1 |
2015 |
| Procedure |
double-balloon enteroscopy (dbe) with biopsy retrieval |
1 |
2017 |
| Procedure |
doubly labelled water method |
1 |
2015 |
| Drug |
doxazosin |
1 |
2007 |
| placebo |
doxycycline placebo |
1 |
2011 |
| Drug |
dpp-4 inhibitor (sitagliptin) |
1 |
2013 |
| Drug |
dppiv inhibitor - |
1 |
2015 |
| Device |
droobi |
1 |
2019 |
| Device |
droplet 33g lancets (htl-strefa s.a.) |
1 |
2020 |
| Device |
droplet lancing device (htl-strefa s.a.) |
1 |
2020 |
| Combination Product |
drug adjustment |
1 |
2018 |
| Combination Product |
drug adjustment/behavioral modification |
1 |
2018 |
| Drug |
ds-1150b |
1 |
2013 |
| Drug |
ds-8500a 25 mg |
1 |
2016 |
| Drug |
ds-8500a 25mg |
1 |
2016 |
| Drug |
ds-8500a 75 mg |
1 |
2016 |
| Other |
dse |
1 |
2008 |
| Behavioral |
dsmes |
1 |
2018 |
| Drug |
dsp-8658 |
1 |
2009 |
| Drug |
dulaglutide pen |
1 |
2018 |
| Behavioral |
dulce digital |
1 |
2017 |
| Behavioral |
dulce digital-me (automated delivery) |
1 |
2017 |
| Behavioral |
dulce digital-me (medical assistant) |
1 |
2017 |
| Procedure |
duodenal-jejunal bypass |
1 |
2007 |
| Procedure |
duodenal exclusion surgery |
1 |
2007 |
| Procedure |
duodenal ileal interposition with sleeve gastrectomy |
1 |
2017 |
| Other |
duodenal meal |
1 |
2011 |
| Device |
duodenal mucosal resurfacing (dmr) |
1 |
2018 |
| Device |
duodenal mucosal resurfacing sham (sham) |
1 |
2018 |
| Other |
duodenal saline |
1 |
2011 |
| Drug |
duration of treatment : 8 weeks |
1 |
2007 |
| Drug |
duration of treatment: 12 weeks |
1 |
2006 |
| Drug |
duration of treatment: 21 weeks |
1 |
2007 |
| Drug |
duration of treatment: 30 weeks |
1 |
2007 |
| placebo |
duration of treatment: 4 wk placebo run in then 6 wk active |
1 |
2005 |
| Drug |
duration of treatment: 6 weeks |
1 |
2007 |
| Drug |
duration of treatment: mean 3.4 years |
1 |
2006 |
| Drug |
duvie tab. 0.5mg / januvia tab. 100mg |
1 |
2016 |
| Drug |
duvie tab. 0.5mg, glucodaun |
1 |
2015 |
| Drug |
duvie tab. 0.5mg, glucodaun/tab. 750mg |
1 |
2015 |
| Drug |
duvie tab. 0.5mg, glucophage xr tab. 1000mg |
1 |
2015 |
| Drug |
duvie tab. 0.5mg, glucophage xr tab. 500mg |
1 |
2016 |
| Device |
dv3316 pen-injector |
1 |
2015 |
| Device |
dv3372 |
1 |
2018 |
| Device |
dv3372, 0.5 mg |
1 |
2018 |
| Device |
dv3372, 0.5 mg/ml |
1 |
2018 |
| Device |
dv3372, 1.0 mg |
1 |
2018 |
| Device |
dv3372, 1.0 mg/ml |
1 |
2018 |
| Behavioral |
dvd knowledge |
1 |
2007 |
| Behavioral |
dwell (diabetes |
1 |
2020 |
| Behavioral |
dwell (diabetes/wellbeing) programme |
1 |
2020 |
| Drug |
dwp16001 |
1 |
2019 |
| Other |
dxa, whole body |
1 |
2019 |
| Behavioral |
e-coaching |
1 |
2015 |
| Behavioral |
e-intervention |
1 |
2010 |
| Other |
e-mail reports |
1 |
2017 |
| Other |
e-mail reports/technical support for mhealth system |
1 |
2017 |
| Drug |
e mandibular anesthesia |
1 |
2015 |
| Drug |
e maxillary anesthesia |
1 |
2015 |
| Drug |
e.-coli-nissle |
1 |
2014 |
| Drug |
e1 |
1 |
2005 |
| Drug |
e1/g1 |
1 |
2005 |
| Other |
ea |
1 |
2012 |
| Other |
ea / rosiglitazone |
1 |
2012 |
| Drug |
ecklonia cava phlorotannin |
1 |
2019 |
| Drug |
edta chelating agents |
1 |
2005 |
| Procedure |
educated by nurses specialized in diabetes. |
1 |
2006 |
| Behavioral |
education / group problem-solving training |
1 |
2009 |
| Behavioral |
education / individual problem-solving training |
1 |
2009 |
| Behavioral |
education / problem-solving training self-study |
1 |
2009 |
| Behavioral |
education about the self monitoring blood glucose |
1 |
2007 |
| Behavioral |
education of general practitioners on the idf-wpr guidelines |
1 |
2007 |
| Behavioral |
education of goal setting |
1 |
2015 |
| Behavioral |
education of goal setting/achievement |
1 |
2015 |
| Behavioral |
education program |
1 |
2015 |
| Behavioral |
education/exercise program for adults with type 2 diabetes |
1 |
2019 |
| Behavioral |
education/patient liaison combination |
1 |
2011 |
| Behavioral |
educational control arm |
1 |
2012 |
| Behavioral |
educational intervention |
1 |
2011 |
| Behavioral |
educational newsletter |
1 |
2010 |
| Behavioral |
educational program |
1 |
2012 |
| Drug |
efb0026 (metformin immediate-release) |
1 |
2012 |
| Drug |
efb0027 (metformin delayed release) |
1 |
2012 |
| Behavioral |
effect of physical activity on type ii diabetes mellitus |
1 |
2007 |
| Dietary Supplement |
effect of the green tea extract teavigo, high in egcg, on postprandial fat oxidation |
1 |
2009 |
| Behavioral |
effectiveness of an intensified dsme in t2d adult patients |
1 |
2017 |
| Other |
egg |
1 |
2017 |
| Behavioral |
egg breakfast |
1 |
2017 |
| Behavioral |
egg breakfast with high saturated fat |
1 |
2017 |
| Dietary Supplement |
egg exclusion |
1 |
2014 |
| Other |
egg included vegan phase |
1 |
2020 |
| Dietary Supplement |
egg inclusion |
1 |
2014 |
| Other |
egg white |
1 |
2017 |
| Other |
egg/egg white |
1 |
2017 |
| Drug |
egt0001474 |
1 |
2009 |
| Other |
ehealth education |
1 |
2011 |
| Other |
ehr-integrated diabetes dashboard |
1 |
2019 |
| Other |
ehr based strategy to promote safe |
1 |
2012 |
| Other |
ehr based strategy to promote safe/appropriate drug use |
1 |
2012 |
| Other |
elastic band resistance exercise |
1 |
2019 |
| Device |
electroacupuncture |
1 |
2006 |
| Procedure |
electrocardiogram (ecg) |
1 |
2012 |
| Dietary Supplement |
electrolyte solution |
1 |
2019 |
| Device |
electronic medicine reminder system |
1 |
2018 |
| Diagnostic Test |
electronic reminder messages |
1 |
2020 |
| Device |
electrostimulation (with compexâ® compex2* (djo, vista, ca, usa)) 3 days per week . |
1 |
2014 |
| Device |
electrostimulation (with compexâ® compex2* (djo, vista, ca, usa)) 5 days per week |
1 |
2014 |
| Drug |
empa / lina highdose placebo |
1 |
2015 |
| Drug |
empa 5 |
1 |
2017 |
| Drug |
empa/lina 10/5 mg qd (n=22) |
1 |
2017 |
| Drug |
empagliflozin (high dose bid) |
1 |
2012 |
| Drug |
empagliflozin (high dose qd) |
1 |
2012 |
| Drug |
empagliflozin (low dose bid) |
1 |
2012 |
| Drug |
empagliflozin (low dose qd) |
1 |
2012 |
| Drug |
empagliflozin / linagliptin |
1 |
2012 |
| Drug |
empagliflozin / linagliptin high dose |
1 |
2015 |
| Drug |
empagliflozin / linagliptin low dose |
1 |
2015 |
| Drug |
empagliflozin 10 mg / linagliptin 5 mg |
1 |
2015 |
| Drug |
empagliflozin 10 mg [jardiance] |
1 |
2017 |
| Drug |
empagliflozin 10mg |
1 |
2015 |
| Drug |
empagliflozin 25 mg / linagliptin 5 mg |
1 |
2015 |
| Drug |
empagliflozin 25mg |
1 |
2017 |
| Drug |
empagliflozin high dose bid |
1 |
2012 |
| Drug |
empagliflozin high dose qd |
1 |
2012 |
| Drug |
empagliflozin low dose bid |
1 |
2012 |
| Drug |
empagliflozin low dose qd |
1 |
2012 |
| Drug |
empagliflozin medium dose |
1 |
2014 |
| placebo |
empagliflozin placebo |
1 |
2015 |
| Drug |
empagliflozin placebo / linagliptin placebo low dose |
1 |
2015 |
| Drug |
empagliflozin/linagliptin |
1 |
2016 |
| Drug |
empaglifozin |
1 |
2019 |
| placebo |
empaglifozin placebo |
1 |
2012 |
| Drug |
empaglifozin placebo / linagliptin placebo |
1 |
2012 |
| Device |
empathy toolkit |
1 |
2014 |
| Other |
empower-par intervention |
1 |
2012 |
| Behavioral |
empowerment |
1 |
2013 |
| Behavioral |
empowerment/cbt classes |
1 |
2013 |
| Drug |
ems acarbose |
1 |
2011 |
| Drug |
enalaprilat |
1 |
2015 |
| Drug |
enalaprilat (ace inhibitor) |
1 |
2011 |
| Behavioral |
encompass intervention |
1 |
2017 |
| Behavioral |
encourage 2.0 |
1 |
2016 |
| Other |
endocrinologist intensive managment |
1 |
2019 |
| Device |
endovascular denervation |
1 |
2019 |
| Behavioral |
endurance exercise training |
1 |
2020 |
| Behavioral |
endurance training |
1 |
2008 |
| Biological |
engerixâ„¢-b vaccine |
1 |
2012 |
| Behavioral |
enhanced dpp |
1 |
2014 |
| Behavioral |
enhanced engagement |
1 |
2017 |
| Behavioral |
enhanced engagement protocol for cth (ee-cth) |
1 |
2016 |
| Behavioral |
enhanced gi concept education |
1 |
2016 |
| Behavioral |
enhanced physical activity intervention |
1 |
2019 |
| Behavioral |
enhanced standard care |
1 |
2013 |
| Other |
enhanced standard care (esc) |
1 |
2018 |
| Behavioral |
enhanced usual care |
1 |
2014 |
| Behavioral |
enhanced usual care control group |
1 |
2005 |
| Other |
enhancefitness community exercise program |
1 |
2016 |
| Device |
enlite 3 |
1 |
2014 |
| Dietary Supplement |
ensureâ® abbott nutrition |
1 |
2019 |
| Other |
enteral nutrition formula |
1 |
2016 |
| Other |
enteral nutritional formula |
1 |
2007 |
| Device |
enterra therapy system (h9900014) |
1 |
2005 |
| Drug |
entresto |
1 |
2019 |
| placebo |
epa placebo |
1 |
2017 |
| Dietary Supplement |
epa supplement |
1 |
2017 |
| Dietary Supplement |
epa/dha capsules of 2 g/day |
1 |
2016 |
| Drug |
epanovaâ® (omega-3 carboxylic acids) |
1 |
2015 |
| Behavioral |
episodic future thinking |
1 |
2018 |
| Drug |
er niacin |
1 |
2007 |
| Drug |
er niacin/laropiprant |
1 |
2007 |
| placebo |
ergocalciferol, placebo |
1 |
2014 |
| Drug |
ertugliflozin 2 mg single dose |
1 |
2010 |
| Drug |
ertugliflozin 2 mg split into twice daily |
1 |
2010 |
| Drug |
ertugliflozin 4 mg single dose |
1 |
2010 |
| Drug |
ertugliflozin 4 mg split into twice daily |
1 |
2010 |
| Dietary Supplement |
erythritol |
1 |
2013 |
| Dietary Supplement |
erythritol-containing beverage |
1 |
2012 |
| Drug |
erythropoietin |
1 |
2007 |
| Drug |
escherichia coli endotoxin |
1 |
2006 |
| Drug |
esomeprazole 40mg |
1 |
2018 |
| Drug |
estradiol |
1 |
2018 |
| Drug |
etc-1002 |
1 |
2012 |
| Drug |
ethinyl estradiol |
1 |
2005 |
| Drug |
ethinyl estradiol/levonorgestrel; exenatide |
1 |
2005 |
| Drug |
ethinylestradiol |
1 |
2012 |
| Other |
euglycaemic hyperinsulinaemic clamp |
1 |
2009 |
| Device |
euglycaemic hypoglycaemic insulin clamp |
1 |
2014 |
| Device |
euglycemic clamp |
1 |
2015 |
| Procedure |
euinsulinemic euglycemic glucose clamp |
1 |
2009 |
| Procedure |
euinsulinemic hyperglycemic glucose clamp |
1 |
2009 |
| Behavioral |
evaluation of quality of life health related |
1 |
2019 |
| Behavioral |
evaluation of whiteboard videos |
1 |
2019 |
| Device |
eversenseâ® cgm system |
1 |
2019 |
| Other |
evidence linker |
1 |
2013 |
| Drug |
evogliptin 5mg |
1 |
2014 |
| Drug |
evolocumab 140 mg |
1 |
2019 |
| Drug |
evolocumab 140 mg/ml |
1 |
2019 |
| Other |
evoo with 250 mg |
1 |
2020 |
| Other |
evoo with 250 mg/kg oleocanthal |
1 |
2020 |
| Other |
evoo with 500 mg |
1 |
2020 |
| Other |
evoo with 500 mg/kg oleocanthal |
1 |
2020 |
| Other |
ex inj |
1 |
2009 |
| Other |
ex inj/itca 650 |
1 |
2009 |
| Drug |
ex vivo activated immune cells |
1 |
2014 |
| Drug |
exenatide-bayetta |
1 |
2010 |
| placebo |
exenatide - exenatide - placebo |
1 |
2005 |
| placebo |
exenatide - placebo - exenatide |
1 |
2005 |
| Drug |
exenatide (ac2993) |
1 |
2004 |
| Drug |
exenatide (byetta) |
1 |
2009 |
| Drug |
exenatide (ly2148568) |
1 |
2006 |
| Drug |
exenatide / exendin (9-39) |
1 |
2011 |
| Drug |
exenatide 10 mcg |
1 |
2010 |
| Drug |
exenatide 20 mcg once daily |
1 |
2004 |
| Drug |
exenatide 5 mcg |
1 |
2010 |
| Biological |
exenatide injection(byetta) |
1 |
2017 |
| Drug |
exenatide iv |
1 |
2010 |
| placebo |
exenatide matching placebo |
1 |
2016 |
| Drug |
exenatide once weekly (bydureonâ„¢) |
1 |
2015 |
| placebo |
exenatide placebo |
1 |
2012 |
| Drug |
exenatide sc |
1 |
2010 |
| Drug |
exenatide twice daily (bid) |
1 |
2007 |
| Drug |
exenatide, long acting release |
1 |
2006 |
| Drug |
exenatide/dapagliflozin |
1 |
2017 |
| Drug |
exenatide/insulin glargine |
1 |
2004 |
| Drug |
exenatide/metformin hydrochloride |
1 |
2017 |
| Drug |
exenatide/sitagliptin |
1 |
2009 |
| Drug |
exendin-9 |
1 |
2010 |
| Drug |
exendin-9,39 |
1 |
2016 |
| Drug |
exendin (9-39) |
1 |
2011 |
| Drug |
exendin [9-39] |
1 |
2015 |
| Drug |
exendin 9, 39 |
1 |
2013 |
| Drug |
exendin 9,39 |
1 |
2013 |
| Drug |
exendin(9-39) infusion |
1 |
2007 |
| Drug |
exendin(9-39)amide |
1 |
2011 |
| Drug |
exendin9 |
1 |
2014 |
| Behavioral |
exercise - continuous walking |
1 |
2010 |
| Other |
exercise / acarbose |
1 |
2010 |
| Other |
exercise based-cardiac rehabilitation (eb-cr) program |
1 |
2019 |
| Procedure |
exercise cardiopulmonary metabolic testing |
1 |
2004 |
| Behavioral |
exercise counseling |
1 |
2009 |
| Behavioral |
exercise education |
1 |
2014 |
| Behavioral |
exercise group |
1 |
2009 |
| Behavioral |
exercise healthy volunteers |
1 |
2013 |
| Behavioral |
exercise on prescription |
1 |
2010 |
| Behavioral |
exercise program for adults with type 2 diabetes |
1 |
2019 |
| Other |
exercise then meal |
1 |
2014 |
| Behavioral |
exercise training - interval walking |
1 |
2010 |
| Behavioral |
exercise training for 6 months |
1 |
2005 |
| Other |
exercise training intervention |
1 |
2019 |
| Behavioral |
exercise training, endurance training |
1 |
2010 |
| Behavioral |
exercise under observation |
1 |
2012 |
| Behavioral |
exercise, dietary |
1 |
2012 |
| Behavioral |
exercise, dietary/educational program |
1 |
2012 |
| Other |
exercise, insulin infusion |
1 |
2019 |
| Behavioral |
exercise/nutrition intervention |
1 |
2012 |
| Behavioral |
exercise/weight loss |
1 |
2008 |
| Other |
exergaming training group |
1 |
2019 |
| Device |
exoskeleton |
1 |
2018 |
| Combination Product |
expanded autologous bone marrow-derived mesenchymal stem cell |
1 |
2017 |
| Behavioral |
experimental |
1 |
2009 |
| Other |
experimental nutritional formula #m979 |
1 |
2010 |
| placebo |
experimental: motivational interviewing placebo comparator: traditional lectures |
1 |
2020 |
| Biological |
exploration of microcirculation |
1 |
2018 |
| Biological |
exploration of neuropathy |
1 |
2018 |
| Behavioral |
explore |
1 |
2019 |
| Behavioral |
explore/address other drug related problems |
1 |
2019 |
| Behavioral |
exposure to bright light during the day |
1 |
2019 |
| Behavioral |
exposure to dim light during the day |
1 |
2019 |
| Drug |
extended release metformin |
1 |
2009 |
| Behavioral |
extended sleep intervention |
1 |
2019 |
| Other |
extension of care |
1 |
2013 |
| Other |
external validated risk prediction model |
1 |
2017 |
| Other |
extra virgin olive oil |
1 |
2019 |
| Dietary Supplement |
extra virgin olive oil (evoo) |
1 |
2019 |
| Drug |
extract from hintonia latiflora bark |
1 |
2006 |
| Drug |
extract of agaricus blazei murill |
1 |
2005 |
| Drug |
exubera (inhaled insulin) |
1 |
2005 |
| Drug |
ezetimibe 10 |
1 |
2011 |
| Drug |
ezetimibe 10 mg |
1 |
2007 |
| Drug |
ezetimibe 10 mg oral tablet |
1 |
2018 |
| Drug |
ezetimibe 10/simvastatin 20 |
1 |
2011 |
| Drug |
ezetimibe fdc oral tablet |
1 |
2018 |
| placebo |
ezetimibe placebo |
1 |
2007 |
| Drug |
ezetimibe tablets |
1 |
2008 |
| Behavioral |
face-it intervention |
1 |
2019 |
| Other |
face-to-face |
1 |
2013 |
| Other |
face-to-face intervention |
1 |
2013 |
| Other |
face-to-face intervention/telephone reinforcement |
1 |
2013 |
| Behavioral |
face-to-face lifestyle intervention group |
1 |
2017 |
| Other |
facilitation |
1 |
2011 |
| Device |
fake fir-c abdominal pad |
1 |
2019 |
| Device |
fake fir-c mattress |
1 |
2019 |
| Behavioral |
family-focused intervention arm |
1 |
2017 |
| Behavioral |
family focused lifestyle intervention |
1 |
2010 |
| Behavioral |
farewell program |
1 |
2017 |
| Drug |
farxiga |
1 |
2015 |
| Drug |
fasiglifam |
1 |
2011 |
| Other |
fast |
1 |
2017 |
| Behavioral |
fasted exercise |
1 |
2019 |
| Other |
fasting mimicking diet |
1 |
2019 |
| Behavioral |
fdsme |
1 |
2010 |
| Behavioral |
fdsme group |
1 |
2010 |
| Other |
featforward app (on study smartphone) |
1 |
2015 |
| Procedure |
fecal microbiota transplantation |
1 |
2017 |
| Behavioral |
female inactivity |
1 |
2013 |
| Behavioral |
female inactivity/hypercaloric diet |
1 |
2013 |
| Drug |
fenfuro |
1 |
2016 |
| Drug |
fenofibrate 160 mg |
1 |
2006 |
| Drug |
fenofibrate 160 mg/placebo |
1 |
2006 |
| Drug |
fenofibrate 160 mg/simvastatin 20 mg |
1 |
2006 |
| Drug |
fenofibrate 80 mg |
1 |
2007 |
| Drug |
fenofibrate 80 mg/metformin 1000 mg (fixed combination) |
1 |
2007 |
| Drug |
fenofibrate/coq10 |
1 |
2008 |
| Other |
fenugreek gum fibre |
1 |
2014 |
| Dietary Supplement |
fenugreek seed extract |
1 |
2016 |
| Dietary Supplement |
fermented red ginseng |
1 |
2013 |
| Drug |
ferric carboxymaltose |
1 |
2012 |
| Other |
fiber |
1 |
2011 |
| Dietary Supplement |
fiber mix |
1 |
2017 |
| Other |
fiber rich cereal bars |
1 |
2016 |
| Drug |
fibrate |
1 |
2007 |
| Dietary Supplement |
fibre grain |
1 |
2019 |
| Behavioral |
financial incentive augmented education |
1 |
2016 |
| Behavioral |
financial incentive augmented education/skills training |
1 |
2016 |
| Behavioral |
financial incentives |
1 |
2018 |
| Drug |
finerenone (bay 94-8862) |
1 |
2013 |
| Device |
fir-c abdominal pad |
1 |
2019 |
| Device |
fir-c mattress |
1 |
2019 |
| Dietary Supplement |
fish oil |
1 |
2015 |
| placebo |
fish oil placebo |
1 |
2012 |
| Other |
fish protein hydrolysates |
1 |
2017 |
| Behavioral |
fitness tracker |
1 |
2016 |
| Combination Product |
flash glucose monitoring |
1 |
2019 |
| Behavioral |
flash glucose monitoring with online peer support |
1 |
2019 |
| Combination Product |
flash glucose monitoring/structured education |
1 |
2019 |
| Dietary Supplement |
flavonoid enrichment (cocoa |
1 |
2008 |
| Dietary Supplement |
flavonoid enrichment (cocoa / soy compounds) |
1 |
2008 |
| Drug |
flax lignans |
1 |
2006 |
| Behavioral |
flex |
1 |
2011 |
| Behavioral |
flex/toning health education program |
1 |
2011 |
| Device |
flextouchâ® |
1 |
2008 |
| Drug |
flurbiprofen |
1 |
2008 |
| Dietary Supplement |
folic acid |
1 |
2016 |
| Procedure |
follow-up visits over 6 months |
1 |
2006 |
| Other |
follow up by phone |
1 |
2018 |
| Other |
food boxes |
1 |
2016 |
| Other |
foot exercise training |
1 |
2019 |
| Behavioral |
for diabetics meal replacement supplements |
1 |
2005 |
| Dietary Supplement |
fortified yogurt drink |
1 |
2010 |
| Drug |
forxiga |
1 |
2015 |
| Device |
fractyl duodenal remodeling system |
1 |
2013 |
| Device |
freestyle libre |
1 |
2016 |
| Device |
freestyle libre device, a flash continuous glucose monitoring system |
1 |
2018 |
| Behavioral |
frequency of self monitoring blood glucose |
1 |
2005 |
| Dietary Supplement |
fresh organic vegetables |
1 |
2019 |
| Other |
fresh pomegranate juice |
1 |
2019 |
| Drug |
frio mouth rinse |
1 |
2008 |
| placebo |
frio mouth rinse placebo |
1 |
2008 |
| Other |
fructose |
1 |
2017 |
| Other |
fructose-sweetened beverages |
1 |
2011 |
| Other |
fructose/pizza |
1 |
2017 |
| Other |
fruit juice |
1 |
2014 |
| Drug |
frusemide |
1 |
2017 |
| Drug |
fulacimstat (bay1142524) |
1 |
2018 |
| Other |
full fat dairy |
1 |
2016 |
| Behavioral |
full social interaction program) |
1 |
2013 |
| Behavioral |
functional circuit training with lifestyle behavior |
1 |
2006 |
| Dietary Supplement |
functional medicine |
1 |
2017 |
| Drug |
fx006 32 mg |
1 |
2016 |
| Drug |
g1 |
1 |
2005 |
| Radiation |
ga-68-nodaga-exendin-4 pet |
1 |
2019 |
| Radiation |
ga-68-nodaga-exendin-4 pet/ct |
1 |
2019 |
| Drug |
gadoterate meglumine |
1 |
2010 |
| Other |
game |
1 |
2012 |
| Biological |
gan |
1 |
2017 |
| Biological |
gan/lee insulin glargine injection |
1 |
2017 |
| Device |
gastric banding |
1 |
2013 |
| Procedure |
gastric by-pass surgery |
1 |
2016 |
| Procedure |
gastric bypass w |
1 |
2012 |
| Procedure |
gastric bypass w/ matched hypocaloric diet |
1 |
2012 |
| Radiation |
gastric emptying test |
1 |
2016 |
| Procedure |
gastric sleeve |
1 |
2016 |
| Other |
gather app |
1 |
2015 |
| Drug |
gelofusine |
1 |
2015 |
| Behavioral |
gem |
1 |
2015 |
| Behavioral |
gem lifestyle modification |
1 |
2016 |
| Behavioral |
gem lifestyle modification/continuous glucose monitoring |
1 |
2016 |
| Drug |
gemigliptin / metformin / sitagliptin / metformin / glimepiride / metformin |
1 |
2013 |
| Drug |
gemigliptin 100mg |
1 |
2019 |
| Drug |
gemigliptin 25mg |
1 |
2019 |
| Drug |
gemigliptin 50 mg q.d. |
1 |
2017 |
| Drug |
gemigliptin 50 mg q.d. / metformin 1000 mg twice a day |
1 |
2017 |
| Drug |
gemigliptin and |
1 |
2014 |
| Drug |
gemigliptin and/or rosuvastatin |
1 |
2014 |
| Drug |
gemigliptin ls15-0444 |
1 |
2015 |
| placebo |
gemigliptin placebo |
1 |
2016 |
| Drug |
gemiglptin 50mg multiple dose |
1 |
2019 |
| Behavioral |
general advice on exercise |
1 |
2012 |
| Behavioral |
general health education |
1 |
2009 |
| Other |
general treatment |
1 |
2018 |
| Genetic |
genetic risk counseling |
1 |
2013 |
| Dietary Supplement |
genistein |
1 |
2009 |
| Drug |
gft505 120mg - new formulation |
1 |
2011 |
| Drug |
gft505 120mg - old formulation |
1 |
2011 |
| Drug |
gft505 180mg - new formulation |
1 |
2011 |
| Drug |
gft505 240mg - new formulation |
1 |
2011 |
| Drug |
gft505 300mg - new formulation |
1 |
2011 |
| Drug |
gft505 80mg |
1 |
2010 |
| Device |
gi liner |
1 |
2008 |
| Drug |
gik infusion |
1 |
2014 |
| Drug |
ginkgo biloba extract |
1 |
2002 |
| Dietary Supplement |
ginoff1 |
1 |
2019 |
| Dietary Supplement |
ginseng |
1 |
2012 |
| Drug |
gip bolus |
1 |
2016 |
| Drug |
gip clamp |
1 |
2016 |
| Other |
gip(3-30)nh2 |
1 |
2017 |
| Biological |
gip1-42 infusion |
1 |
2017 |
| Drug |
gk1-399 (formerly ttp399) |
1 |
2011 |
| Drug |
gkt137831 |
1 |
2013 |
| Drug |
glargine / exenatide |
1 |
2015 |
| Drug |
glargine / glulisine |
1 |
2016 |
| Biological |
glargine 0.4 u |
1 |
2017 |
| Biological |
glargine 0.4 u/kg |
1 |
2017 |
| Biological |
glargine 0.6 u |
1 |
2017 |
| Biological |
glargine 0.6 u/kg |
1 |
2017 |
| Drug |
glargine 3.0 nmol |
1 |
2017 |
| Drug |
glargine 3.0 nmol/kg |
1 |
2017 |
| Drug |
glargine 50% |
1 |
2013 |
| Drug |
glargine 80% |
1 |
2013 |
| Drug |
glargine basal-bolus therapy |
1 |
2005 |
| Drug |
glargine insulin vs regular insulin |
1 |
2005 |
| Drug |
glargine u100 |
1 |
2017 |
| Drug |
glargine u300 |
1 |
2017 |
| Drug |
glargine/lispro insulin |
1 |
2017 |
| Drug |
glargine/metformin |
1 |
2013 |
| Drug |
glibenclamide 5 mg |
1 |
2016 |
| Drug |
glibenclamide 5mg tablet |
1 |
2017 |
| Drug |
glicazide |
1 |
2007 |
| Drug |
gliclazide (diamicron, servier) |
1 |
2005 |
| Drug |
gliclazide 30 mg qd |
1 |
2017 |
| Drug |
gliclazide 30 mg qd/bid (n=22) |
1 |
2017 |
| Drug |
gliclazide 30mg qd |
1 |
2016 |
| Drug |
gliclazide 80mg od |
1 |
2013 |
| placebo |
gliclazide matched placebo capsule |
1 |
2013 |
| Drug |
gliclazide mr-based glucose lowering |
1 |
2005 |
| Drug |
gliclazide mr/insulin glargine injection |
1 |
2008 |
| Dietary Supplement |
glicolabâ® |
1 |
2019 |
| Drug |
glimepirde |
1 |
2015 |
| Drug |
glimepiride (low dosage) |
1 |
2020 |
| Drug |
glimepiride (regular dosage) |
1 |
2020 |
| Drug |
glimepiride / insulin glargine (amaryl / lantus) |
1 |
2009 |
| Drug |
glimepiride 1 mg qd (n=24) |
1 |
2014 |
| Drug |
glimepiride 1mg tablet |
1 |
2017 |
| Drug |
glimepiride 4 mg |
1 |
2012 |
| Drug |
glimepiride combination |
1 |
2009 |
| placebo |
glimepiride matching placebo |
1 |
2005 |
| Drug |
glimepiride rescue medication |
1 |
2014 |
| Drug |
glimepiride upto 4 mg oral tablet |
1 |
2018 |
| Drug |
glimepiride/ metformin |
1 |
2011 |
| Drug |
glimepiride/gliclazide |
1 |
2010 |
| Drug |
glimepiride/metformin (amaryl mâ®) - hoe4900 |
1 |
2012 |
| Drug |
glimepiride/metformin fixed combination |
1 |
2008 |
| Drug |
glimepiride/metformin fixed combination/insulin glargine (amarylm / lantus) |
1 |
2009 |
| Drug |
glimepiride/metformin hydrochloride combination (hoe490) |
1 |
2011 |
| Drug |
glimepride |
1 |
2012 |
| Drug |
glimerpiride |
1 |
2013 |
| Drug |
glimiperide |
1 |
2006 |
| Drug |
glinides |
1 |
2011 |
| Drug |
globalagliatin hydrochloride |
1 |
2018 |
| Device |
glooko’s mobile application |
1 |
2016 |
| Device |
glooko mobile insulin dosing system(mids) |
1 |
2017 |
| Drug |
gloucose |
1 |
2010 |
| Drug |
glp-1 |
1 |
2009 |
| Drug |
glp-1 analog |
1 |
2012 |
| Drug |
glp-1 high dose |
1 |
2012 |
| Drug |
glp-1 low dose |
1 |
2012 |
| Drug |
glp-1 mid-range dose |
1 |
2012 |
| Drug |
glp-1 receptor agonist (liraglutide) |
1 |
2013 |
| Other |
glp-2 |
1 |
2019 |
| Drug |
glucagon-like peptide- 1 (glp-1) infusion |
1 |
2013 |
| Drug |
glucagon-like peptide-1, |
1 |
2008 |
| Drug |
glucagon-like peptide 1 |
1 |
2011 |
| Drug |
glucagon / gsk1362885 |
1 |
2009 |
| Drug |
glucagon like peptide-1 |
1 |
2009 |
| Dietary Supplement |
glucerna formula |
1 |
2016 |
| Dietary Supplement |
glucerna; ensure; slimfast |
1 |
2009 |
| Dietary Supplement |
glucernaâ® abbott nutrition |
1 |
2019 |
| Drug |
glucobay |
1 |
2019 |
| Drug |
glucobayâ® |
1 |
2007 |
| Device |
glucoject dual s lancing device (menarini) |
1 |
2020 |
| Drug |
glucokinase activator |
1 |
2019 |
| Drug |
gluconorm |
1 |
2007 |
| Drug |
glucophage tablet fasted |
1 |
2012 |
| Drug |
glucophage tablet fed |
1 |
2012 |
| Drug |
glucophage xr 500 mg er tablets bristol-myers squibb |
1 |
2009 |
| Drug |
glucophageâ® |
1 |
2018 |
| Other |
glucose-potentiated arginine-induced insulin secretion |
1 |
2015 |
| Other |
glucose-sweetened beverages |
1 |
2011 |
| Drug |
glucose dependent insulinotropic polypeptide |
1 |
2008 |
| Behavioral |
glucose fluctuation targeted intervention |
1 |
2019 |
| Drug |
glucose infusion |
1 |
2008 |
| Drug |
glucose lowering therapy |
1 |
2006 |
| Device |
glucose meter |
1 |
2012 |
| Other |
glucose reference 1 |
1 |
2019 |
| Other |
glucose reference 2 |
1 |
2019 |
| Other |
glucose reference 3 |
1 |
2019 |
| Other |
glucose solution |
1 |
2013 |
| Device |
glucotab |
1 |
2017 |
| Procedure |
glucotoxicity |
1 |
2011 |
| Drug |
glulisine |
1 |
2016 |
| Drug |
glulisine (apidra) |
1 |
2007 |
| Drug |
glulisine insulin |
1 |
2017 |
| Drug |
glurenormâ® |
1 |
2007 |
| Drug |
glutamine (pharmacological doses) |
1 |
2014 |
| Dietary Supplement |
glutathione |
1 |
2016 |
| Dietary Supplement |
gluten |
1 |
2009 |
| Dietary Supplement |
glycated beta-lactoglobulins. |
1 |
2011 |
| Drug |
glycemic rescue 1 |
1 |
2011 |
| Biological |
glycemic rescue 2 |
1 |
2011 |
| Device |
glycemic sensor freestyle libre pro |
1 |
2017 |
| Drug |
glyclazide |
1 |
2006 |
| Behavioral |
glycoleap |
1 |
2017 |
| Other |
gmnl-263 |
1 |
2014 |
| Behavioral |
goal setting |
1 |
2016 |
| Dietary Supplement |
golo release |
1 |
2018 |
| Drug |
gosogliptin |
1 |
2017 |
| Dietary Supplement |
gp group |
1 |
2008 |
| Drug |
gp40081 |
1 |
2020 |
| Other |
graded intravenous glucose infusion |
1 |
2017 |
| Drug |
grape seed polyphenolic extract, resveratrol |
1 |
2015 |
| Other |
green beans - control |
1 |
2019 |
| Dietary Supplement |
greenyn momordica charantia extracts |
1 |
2017 |
| Behavioral |
group-based lifestyle intervention |
1 |
2012 |
| Behavioral |
group 1 |
1 |
2017 |
| Behavioral |
group 2 |
1 |
2017 |
| Behavioral |
group based non-pharmacological rehabilitation |
1 |
2006 |
| Other |
group course |
1 |
2019 |
| Other |
group exercise training |
1 |
2016 |
| Behavioral |
group lifestyle programme |
1 |
2011 |
| Behavioral |
group meetings |
1 |
2015 |
| Behavioral |
group problem-solving training |
1 |
2009 |
| Other |
group program |
1 |
2013 |
| Behavioral |
group treatment |
1 |
2011 |
| Behavioral |
group treatment/par |
1 |
2011 |
| Behavioral |
group visits |
1 |
2011 |
| placebo |
gsk189075-placebo |
1 |
2006 |
| Drug |
gsk189075 (modified |
1 |
2007 |
| Drug |
gsk189075 (modified/immediate release formulations) |
1 |
2007 |
| Drug |
gsk189075a |
1 |
2012 |
| Drug |
gsk2376497 |
1 |
2011 |
| Drug |
gsk256073 |
1 |
2010 |
| Drug |
gsk256073 10mg |
1 |
2011 |
| Drug |
gsk256073 1mg |
1 |
2011 |
| Drug |
gsk256073 25mg |
1 |
2011 |
| Drug |
gsk256073 5mg |
1 |
2011 |
| Drug |
gsk523338 |
1 |
2005 |
| Drug |
gsk716155 |
1 |
2007 |
| Drug |
gsk716155 for injection |
1 |
2007 |
| Device |
gts (continuous glucose monitoring) |
1 |
2018 |
| Dietary Supplement |
guar gum |
1 |
2008 |
| Device |
guardian mobile app |
1 |
2014 |
| Device |
guardian rt |
1 |
2007 |
| Drug |
guazuma ulmifolia |
1 |
2017 |
| Drug |
guazuma ulmifolia/tecoma stans |
1 |
2017 |
| Behavioral |
guided self-determination |
1 |
2019 |
| Behavioral |
guidelines |
1 |
2005 |
| Behavioral |
guidelines breakfast |
1 |
2016 |
| Behavioral |
guilty feelings |
1 |
2020 |
| Drug |
gw677954 |
1 |
2005 |
| Drug |
gw823093 15mg |
1 |
2006 |
| Drug |
gw823093 30mg |
1 |
2006 |
| placebo |
gw823093 placebo capsule |
1 |
2006 |
| Drug |
gw869682 |
1 |
2006 |
| placebo |
gw869682-placebo |
1 |
2006 |
| Drug |
gw869682 oral tablets |
1 |
2006 |
| Drug |
gwp42003 |
1 |
2010 |
| Device |
h-tron |
1 |
2005 |
| Device |
h-tron/v100; disetronic medical system, burgdorf, switzerland |
1 |
2005 |
| Device |
haemofine 33g lancets (htl-strefa s.a.) |
1 |
2020 |
| Device |
handgrip strength measurement |
1 |
2018 |
| Other |
hba1c measurement |
1 |
2012 |
| Drug |
hctz |
1 |
2008 |
| Drug |
hctz 12.5mg |
1 |
2010 |
| Drug |
he3286 |
1 |
2008 |
| Behavioral |
heal-d |
1 |
2018 |
| Behavioral |
health |
1 |
2016 |
| Behavioral |
health at every size (haes) |
1 |
2003 |
| Device |
health counseling based on ttm |
1 |
2011 |
| Behavioral |
health education app |
1 |
2017 |
| Behavioral |
health education group |
1 |
2017 |
| Behavioral |
health education/coaching strategy |
1 |
2015 |
| Behavioral |
health education/physical activity program |
1 |
2018 |
| Other |
health promotion outreach |
1 |
2011 |
| Other |
health usual care |
1 |
2011 |
| Behavioral |
health/wellness website |
1 |
2016 |
| Behavioral |
health[e]teen |
1 |
2012 |
| Behavioral |
health[e]teen / cst |
1 |
2012 |
| Behavioral |
healthium |
1 |
2006 |
| Drug |
healthy diet |
1 |
2018 |
| Behavioral |
healthy diet a |
1 |
2013 |
| Behavioral |
healthy diet b |
1 |
2013 |
| Behavioral |
healthy lifestyle intervention |
1 |
2019 |
| Behavioral |
healthy lifestyle prescription |
1 |
2017 |
| Diagnostic Test |
heating |
1 |
2018 |
| Other |
herbal extract; root of woody shrub grown in india |
1 |
2007 |
| Other |
herbal extract; root of woody shrub grown in india/sri-lanka |
1 |
2007 |
| Dietary Supplement |
herbal tea |
1 |
2019 |
| Other |
hfd meal: high fiber from food |
1 |
2014 |
| Dietary Supplement |
hfs meal: high fiber from supplement |
1 |
2014 |
| Behavioral |
high-age vs. low-age meal |
1 |
2007 |
| Behavioral |
high-carbohydrate diet |
1 |
2016 |
| Other |
high-carbohydrate meal intake |
1 |
2018 |
| Other |
high-cho diet |
1 |
2008 |
| Drug |
high-dose colesevelam |
1 |
2010 |
| Other |
high-fat meal intake |
1 |
2018 |
| Dietary Supplement |
high-fiber vegetarian meal |
1 |
2019 |
| Other |
high-fructose corn syrup-sweetened beverages |
1 |
2011 |
| Behavioral |
high-fruit diet |
1 |
2018 |
| Procedure |
high-intensity exercise |
1 |
2013 |
| Other |
high-intensity interval exercise training (hiit) |
1 |
2017 |
| Other |
high-intensity interval training physical activity (pa) advice |
1 |
2019 |
| Other |
high-mufa diet |
1 |
2008 |
| Other |
high-protein meal intake |
1 |
2018 |
| Other |
high animal protein diet (hapd) |
1 |
2019 |
| Other |
high animal protein diet group |
1 |
2015 |
| Other |
high caloric diet |
1 |
2018 |
| Other |
high calorie meal |
1 |
2013 |
| Other |
high carb breakfast |
1 |
2014 |
| Dietary Supplement |
high carbohydrate - low fat diet |
1 |
2009 |
| Other |
high carbohydrate (hc) weight loss diet |
1 |
2019 |
| Dietary Supplement |
high carbohydrate overfeeding |
1 |
2016 |
| Drug |
high carbohydrate, low glycemic index foods |
1 |
2005 |
| Dietary Supplement |
high cereal fibre |
1 |
2010 |
| Other |
high cereal fibre diets |
1 |
2007 |
| Dietary Supplement |
high content of mc-sfa |
1 |
2011 |
| Behavioral |
high dairy |
1 |
2007 |
| Behavioral |
high dairy/calcium intake |
1 |
2007 |
| Other |
high dialysate bath |
1 |
2011 |
| placebo |
high dose bi 10773 placebo |
1 |
2011 |
| Drug |
high dose fdc |
1 |
2011 |
| placebo |
high dose fdc placebo |
1 |
2011 |
| Drug |
high dose of bi 1356 bs |
1 |
2014 |
| Dietary Supplement |
high dose plant based ingredient |
1 |
2014 |
| Other |
high fat |
1 |
2013 |
| Other |
high fat meal |
1 |
2019 |
| Other |
high fat/high calorie meal |
1 |
2013 |
| Other |
high fiber vs. low-carbohydrate diets |
1 |
2010 |
| Other |
high fiber/low glycemic index diet / pa |
1 |
2009 |
| Other |
high fiber/moderate fiber diets |
1 |
2009 |
| Other |
high fibre |
1 |
2009 |
| Other |
high fibre/low glycemic index diet-pa |
1 |
2009 |
| Dietary Supplement |
high glycaemic diet |
1 |
2017 |
| Other |
high glycemic index |
1 |
2016 |
| Other |
high glycemic index meal |
1 |
2014 |
| Behavioral |
high intensity |
1 |
2009 |
| Other |
high intensity aerobic interval training |
1 |
2013 |
| Behavioral |
high intensity exercise training |
1 |
2011 |
| Behavioral |
high intensity interval exercise |
1 |
2010 |
| Other |
high monounsaturated fat shake |
1 |
2009 |
| Other |
high oleic sunflower oil |
1 |
2013 |
| Other |
high plant protein diet (hppd) |
1 |
2019 |
| Other |
high plant protein diet group |
1 |
2015 |
| Other |
high polyunsaturated fat shake |
1 |
2009 |
| Other |
high protein (hp) weight loss diet |
1 |
2019 |
| Other |
high protein breakfast |
1 |
2014 |
| Behavioral |
high protein diet |
1 |
2019 |
| Other |
high saturated fat shake |
1 |
2009 |
| Other |
higher carbohydrate, lower fat diet |
1 |
2011 |
| Dietary Supplement |
highland barley diet |
1 |
2017 |
| Behavioral |
hiit |
1 |
2017 |
| Behavioral |
hiit/with rt group |
1 |
2017 |
| Drug |
hip2b |
1 |
2013 |
| Other |
hipa |
1 |
2017 |
| Other |
home-training |
1 |
2017 |
| Behavioral |
home exercise |
1 |
2011 |
| Behavioral |
home exercise/physical activity (pa) enhancement program with behavioral support |
1 |
2011 |
| Behavioral |
home health |
1 |
2010 |
| Behavioral |
home health/primary care collaboration |
1 |
2010 |
| Other |
home healthcare services |
1 |
2020 |
| Device |
home telehealth system |
1 |
2014 |
| Other |
home visits, health education |
1 |
2019 |
| Other |
home visits/group program |
1 |
2013 |
| Behavioral |
home visits/lifestyle education support |
1 |
2014 |
| Drug |
htd1801 |
1 |
2018 |
| Drug |
htd4010 |
1 |
2015 |
| Drug |
htn medications as needed |
1 |
2017 |
| Drug |
humalog mix 50 |
1 |
2005 |
| Drug |
humalog mix 75 |
1 |
2014 |
| Drug |
humalog mix 75/25 |
1 |
2014 |
| Drug |
humalogâ® mix25 |
1 |
2016 |
| Drug |
humalogâ® mix25 at 0.8 u |
1 |
2017 |
| Drug |
humalogâ® mix25 at 0.8 u/kg |
1 |
2017 |
| Other |
human glucagon-like peptide 1 (7-36)amide |
1 |
2012 |
| Other |
human glucagon-like peptide 1 (9-36)amide |
1 |
2012 |
| Drug |
human insulin (novolin-r, novo nordisk) |
1 |
2005 |
| Drug |
human insulin [nph] |
1 |
2009 |
| Drug |
human insulin isophane suspension |
1 |
2005 |
| Drug |
human insulin isophane suspension (nph) |
1 |
2005 |
| Drug |
human insulin mix 50:50 |
1 |
2005 |
| Drug |
human insulin nph |
1 |
2013 |
| Drug |
human insulin nph (novolin-n, novo nordisk) |
1 |
2005 |
| Drug |
human regular insulin (low dosage) |
1 |
2020 |
| Drug |
human regular insulin (regular dosage) |
1 |
2020 |
| Drug |
human regular insulin intravenously |
1 |
2009 |
| Drug |
human regular u-500 insulin |
1 |
2013 |
| Drug |
human regular u-500 insulin (csii) |
1 |
2015 |
| Drug |
human regular u-500 insulin (mdi) |
1 |
2015 |
| Drug |
humulin-r |
1 |
2009 |
| Drug |
humulin r u-500 |
1 |
2014 |
| Drug |
humulin s |
1 |
2016 |
| Device |
hydrasolve t2dâ„¢ |
1 |
2019 |
| Drug |
hydrochlorothiazide (hctz) |
1 |
2008 |
| placebo |
hydrochlorothiazide placebo |
1 |
2017 |
| Dietary Supplement |
hydrolyzed pine nut oil/olive oil |
1 |
2018 |
| Other |
hyperbaric oxygen |
1 |
2018 |
| Device |
hyperbaric oxygen chamber |
1 |
2019 |
| Procedure |
hyperinsulinaemia |
1 |
2009 |
| Other |
hyperinsulinaemic |
1 |
2018 |
| Other |
hyperinsulinaemic/hypoglycaemic clamp |
1 |
2018 |
| Procedure |
hyperinsulinemic euglycemic clamp |
1 |
2018 |
| Procedure |
hyperinsulinemic euglycemic glucose clamp |
1 |
2009 |
| Other |
hyperinsulinemic hyperglycemic clamp |
1 |
2007 |
| Procedure |
hyperinsulinemic hyperglycemic glucose clamp |
1 |
2009 |
| Other |
hyperinsulinemic hypoglycemic clamp |
1 |
2007 |
| Procedure |
hyperinsulinemic normoglycaemic-hypoglycaemic glucose clamp |
1 |
2018 |
| Drug |
hyperinsulinemic, euglycemic clamp |
1 |
2016 |
| Other |
hypocaloric diet |
1 |
2012 |
| Procedure |
hypoglycemic event monitoring |
1 |
2005 |
| Other |
hypoxia |
1 |
2019 |
| Device |
hypoxico altitude training systems |
1 |
2015 |
| Procedure |
i-ace intervention |
1 |
2013 |
| Behavioral |
i-start |
1 |
2019 |
| Drug |
i.v. nnc 0113-0987 |
1 |
2011 |
| Other |
ibg star (iphone) internet blood glucose method |
1 |
2013 |
| Other |
ibuprofen |
1 |
2020 |
| Procedure |
iigi |
1 |
2015 |
| Drug |
il-1ra |
1 |
2006 |
| Procedure |
ileal interposition with a sleeve gastrectomy |
1 |
2007 |
| Drug |
iloprost infusion |
1 |
2017 |
| Other |
imm |
1 |
2008 |
| Drug |
immediate-release aspirin tablets |
1 |
2012 |
| Behavioral |
immediate cognitive behavioural therapy (cbt) |
1 |
2008 |
| Drug |
immediate release formulations) |
1 |
2007 |
| Drug |
imp oral tablet |
1 |
2020 |
| Procedure |
implant placement |
1 |
2009 |
| Procedure |
implants surgery |
1 |
2009 |
| Drug |
in-105 (insulin tregopil) |
1 |
2017 |
| Behavioral |
in-person diabetes prevention program |
1 |
2015 |
| Dietary Supplement |
inactive comparator |
1 |
2010 |
| Behavioral |
inactivity/hypercaloric diet |
1 |
2013 |
| Behavioral |
inactivity/iso-caloric diet |
1 |
2013 |
| Drug |
incb013739 |
1 |
2007 |
| Behavioral |
increased fiber intake |
1 |
2017 |
| Behavioral |
increased intensity |
1 |
2018 |
| Drug |
incretin analogues |
1 |
2014 |
| Drug |
incretin effect |
1 |
2017 |
| Drug |
incretinomimetics |
1 |
2014 |
| Drug |
indapamide |
1 |
2009 |
| Device |
indirect calorimetry |
1 |
2016 |
| Behavioral |
individual-focused intervention arm |
1 |
2017 |
| Behavioral |
individual consultations |
1 |
2015 |
| Behavioral |
individual education (ie) |
1 |
2008 |
| Behavioral |
individual non-pharmacological rehabilitation |
1 |
2006 |
| Behavioral |
individual problem-solving training |
1 |
2009 |
| Behavioral |
individual reward |
1 |
2016 |
| Other |
individual treatment |
1 |
2013 |
| Other |
individualized counseling |
1 |
2011 |
| Other |
individualized structured dietary plan based on md |
1 |
2020 |
| Other |
indoor rowing |
1 |
2015 |
| Behavioral |
information |
1 |
2009 |
| Behavioral |
information on high risk factor levels |
1 |
2014 |
| Behavioral |
information on high risk factor levels/lifestyle advice |
1 |
2014 |
| Drug |
infusion bmmncs |
1 |
2012 |
| Drug |
infusion of bmmscs |
1 |
2012 |
| Drug |
ingap-peptide |
1 |
2003 |
| Drug |
ingap peptide |
1 |
2002 |
| Drug |
inh 139 u |
1 |
2016 |
| Drug |
inh 208 u |
1 |
2016 |
| Drug |
inh 69 u (high) |
1 |
2016 |
| Drug |
inh 69 u (low) |
1 |
2016 |
| Drug |
inhaled human insulin (exubera) |
1 |
2006 |
| Drug |
inhaled human insulin (exuberaâ„¢) |
1 |
2007 |
| Drug |
inhaled human insulin (exuberaâ®) |
1 |
2006 |
| Drug |
inhaled insulin |
1 |
2005 |
| Drug |
inhaled insulin (exubera) |
1 |
2007 |
| Drug |
injectable insulin |
1 |
2006 |
| Procedure |
injection-meal-interval |
1 |
2007 |
| Drug |
injection of 6-dig |
1 |
2010 |
| placebo |
inpiratory muscle training placebo |
1 |
2008 |
| Behavioral |
insomnia intervention |
1 |
2017 |
| Behavioral |
inspiratory muscle training |
1 |
2008 |
| Drug |
inspra (eplerenone) |
1 |
2013 |
| Device |
insulclock with feedback |
1 |
2017 |
| Device |
insulclock without feedback |
1 |
2017 |
| Drug |
insulin-levemir |
1 |
2010 |
| Drug |
insulin-levemir/exenatide-bayetta |
1 |
2010 |
| Drug |
insulin (glargine) |
1 |
2013 |
| Drug |
insulin (humulin s) |
1 |
2014 |
| Drug |
insulin (nph |
1 |
2008 |
| Drug |
insulin (nph/regular) |
1 |
2008 |
| Drug |
insulin 320 |
1 |
2015 |
| Drug |
insulin analog mid mixture |
1 |
2017 |
| Drug |
insulin aspart 100 ie |
1 |
2012 |
| Drug |
insulin aspart 100 ie/ml |
1 |
2012 |
| Drug |
insulin aspart 30 |
1 |
2013 |
| Drug |
insulin aspart 40 |
1 |
2013 |
| Drug |
insulin aspart 50 |
1 |
2013 |
| Drug |
insulin aspart, insulin glargine |
1 |
2011 |
| Drug |
insulin biasp30 (novolog 70 |
1 |
2005 |
| Drug |
insulin biasp30 (novolog 70/30) |
1 |
2005 |
| Drug |
insulin biphasic aspart 30 |
1 |
2006 |
| Drug |
insulin biphasic aspart 30/70 |
1 |
2006 |
| Drug |
insulin bolus |
1 |
2014 |
| Drug |
insulin degludec, 100 u |
1 |
2016 |
| Drug |
insulin degludec, 100 u/ml |
1 |
2016 |
| Drug |
insulin degludec/insulin aspart 30 |
1 |
2013 |
| Drug |
insulin degludec/insulin aspart 40 |
1 |
2013 |
| Drug |
insulin degludec/insulin aspart 50 |
1 |
2013 |
| Drug |
insulin detemir, insulin insulatard |
1 |
2008 |
| Drug |
insulin detemir/pre-meal insulin aspart. |
1 |
2009 |
| Drug |
insulin detemir; insulin insulatard |
1 |
2008 |
| Other |
insulin dose titration system using a sms |
1 |
2009 |
| Other |
insulin education class |
1 |
2008 |
| Drug |
insulin glargine (amaryl |
1 |
2009 |
| Drug |
insulin glargine (amarylm |
1 |
2009 |
| Drug |
insulin glargine (hoe901 - u100) |
1 |
2014 |
| Drug |
insulin glargine (hoe901 - u300) |
1 |
2014 |
| Drug |
insulin glargine (hoe901) [lantus] |
1 |
2009 |
| Drug |
insulin glargine (hoe901)/nph insulin |
1 |
2009 |
| Drug |
insulin glargine (lantusâ®) |
1 |
2006 |
| Drug |
insulin glargine (mandatory background drug) |
1 |
2013 |
| Drug |
insulin glargine / exenatide / preexisting metformin |
1 |
2009 |
| Drug |
insulin glargine / preexisting metformin |
1 |
2009 |
| Drug |
insulin glargine / preprandial lispro insulin |
1 |
2009 |
| Drug |
insulin glargine / sitagliptin / preexisting metformin |
1 |
2009 |
| Drug |
insulin glargine /lixisenatide fixed ratio combination |
1 |
2011 |
| Drug |
insulin glargine [rdna origin] injection |
1 |
2006 |
| Drug |
insulin glargine 0.5 u |
1 |
2007 |
| Drug |
insulin glargine 0.5 u/kg body wt sc |
1 |
2007 |
| Drug |
insulin glargine 1.0 u |
1 |
2007 |
| Drug |
insulin glargine 1.0 u/kg body wt sc |
1 |
2007 |
| Drug |
insulin glargine 1.5 u |
1 |
2007 |
| Drug |
insulin glargine 1.5 u/kg body wt sc |
1 |
2007 |
| Drug |
insulin glargine 100 unt |
1 |
2019 |
| Drug |
insulin glargine 100 unt/ml |
1 |
2019 |
| Drug |
insulin glargine 2.0 u |
1 |
2007 |
| Drug |
insulin glargine 2.0 u/kg body wt sc |
1 |
2007 |
| Drug |
insulin glargine 300 unt |
1 |
2017 |
| Drug |
insulin glargine 300 unt/ml |
1 |
2017 |
| Drug |
insulin glargine at bedtime instead of nph |
1 |
2008 |
| Drug |
insulin glargine ezelin |
1 |
2017 |
| Drug |
insulin glargine hoe 901 |
1 |
2011 |
| Drug |
insulin glargine injection |
1 |
2008 |
| Drug |
insulin glargine new formulation (hoe901) |
1 |
2012 |
| Drug |
insulin glargine pen injector [lantus] |
1 |
2017 |
| Biological |
insulin glargine rescue medication |
1 |
2014 |
| Drug |
insulin glargine u100 (hoe901) |
1 |
2016 |
| Drug |
insulin glargine u100 (low dosage) |
1 |
2020 |
| Drug |
insulin glargine u100 (regular dosage) |
1 |
2020 |
| Drug |
insulin glargine u300 (new formulation of insulin glargine) hoe901 |
1 |
2014 |
| Drug |
insulin glargine, 100 u |
1 |
2015 |
| Drug |
insulin glargine, 100 u/ml |
1 |
2015 |
| Drug |
insulin glargine, 300 u |
1 |
2015 |
| Drug |
insulin glargine, 300 u/ml |
1 |
2015 |
| Drug |
insulin glargine, 300u |
1 |
2016 |
| Drug |
insulin glargine, 300u/ml |
1 |
2016 |
| Drug |
insulin glargine/ lixisenatide fixed-ratio combination hoe901/ave0010 |
1 |
2016 |
| Drug |
insulin glargine/exenatide |
1 |
2004 |
| Drug |
insulin glargine/insulin lispro |
1 |
2014 |
| Drug |
insulin glargine/lixisenatide hoe901/ave0010 |
1 |
2018 |
| Drug |
insulin glulisine qd |
1 |
2013 |
| Drug |
insulin glulisine tid |
1 |
2013 |
| Drug |
insulin glulisine, insulin glargine |
1 |
2012 |
| Drug |
insulin human |
1 |
2011 |
| Drug |
insulin human (hr1799) |
1 |
2012 |
| Drug |
insulin human/insuman comb 25 (hr1799) |
1 |
2011 |
| Drug |
insulin human/novolinâ® 30r |
1 |
2011 |
| Biological |
insulin humulinâ® nph |
1 |
2019 |
| Other |
insulin infusion protocol |
1 |
2019 |
| Drug |
insulin lispro (humalog u-100) |
1 |
2019 |
| Drug |
insulin lispro biphasic 25 |
1 |
2019 |
| Drug |
insulin lispro injection |
1 |
2013 |
| Drug |
insulin lispro injection [rdna origin] low mix |
1 |
2005 |
| Drug |
insulin lispro injection, exenatide injection |
1 |
2013 |
| Drug |
insulin lispro lm |
1 |
2006 |
| Drug |
insulin lispro low mix |
1 |
2007 |
| Drug |
insulin lispro low mixture |
1 |
2007 |
| Drug |
insulin lispro low mixture (lm) |
1 |
2010 |
| Drug |
insulin lispro mid mixture (mm) |
1 |
2006 |
| Drug |
insulin lispro mix 25 |
1 |
2007 |
| Drug |
insulin lispro mix25 |
1 |
2013 |
| Drug |
insulin lispro mix50 |
1 |
2013 |
| Drug |
insulin lispro mm |
1 |
2006 |
| Drug |
insulin lispro premix |
1 |
2010 |
| Drug |
insulin lispro premix (mid-mixture |
1 |
2008 |
| Drug |
insulin lispro premix (mid-mixture/low-mixture) |
1 |
2008 |
| Drug |
insulin lispro protamine suspension (ilps) |
1 |
2008 |
| Drug |
insulin lispro protamine suspension:insulin lispro rdna origin low mix |
1 |
2005 |
| Drug |
insulin monotherapy with premixed insulin nph 30 |
1 |
2008 |
| Drug |
insulin monotherapy with premixed insulin nph 30/70 |
1 |
2008 |
| Device |
insulin pen (novo-nordisk flexpenâ®) |
1 |
2015 |
| Biological |
insulin protocol |
1 |
2013 |
| Device |
insulin pump (medtronic minimed paradigmâ® veo) |
1 |
2010 |
| Device |
insulin pump accu-chek combo |
1 |
2015 |
| Device |
insulin pump therapy |
1 |
2008 |
| Biological |
insulin rinsulinâ® nph |
1 |
2019 |
| Drug |
insulin sc |
1 |
2016 |
| Drug |
insulin secretagogue |
1 |
2005 |
| Drug |
insulin sensitizer |
1 |
2003 |
| Drug |
insulin treatment during ramadan |
1 |
2011 |
| Drug |
insulin tregopil |
1 |
2017 |
| Drug |
insulin viajectâ„¢ (75%) |
1 |
2009 |
| Drug |
insulin viajectâ„¢ (90%) |
1 |
2009 |
| Drug |
insulin, asp(b28)- |
1 |
2015 |
| Drug |
insulin, regular - act rapid |
1 |
2012 |
| Drug |
insulin, sulfonylurea |
1 |
2000 |
| Drug |
insulin/ glargine |
1 |
2009 |
| Drug |
insulin/canaglifozin |
1 |
2019 |
| Drug |
insulin/dapaglifozin |
1 |
2019 |
| Drug |
insulin/empaglifozin |
1 |
2019 |
| Drug |
insuline glargine |
1 |
2006 |
| Drug |
insulins aspart |
1 |
2007 |
| Drug |
insulins aspart/detemir |
1 |
2007 |
| Drug |
insuman comb 25 (hr1799) |
1 |
2011 |
| Device |
insupad |
1 |
2012 |
| Drug |
int-747 |
1 |
2007 |
| Drug |
int131 besylate |
1 |
2008 |
| Behavioral |
integrated program of nutrition, activity, behavior, |
1 |
2007 |
| Behavioral |
integrated program of nutrition, activity, behavior,/promotion |
1 |
2007 |
| Behavioral |
integration of a team based clinical pharmacist |
1 |
2006 |
| Other |
intense education intervention |
1 |
2019 |
| Procedure |
intensified insulin therapy |
1 |
2016 |
| Behavioral |
intensified lifestyle intervention |
1 |
2013 |
| Behavioral |
intensive |
1 |
2018 |
| Behavioral |
intensive behavioral intervention |
1 |
2018 |
| Other |
intensive control |
1 |
2011 |
| Drug |
intensive diabetes management starting with an adjusted dose of human insulin inhalation powder |
1 |
2006 |
| Behavioral |
intensive diet intervention |
1 |
2019 |
| Other |
intensive discharge intervention |
1 |
2013 |
| Behavioral |
intensive education |
1 |
2010 |
| Behavioral |
intensive education of the doctor |
1 |
2010 |
| Behavioral |
intensive education of the doctor/nursing team on the protocol |
1 |
2010 |
| Behavioral |
intensive exercise |
1 |
2009 |
| Drug |
intensive glycemic control |
1 |
2009 |
| Drug |
intensive insulin |
1 |
2010 |
| Drug |
intensive insulin group |
1 |
2007 |
| Other |
intensive insulin treatment |
1 |
2006 |
| Behavioral |
intensive intervention |
1 |
2015 |
| Behavioral |
intensive life-style |
1 |
2012 |
| Behavioral |
intensive lifestyle |
1 |
2000 |
| Behavioral |
intensive treatment |
1 |
2007 |
| Other |
inteprofessional medication adherence support program (imap) |
1 |
2019 |
| Behavioral |
interactive dialogue to educate |
1 |
2008 |
| Behavioral |
interactive dialogue to educate/activate (idea) |
1 |
2008 |
| Other |
interactive digital platform |
1 |
2018 |
| Behavioral |
interactive technology (it) |
1 |
2003 |
| Device |
interactive videogame wii fit plus |
1 |
2012 |
| Behavioral |
interactive web-based materials |
1 |
2013 |
| Behavioral |
intergenerational mobile technology opportunities program |
1 |
2016 |
| Other |
intermediate care clinics (iccs) |
1 |
2009 |
| Other |
internet based exercise training |
1 |
2016 |
| Behavioral |
internet diabetes self-management program |
1 |
2005 |
| Behavioral |
internet insulin education |
1 |
2011 |
| Other |
interval walking training |
1 |
2015 |
| Other |
intervention 1 |
1 |
2015 |
| Other |
intervention 2 |
1 |
2015 |
| Dietary Supplement |
intervention a |
1 |
2017 |
| Dietary Supplement |
intervention b |
1 |
2017 |
| Dietary Supplement |
intervention c |
1 |
2017 |
| Dietary Supplement |
intervention d |
1 |
2017 |
| Device |
intervention group |
1 |
2012 |
| Other |
intervention ingest a 48 mg of sucralose |
1 |
2018 |
| Other |
intervention ingest a 96 mg of stevia |
1 |
2018 |
| Behavioral |
intervention ppil |
1 |
2014 |
| Behavioral |
intervention to patients |
1 |
2012 |
| Behavioral |
intervention to professionals |
1 |
2012 |
| Behavioral |
intervention: pharmaceutical care |
1 |
2012 |
| Biological |
intima-media thickness measurement |
1 |
2018 |
| Device |
intradermal insulin delivery: bd research catheter set |
1 |
2010 |
| Procedure |
intragastric balloon |
1 |
2016 |
| Device |
intragastric balloon implantation |
1 |
2016 |
| Dietary Supplement |
intralipid |
1 |
2009 |
| Dietary Supplement |
intralipid //- omegaven |
1 |
2009 |
| Drug |
intralipid, 20% intravenous emulsion |
1 |
2018 |
| Drug |
intravenous insulin |
1 |
2011 |
| Drug |
intravitreous injection of pegaptanib |
1 |
2011 |
| Dietary Supplement |
inulin |
1 |
2015 |
| Drug |
inv-144 |
1 |
2011 |
| Drug |
iobitridol |
1 |
2010 |
| Drug |
ionis dgat2rx |
1 |
2017 |
| Drug |
ipragliflozin l-proline |
1 |
2016 |
| Device |
ipro2 cgm with enlite sensors |
1 |
2017 |
| Device |
ipro2 glucose sensor attachment |
1 |
2013 |
| Device |
ipro2 professional cgm |
1 |
2017 |
| Drug |
irbesartan treatment |
1 |
2006 |
| Device |
irf system hepatic denervation |
1 |
2020 |
| Other |
isage |
1 |
2018 |
| Device |
isage app with connected glucometer |
1 |
2019 |
| Other |
ischemic preconditioning |
1 |
2018 |
| Drug |
isis-gccrrx |
1 |
2013 |
| Drug |
isis-gcgrrx |
1 |
2016 |
| Drug |
isis-gcgrrx- dose level 1 |
1 |
2015 |
| Drug |
isis-gcgrrx- dose level 2 |
1 |
2015 |
| Drug |
isis-gcgrrx - dose level 1 |
1 |
2013 |
| Drug |
isis-gcgrrx - dose level 2 |
1 |
2013 |
| Drug |
isis-ptp1brx |
1 |
2013 |
| Drug |
isis 325568 |
1 |
2007 |
| Drug |
isis 388626 |
1 |
2009 |
| Drug |
isis 703802 |
1 |
2017 |
| Behavioral |
iso-caloric diet |
1 |
2013 |
| Dietary Supplement |
isoflavones |
1 |
2012 |
| Other |
isomaltooligosaccharides (imos) |
1 |
2018 |
| Dietary Supplement |
isomaltulose |
1 |
2010 |
| Other |
isometric contraction exercises |
1 |
2019 |
| Other |
isometric exercise |
1 |
2014 |
| Drug |
itca 650 (exenatide in duros) |
1 |
2013 |
| Drug |
itca 650 60 mcg |
1 |
2011 |
| Drug |
itca 650 60 mcg/day |
1 |
2011 |
| Drug |
itca 650 osmotic mini pump 20 |
1 |
2015 |
| Drug |
itca 650 osmotic mini pump 20/60 mcg/day |
1 |
2015 |
| Drug |
itca 650 osmotic mini pump 60 mcg |
1 |
2015 |
| Drug |
itca 650 osmotic mini pump 60 mcg/day |
1 |
2015 |
| Other |
iv ethanol |
1 |
2007 |
| Drug |
iw-1973 oral tablet |
1 |
2017 |
| Behavioral |
iw1 |
1 |
2014 |
| Behavioral |
iw3 |
1 |
2014 |
| Drug |
janumet, lantus |
1 |
2011 |
| Drug |
januvia |
1 |
2006 |
| Drug |
januvia tab. 100mg / duvie tab. 0.5mg |
1 |
2016 |
| Drug |
januviaâ® |
1 |
2011 |
| Dietary Supplement |
jasmine white rice |
1 |
2019 |
| Drug |
jinshuibao capsule |
1 |
2017 |
| Drug |
jnj-38431055 / sitagliptin 100 mg |
1 |
2010 |
| Drug |
jnj-38431055 dose 1 |
1 |
2009 |
| Drug |
jnj-38431055 dose 2 |
1 |
2009 |
| Drug |
jnj-41443532 |
1 |
2010 |
| Drug |
jnj-64565111 |
1 |
2017 |
| Drug |
jnj-64565111 dose level 1 |
1 |
2018 |
| Drug |
jnj-64565111 dose level 2 |
1 |
2018 |
| Drug |
jnj-64565111 dose level 3 |
1 |
2018 |
| Drug |
jnj 28431754 |
1 |
2009 |
| Drug |
jnj 28431754 100 mg |
1 |
2010 |
| Drug |
jnj 28431754 100 mg/placebo |
1 |
2010 |
| Drug |
jnj 28431754 300 mg |
1 |
2010 |
| Drug |
jnj 28431754 300 mg/placebo |
1 |
2010 |
| Drug |
jnj16269110 |
1 |
2008 |
| Drug |
jtt-130 |
1 |
2009 |
| placebo |
jtt-130 placebo |
1 |
2009 |
| Drug |
jtt-851 |
1 |
2012 |
| Drug |
jy09 |
1 |
2020 |
| Drug |
kd026 |
1 |
2015 |
| Drug |
kdt501 |
1 |
2015 |
| Drug |
ketoconazole |
1 |
2007 |
| Other |
ketogenic diet |
1 |
2013 |
| Drug |
ketone infusion |
1 |
2018 |
| Dietary Supplement |
ketone monoester |
1 |
2019 |
| Drug |
ketorolac |
1 |
2013 |
| Drug |
kg body wt sc |
1 |
2007 |
| Drug |
kg daily insulin |
1 |
2009 |
| Other |
kg oleocanthal |
1 |
2020 |
| Behavioral |
know your medicine - take it for health (kym-tifh) |
1 |
2017 |
| Drug |
komboglyze xr 5 |
1 |
2012 |
| Drug |
komboglyze xr 5/1000 mg |
1 |
2012 |
| Drug |
komboglyze xr 5/500 mg |
1 |
2012 |
| Dietary Supplement |
konjac-glucomannan fiber blend |
1 |
2016 |
| Dietary Supplement |
konjac glucomannan |
1 |
2018 |
| Dietary Supplement |
korean traditional diets |
1 |
2012 |
| Drug |
kothala himbutu biscuit |
1 |
2014 |
| Drug |
kq-791 |
1 |
2015 |
| Drug |
krp-104 |
1 |
2009 |
| placebo |
krp-104 bid drug: placebo drug: metformin |
1 |
2007 |
| placebo |
krp-104 qd drug: placebo drug: metformin |
1 |
2007 |
| Device |
kyboot shoes |
1 |
2015 |
| Drug |
l |
1 |
2015 |
| Drug |
l-acetylcarnitine |
1 |
2006 |
| Drug |
l-nmma |
1 |
2012 |
| Drug |
l/c mandibular anesthesia |
1 |
2015 |
| Drug |
l/c maxillary anesthesia |
1 |
2015 |
| Drug |
l/e mandibular anesthesia |
1 |
2015 |
| Drug |
l/e maxillary anesthesia |
1 |
2015 |
| Other |
la cocina alegre |
1 |
2019 |
| Other |
la cocina alegre/ the happy kitchen |
1 |
2019 |
| Procedure |
laboratory assessments |
1 |
2005 |
| Other |
laboratory evaluations, sleep study |
1 |
2010 |
| Diagnostic Test |
laboratory tests |
1 |
2018 |
| Drug |
lacidipine |
1 |
2006 |
| Dietary Supplement |
lactobacillus reuteri |
1 |
2013 |
| Dietary Supplement |
lactobacillus reuteri dsm 17938 |
1 |
2012 |
| Dietary Supplement |
lactobacillus reuteri dsm17938 |
1 |
2013 |
| Drug |
lactulose crystals 20 g |
1 |
2018 |
| Drug |
lactulose crystals 30 g |
1 |
2018 |
| Drug |
lactulose liquid 20 g |
1 |
2018 |
| Drug |
lactulose liquid 30 g |
1 |
2018 |
| Drug |
laf 237 |
1 |
2005 |
| Drug |
laf237 |
1 |
2012 |
| Drug |
laf237 (vildagliptin) |
1 |
2013 |
| Drug |
laf237 = vildagliptin |
1 |
2009 |
| placebo |
laf237 placebo |
1 |
2004 |
| Other |
lancing depth setting (1) |
1 |
2018 |
| Other |
lancing depth setting (5) |
1 |
2018 |
| Device |
lancing device a |
1 |
2018 |
| Device |
lancing device b |
1 |
2018 |
| Device |
lancing device c |
1 |
2018 |
| Other |
land based cycling exercise |
1 |
2015 |
| Other |
land exercise |
1 |
2013 |
| Drug |
lanifibranor |
1 |
2018 |
| Drug |
lantus insulin |
1 |
2007 |
| Drug |
lantus) |
1 |
2009 |
| Drug |
lantusâ„¢ |
1 |
2014 |
| Drug |
lapaquistat acetate |
1 |
2005 |
| Drug |
lapaquistat acetate/lipid-lowering therapy |
1 |
2005 |
| Procedure |
laparoscopic adjustable gastric banding surgery |
1 |
2009 |
| Procedure |
laparoscopic gastric bypass |
1 |
2016 |
| Procedure |
laparoscopic gastric plication |
1 |
2016 |
| Procedure |
laparoscopic mini gastric bypass |
1 |
2017 |
| Procedure |
laparoscopic roux-en-y gastric bypass (rygb) procedure |
1 |
2011 |
| Procedure |
laparoscopic roux en y gastric by pass surgery |
1 |
2018 |
| Procedure |
laparoscopic roux en y gastric bypass |
1 |
2012 |
| Procedure |
laparoscopic roux en y gastric bypass / open duodenojejunal bypass |
1 |
2012 |
| Procedure |
laparoscopic roux en y gastric bypass operation |
1 |
2011 |
| Procedure |
laparoscopic sleeve surgery |
1 |
2018 |
| Behavioral |
late meal |
1 |
2015 |
| Behavioral |
late sleep |
1 |
2015 |
| Behavioral |
late sleep/ late meal |
1 |
2015 |
| Behavioral |
late sleep/ normal meal |
1 |
2015 |
| Drug |
lavender oil |
1 |
2017 |
| Drug |
lc15-0444 25mg bid |
1 |
2012 |
| Drug |
lcq908a |
1 |
2009 |
| Drug |
lcz 696 |
1 |
2018 |
| Biological |
lee insulin glargine injection |
1 |
2017 |
| Dietary Supplement |
lehel multi-nutrients supplement |
1 |
2013 |
| Dietary Supplement |
leucine |
1 |
2008 |
| Behavioral |
level of physical activity |
1 |
2018 |
| Other |
levels of blood glucose control |
1 |
2020 |
| Drug |
levemirâ® [insulin detemir]) |
1 |
2007 |
| Drug |
levonorgestrel |
1 |
2012 |
| Drug |
levonorgestrel / ethinylestradiol |
1 |
2012 |
| Drug |
levonorgestrel; exenatide |
1 |
2005 |
| Drug |
lez763 |
1 |
2012 |
| Drug |
lgd-6972-10 mg |
1 |
2016 |
| Drug |
lgd-6972-15 mg |
1 |
2016 |
| Drug |
lgd-6972-5 mg |
1 |
2016 |
| Drug |
lgd-6972 capsules |
1 |
2016 |
| Drug |
lgd-6972 solution |
1 |
2016 |
| Other |
life style intervention |
1 |
2013 |
| Other |
life style modification |
1 |
2013 |
| Behavioral |
life style program using a mobile phone (eco mentally |
1 |
2016 |
| Behavioral |
life style program using a mobile phone (eco mentally/newme) |
1 |
2016 |
| Behavioral |
lifestyle advice |
1 |
2014 |
| Behavioral |
lifestyle case management |
1 |
2008 |
| Behavioral |
lifestyle change |
1 |
2014 |
| Behavioral |
lifestyle changes |
1 |
2017 |
| Behavioral |
lifestyle consultation: weight control, diet, exercise |
1 |
2006 |
| Behavioral |
lifestyle counselling |
1 |
2012 |
| Behavioral |
lifestyle counselling; opinion leader influence statements |
1 |
2006 |
| Behavioral |
lifestyle education sessions |
1 |
2010 |
| Behavioral |
lifestyle education sessions/youth exercise sessions |
1 |
2010 |
| Behavioral |
lifestyle education support |
1 |
2014 |
| Dietary Supplement |
lifestyle guidance |
1 |
2019 |
| Behavioral |
lifestyle intervention (diet |
1 |
2007 |
| Behavioral |
lifestyle intervention (diet/physical activity) |
1 |
2007 |
| Behavioral |
lifestyle intervention (nutrition) |
1 |
2011 |
| Behavioral |
lifestyle intervention (physical activity) |
1 |
2011 |
| Behavioral |
lifestyle intervention/provider feedback |
1 |
2009 |
| Drug |
lifestyle measures |
1 |
2008 |
| Behavioral |
lifestyle modification counseling |
1 |
2006 |
| Behavioral |
lifestyle modification for type 2 diabetes prevention |
1 |
2012 |
| Behavioral |
lifestyle modification instructional |
1 |
2014 |
| Behavioral |
lifestyle modification instructional/motivational sessions |
1 |
2014 |
| Behavioral |
lifestyle modification program |
1 |
2017 |
| Behavioral |
lifestyle weight loss intervention |
1 |
2010 |
| Behavioral |
lifestyle/activities education program (leap-ahead) |
1 |
2008 |
| Other |
light-emitting diode (led) therapy |
1 |
2018 |
| Dietary Supplement |
light-fat riceâ® |
1 |
2019 |
| Dietary Supplement |
light-fat riceâ®/with active peptideâ®/ lifestyle guidance |
1 |
2019 |
| Drug |
lina |
1 |
2017 |
| Drug |
lina 10 |
1 |
2017 |
| placebo |
lina highdose placebo |
1 |
2015 |
| Drug |
lina/empa 5/10 mg qd (n=22) |
1 |
2017 |
| Drug |
linagliptin / 50% glargine dose on discharge |
1 |
2013 |
| Drug |
linagliptin / 80% glargine |
1 |
2013 |
| Drug |
linagliptin / metformin |
1 |
2009 |
| Drug |
linagliptin / pioglitazone (30 mg) |
1 |
2008 |
| Drug |
linagliptin 5 mg |
1 |
2015 |
| Drug |
linagliptin 5 mg qd (n=24) |
1 |
2014 |
| Drug |
linagliptin 5mg / pioglitazone 15 mg fdc |
1 |
2010 |
| Drug |
linagliptin 5mg / pioglitazone 30 mg fdc |
1 |
2010 |
| Drug |
linagliptin 5mg / pioglitazone 45 mg fdc |
1 |
2010 |
| Drug |
linagliptin blank analog tablet |
1 |
2019 |
| Drug |
linagliptin high dose |
1 |
2015 |
| Drug |
linagliptin medium dose |
1 |
2009 |
| placebo |
linagliptin placebo low dose |
1 |
2015 |
| Drug |
linagliptin qd (once daily) for 7 days |
1 |
2009 |
| Drug |
linagliptin single tablet |
1 |
2011 |
| Drug |
linagliptin tablet |
1 |
2019 |
| Drug |
linagliptin/metformin |
1 |
2009 |
| Drug |
linagliptin/metformin combo |
1 |
2011 |
| Drug |
linagliptin2.5mg |
1 |
2012 |
| Drug |
linagliptin2.5mg/metformin1000mg |
1 |
2012 |
| Drug |
linagliptin2.5mg/metformin500mg |
1 |
2012 |
| Drug |
linagliptine 5 mg |
1 |
2008 |
| Drug |
linagliptine 5 mg/pioglitazone 30 mg |
1 |
2008 |
| Drug |
lipid-lowering therapy |
1 |
2005 |
| Drug |
lipid lowering therapy |
1 |
2006 |
| Dietary Supplement |
lipid meal |
1 |
2015 |
| Procedure |
lipotoxicity |
1 |
2011 |
| Drug |
lipro insulin |
1 |
2017 |
| Other |
liquid meal |
1 |
2016 |
| Drug |
liraglutide-depot |
1 |
2011 |
| Drug |
liraglutide-metformin vs insulin-metformin |
1 |
2011 |
| Drug |
liraglutide 0.6 mg |
1 |
2011 |
| Drug |
liraglutide 0.9 mg daily |
1 |
2012 |
| Drug |
liraglutide 1.2 mg |
1 |
2011 |
| Drug |
liraglutide 3.0 mg |
1 |
2016 |
| Drug |
liraglutide pen injector [victoza] |
1 |
2017 |
| placebo |
liraglutide placebo |
1 |
2012 |
| Drug |
liraglutide/placebo |
1 |
2014 |
| Drug |
liraglutide/standard-of-care treatment |
1 |
2019 |
| Drug |
lis 18 u |
1 |
2016 |
| Drug |
lispro 1.2 nmol |
1 |
2017 |
| Drug |
lispro 1.2 nmol/kg |
1 |
2017 |
| Drug |
lispro low mix |
1 |
2005 |
| Drug |
lispro mid mix |
1 |
2005 |
| Drug |
lispro mix 50 |
1 |
2009 |
| Drug |
lispro mix 50/50 |
1 |
2009 |
| Drug |
lispro mix 75 |
1 |
2007 |
| Drug |
lispro mix 75/25 |
1 |
2007 |
| Drug |
lispro mixture therapy |
1 |
2005 |
| Behavioral |
literacy |
1 |
2007 |
| Behavioral |
literacy/numeracy oriented educational intervention |
1 |
2007 |
| Behavioral |
live |
1 |
2014 |
| Device |
livongo-insulia study app |
1 |
2019 |
| Other |
livongo for diabetes program |
1 |
2016 |
| Drug |
lixisenatide fixed-ratio combination hoe901 |
1 |
2016 |
| Drug |
lixisenatide hoe901 |
1 |
2018 |
| placebo |
lixisenatide placebo |
1 |
2009 |
| Drug |
lmf237 50 |
1 |
2013 |
| Drug |
lmf237 50/250 mg |
1 |
2013 |
| Drug |
lmf237 50/500 mg |
1 |
2013 |
| Other |
lobag diet - control phase |
1 |
2005 |
| Other |
lobag diet - test phase |
1 |
2005 |
| Behavioral |
logbooks |
1 |
2005 |
| Behavioral |
logbooks, telephone counselling |
1 |
2005 |
| Drug |
lokelma 5 gm powder for oral suspension |
1 |
2019 |
| Drug |
long-acting bedtime insulin detemir (levemir) |
1 |
2009 |
| Other |
long-acting insulin glargine titration web tool (lthome) |
1 |
2015 |
| Procedure |
long bpl rygb |
1 |
2019 |
| Procedure |
long limb roux-en-y reconstruction after subtotal gastrectomy |
1 |
2020 |
| Procedure |
long limb roux-en y reconstruction |
1 |
2011 |
| Other |
loose control: goal glucose 600 mg |
1 |
2015 |
| Other |
loose control: goal glucose 600 mg/dl/lower |
1 |
2015 |
| Drug |
lorcaserin hydrochloride |
1 |
2013 |
| Drug |
losartan potassium |
1 |
2019 |
| Drug |
lovaza |
1 |
2007 |
| Dietary Supplement |
low-caloric diet |
1 |
2016 |
| Behavioral |
low-calorie diet |
1 |
2014 |
| Behavioral |
low-carbohydrate diet with post-meal walking |
1 |
2016 |
| Drug |
low-dose colesevelam |
1 |
2010 |
| Other |
low-dose tnf-alpha |
1 |
2013 |
| Behavioral |
low-fat, low-glycemic index, vegan diet |
1 |
2006 |
| Behavioral |
low-fat, vegan diet |
1 |
2007 |
| Other |
low-fructose diet, isocaloric |
1 |
2018 |
| Other |
low-fructose, hypocaloric |
1 |
2018 |
| Other |
low-glycemic index |
1 |
2017 |
| Procedure |
low-intensity exercise |
1 |
2013 |
| Dietary Supplement |
low-intermediate-glycemic index diets |
1 |
2009 |
| Drug |
low-mixture) |
1 |
2008 |
| Other |
low calorie diet |
1 |
2020 |
| Dietary Supplement |
low carbohydrate - high fat diet |
1 |
2009 |
| Behavioral |
low carbohydrate breakfast |
1 |
2016 |
| Dietary Supplement |
low carbohydrate diet high in monounsaturated fats |
1 |
2017 |
| Other |
low carbohydrate meals |
1 |
2015 |
| Drug |
low carbohydrate, high monounsaturate fat foods |
1 |
2005 |
| Behavioral |
low carbohydrate, ketogenic diet |
1 |
2006 |
| Dietary Supplement |
low content of mc-sfa |
1 |
2011 |
| placebo |
low dose bi 10773 placebo |
1 |
2011 |
| Drug |
low dose fdc |
1 |
2011 |
| placebo |
low dose fdc placebo |
1 |
2011 |
| Drug |
low dose of bi 1356 bs |
1 |
2014 |
| Dietary Supplement |
low dose plant based ingredient |
1 |
2014 |
| Other |
low fat dairy |
1 |
2016 |
| Other |
low fat meal |
1 |
2019 |
| Dietary Supplement |
low gi index diet |
1 |
2015 |
| Dietary Supplement |
low glycaemic diet |
1 |
2017 |
| Other |
low glycemic diet |
1 |
2018 |
| Other |
low glycemic index |
1 |
2016 |
| Other |
low glycemic index diet-pa |
1 |
2009 |
| Dietary Supplement |
low glycemic index diet with pulses |
1 |
2010 |
| Other |
low glycemic index meal |
1 |
2014 |
| Behavioral |
low glycemic index, reduced calorie diet |
1 |
2006 |
| Behavioral |
low glycemic load diet versus low fat diet |
1 |
2010 |
| Other |
low humidity |
1 |
2019 |
| Behavioral |
low intensity |
1 |
2009 |
| Other |
low intensity therapeutic ultrasound |
1 |
2016 |
| Dietary Supplement |
low protein at breakfast |
1 |
2013 |
| Other |
lower |
1 |
2015 |
| Behavioral |
lower body heating |
1 |
2017 |
| Other |
lower carbohydrate, higher fat diet |
1 |
2011 |
| Procedure |
lsg |
1 |
2015 |
| Drug |
lx4211 high dose |
1 |
2009 |
| Drug |
lx4211 low dose |
1 |
2009 |
| placebo |
lx4211 placebo |
1 |
2012 |
| Drug |
ly041001 (hiip) |
1 |
2004 |
| Drug |
ly2189102 |
1 |
2009 |
| Drug |
ly2189265/lifestyle measures |
1 |
2008 |
| Drug |
ly2393910 |
1 |
2010 |
| placebo |
ly2409021 placebo |
1 |
2015 |
| Drug |
ly2608204 |
1 |
2010 |
| Drug |
ly2881835 |
1 |
2011 |
| Drug |
ly2922083 |
1 |
2012 |
| Drug |
ly2944876 |
1 |
2014 |
| Drug |
ly3009385 |
1 |
2011 |
| Drug |
ly3025876 |
1 |
2013 |
| Drug |
ly3108743 - capsule |
1 |
2013 |
| Drug |
ly3108743 - solution |
1 |
2013 |
| Drug |
ly3298176 |
1 |
2016 |
| Drug |
ly3325656 |
1 |
2017 |
| Drug |
ly3437943 |
1 |
2019 |
| Drug |
ly900014 (iv) |
1 |
2017 |
| Drug |
ly900014 (sc) |
1 |
2017 |
| Drug |
lycored soft gels jagsonpal pharma, systemic 8mgms |
1 |
2014 |
| Drug |
lycored soft gels jagsonpal pharma, systemic 8mgms/day |
1 |
2014 |
| Drug |
lyophilized albiglutide dcc pen injector |
1 |
2016 |
| placebo |
lyophilized albiglutide dcc pen injector matching placebo |
1 |
2016 |
| Dietary Supplement |
lysulin |
1 |
2020 |
| Behavioral |
m-power rewards |
1 |
2019 |
| Other |
macrocirculation testing |
1 |
2013 |
| Dietary Supplement |
macronutrient isoenergetic control |
1 |
2014 |
| Other |
macronutrients |
1 |
2011 |
| Dietary Supplement |
magnesium citrate |
1 |
2016 |
| Dietary Supplement |
magnesium citrate: a total of 500 mg elemental magnesium |
1 |
2008 |
| Dietary Supplement |
magnesium lactate |
1 |
2013 |
| Behavioral |
magnet |
1 |
2019 |
| Device |
magnet anastomosis system |
1 |
2017 |
| Other |
magnetic resonance imaging- imat |
1 |
2018 |
| Other |
mailed letter |
1 |
2019 |
| Drug |
maintain dual therapy (sulf |
1 |
2011 |
| Drug |
maintain dual therapy (sulf/pio) as comparator to liraglutide |
1 |
2011 |
| Behavioral |
maintained exercise |
1 |
2018 |
| Other |
management |
1 |
2018 |
| Behavioral |
management’ |
1 |
2006 |
| Other |
maritime throat spray (tt) |
1 |
2018 |
| Procedure |
matched hypocaloric diet |
1 |
2012 |
| placebo |
matching liraglutide-placebo pre-filled pens |
1 |
2017 |
| placebo |
matching placebo for dapagliflozin |
1 |
2015 |
| placebo |
matching placebo for dapagliflozin 10 mg |
1 |
2015 |
| Drug |
matching placebo for dapagliflozin 10 mg/saxagliptin 2.5mg |
1 |
2015 |
| placebo |
matching placebo to dapagliflozin |
1 |
2015 |
| placebo |
matching placebo to ertugliflozin 10 mg |
1 |
2014 |
| placebo |
matching placebo to ertugliflozin 5 mg |
1 |
2014 |
| placebo |
matching placebo to sita |
1 |
2007 |
| Drug |
matching placebo to sita/met fdc |
1 |
2007 |
| placebo |
matching placebo to sitagliptin 100 mg |
1 |
2014 |
| Drug |
matching placebo to sitagliptin/metformin fdc |
1 |
2009 |
| Diagnostic Test |
maximal functional capacity by cardiopulmonary exercise testing |
1 |
2019 |
| Drug |
mb07803 |
1 |
2007 |
| Drug |
mbx-102 |
1 |
2006 |
| Drug |
mbx-2044 |
1 |
2007 |
| Other |
mccountry sandwich (mcdonald’s) |
1 |
2012 |
| Drug |
mci-196 |
1 |
2007 |
| Behavioral |
mct |
1 |
2017 |
| Behavioral |
mct/with rt group |
1 |
2017 |
| Dietary Supplement |
meal |
1 |
2018 |
| Behavioral |
meal frequency (6 meals vs. 2 meals |
1 |
2011 |
| Behavioral |
meal frequency (6 meals vs. 2 meals/day) |
1 |
2011 |
| Other |
meal frequency increase with hfhs |
1 |
2011 |
| Other |
meal frequency increase with hs |
1 |
2011 |
| Other |
meal size increase with hfhs |
1 |
2011 |
| Other |
meal size increase with hs |
1 |
2011 |
| Other |
meal then exercise |
1 |
2014 |
| Procedure |
meal tolerance test |
1 |
2005 |
| Drug |
mecobalamin tablets |
1 |
2017 |
| Biological |
medi-4166 |
1 |
2015 |
| Drug |
medi0382 100 î¼g |
1 |
2018 |
| Drug |
medi0382 200 î¼g |
1 |
2018 |
| Drug |
medi0382 300 î¼g |
1 |
2018 |
| Drug |
medi0382 50 ug |
1 |
2018 |
| Drug |
medi0382 formulation 2 |
1 |
2017 |
| Drug |
medi0382 formulation 3 |
1 |
2017 |
| Drug |
medi0382 high dose |
1 |
2017 |
| Drug |
medi0382 low dose |
1 |
2017 |
| Drug |
medi0382 mid dose |
1 |
2017 |
| Biological |
medi6570 |
1 |
2018 |
| Behavioral |
medias 2 ct |
1 |
2016 |
| Behavioral |
medias 2 ict |
1 |
2009 |
| Other |
medical food formulation 1 |
1 |
2019 |
| Other |
medical food formulation 2 |
1 |
2019 |
| Other |
medical management |
1 |
2011 |
| Other |
medical nutrition therapy |
1 |
2019 |
| Other |
medically-tailored meal delivery |
1 |
2019 |
| Other |
medically-tailored meal delivery/medical nutrition therapy |
1 |
2019 |
| Other |
medically tailored meals |
1 |
2020 |
| Device |
medication metronome |
1 |
2012 |
| Other |
medication optimization intervention |
1 |
2018 |
| Other |
medication therapy management consult |
1 |
2019 |
| Behavioral |
medifast |
1 |
2005 |
| Behavioral |
medifast/for diabetics meal replacement supplements |
1 |
2005 |
| Dietary Supplement |
mediterranean-like meal |
1 |
2019 |
| Behavioral |
mediterranean diet (med-plus) |
1 |
2019 |
| Drug |
medium dose of bi 1356 bs |
1 |
2014 |
| Drug |
medtoneâ„¢ inhaler |
1 |
2008 |
| Dietary Supplement |
menaquinone-7 |
1 |
2016 |
| Behavioral |
mental well-being |
1 |
2020 |
| Drug |
mertformin xr 2 x 500 mg |
1 |
2012 |
| Biological |
mesenchymal stem cell transplantation |
1 |
2012 |
| Biological |
mesenchymal stem cells |
1 |
2020 |
| Drug |
met fdc |
1 |
2007 |
| Drug |
met ir |
1 |
2015 |
| Drug |
met xr |
1 |
2013 |
| Behavioral |
metabolic syndrome |
1 |
2017 |
| Drug |
metfomin |
1 |
2005 |
| Drug |
metformin - rescue |
1 |
2004 |
| Drug |
metformin (active rescue) |
1 |
2010 |
| Drug |
metformin (amaryl mâ®) - hoe4900 |
1 |
2012 |
| Drug |
metformin (blinded) |
1 |
2006 |
| Drug |
metformin (diabex) |
1 |
2010 |
| Drug |
metformin (fdc tablet) |
1 |
2010 |
| Drug |
metformin (glucophageâ„¢) |
1 |
2010 |
| Drug |
metformin (open-label) |
1 |
2006 |
| Drug |
metformin (phase b) |
1 |
2005 |
| Drug |
metformin / glimepiride |
1 |
2006 |
| Drug |
metformin / healthy diet |
1 |
2018 |
| Drug |
metformin / intermittent insulin therapy |
1 |
2014 |
| Drug |
metformin / personalized diet |
1 |
2018 |
| Drug |
metformin / placebo |
1 |
2016 |
| Drug |
metformin / rosuvastatin |
1 |
2016 |
| Drug |
metformin >= 1500 mg |
1 |
2014 |
| Drug |
metformin >= 1500 mg/day |
1 |
2014 |
| Drug |
metformin 1000 mg (fixed combination) |
1 |
2007 |
| Drug |
metformin 1000 mg (ttd) |
1 |
2006 |
| Drug |
metformin 1000 mg bid |
1 |
2012 |
| Drug |
metformin 1000 mg oral tablet |
1 |
2018 |
| Drug |
metformin 1000 mg twice a day |
1 |
2017 |
| Drug |
metformin 1000mg |
1 |
2012 |
| Drug |
metformin 1500 mg (ttd) |
1 |
2006 |
| Drug |
metformin 1500 mg daily |
1 |
2006 |
| Drug |
metformin 1500mg |
1 |
2009 |
| Drug |
metformin 1500mg (galvus |
1 |
2009 |
| Drug |
metformin 1500mg/metformin 500mg/1000mg (diabex) |
1 |
2009 |
| Drug |
metformin 2 miligrams (mg) |
1 |
2010 |
| Drug |
metformin 2000 mg (ttd) |
1 |
2006 |
| Drug |
metformin 4 miligrams (mg) |
1 |
2010 |
| Drug |
metformin 50 |
1 |
2005 |
| Drug |
metformin 50 mg |
1 |
2010 |
| Drug |
metformin 500 mg |
1 |
2010 |
| Drug |
metformin 500 mg (ttd) |
1 |
2006 |
| Drug |
metformin 500 mg bid |
1 |
2012 |
| Drug |
metformin 500 mg with titration |
1 |
2014 |
| Drug |
metformin 850 mg |
1 |
2010 |
| Drug |
metformin ≥ 1000 mg |
1 |
2016 |
| Drug |
metformin ≥ 1500 mg |
1 |
2006 |
| Drug |
metformin alone |
1 |
2014 |
| Drug |
metformin combination, repaglinide, metformin |
1 |
2013 |
| Drug |
metformin combo |
1 |
2011 |
| Drug |
metformin comparator |
1 |
2004 |
| Drug |
metformin continue |
1 |
2017 |
| Drug |
metformin discontinue |
1 |
2017 |
| Drug |
metformin er (glucophageâ® long) |
1 |
2016 |
| Drug |
metformin extended-release (xr) |
1 |
2011 |
| Drug |
metformin extended release oral tablet |
1 |
2018 |
| Drug |
metformin fdc (bay81-9783) |
1 |
2012 |
| Drug |
metformin fdc(bay81-9783) |
1 |
2019 |
| Drug |
metformin fixed-dose combination (fdc) |
1 |
2011 |
| Drug |
metformin group |
1 |
2013 |
| Drug |
metformin hcl 500 mg extended-release tablets, geneva ptc |
1 |
2009 |
| placebo |
metformin hcl modified release matching placebo |
1 |
2009 |
| Drug |
metformin hcl tablets |
1 |
2007 |
| Drug |
metformin hcl tablets/colesevelam tablets |
1 |
2007 |
| Drug |
metformin hcl/colesevelam placebo |
1 |
2007 |
| Drug |
metformin hydrochloride combination (hoe490) |
1 |
2011 |
| Drug |
metformin hydrochloride fdc |
1 |
2009 |
| placebo |
metformin hydrochloride placebo |
1 |
2014 |
| Drug |
metformin hydrochloride prolonged release |
1 |
2012 |
| Drug |
metformin hydrochloride sustained release |
1 |
2012 |
| Drug |
metformin hydrochloride sustained release/glimepiride |
1 |
2012 |
| Drug |
metformin hydrochloride tablets |
1 |
2018 |
| Drug |
metformin immediate release |
1 |
2010 |
| Drug |
metformin immediate release (ir) |
1 |
2012 |
| Drug |
metformin intensive exercise |
1 |
2009 |
| Drug |
metformin ir (fdc) |
1 |
2009 |
| Drug |
metformin ir (glucophage) |
1 |
2009 |
| Drug |
metformin ir fdc tablet fasted |
1 |
2012 |
| Drug |
metformin ir fdc tablet fed |
1 |
2012 |
| Drug |
metformin ir, fasted |
1 |
2009 |
| Drug |
metformin ir, fed |
1 |
2009 |
| Drug |
metformin local in at |
1 |
2017 |
| Drug |
metformin on top of intensive insulin therapy |
1 |
2006 |
| Drug |
metformin only |
1 |
2012 |
| Drug |
metformin oral |
1 |
2017 |
| Drug |
metformin oral tablet |
1 |
2019 |
| Drug |
metformin single tablet |
1 |
2011 |
| Drug |
metformin tablet |
1 |
2010 |
| Drug |
metformin vs thiazolidinedione (pioglitazone) |
1 |
2006 |
| Drug |
metformin with pioglitazone |
1 |
2016 |
| Drug |
metformin xr 500 mg |
1 |
2012 |
| Drug |
metformin xr fdc |
1 |
2013 |
| Drug |
metformin xr/liraglutide |
1 |
2010 |
| Drug |
metformin xr/placebo |
1 |
2010 |
| Drug |
metformin) |
1 |
2007 |
| Drug |
metformin, 500 mg (fasted state) |
1 |
2010 |
| Drug |
metformin, 500 mg (fed state) |
1 |
2010 |
| Drug |
metformin, 500 mg fdc (fasted state) |
1 |
2010 |
| Drug |
metformin, 500 mg fdc (fed state) |
1 |
2010 |
| Drug |
metformin, fasting |
1 |
2009 |
| Drug |
metformin, fed |
1 |
2009 |
| Drug |
metformin, gliclazide, protaphane |
1 |
2011 |
| Drug |
metformin, insulin glargine u100, |
1 |
2020 |
| Drug |
metformin, insulin glargine u100,/human regular insulin (low dosage) |
1 |
2020 |
| Drug |
metformin, insulin glargine u100,/human regular insulin (regular dosage) |
1 |
2020 |
| placebo |
metformin, placebo |
1 |
2010 |
| Drug |
metformin, placebo/metformin |
1 |
2010 |
| Drug |
metformin, s-707106 |
1 |
2010 |
| Drug |
metformin, s-707106/metformin |
1 |
2010 |
| Drug |
metformin/ gliclazide |
1 |
2006 |
| Drug |
metformin/ glimepride |
1 |
2012 |
| Drug |
metformin/glimepiride (low dosage) |
1 |
2020 |
| Drug |
metformin/glimepiride (regular dosage) |
1 |
2020 |
| Drug |
metformin/glimepiride combination |
1 |
2009 |
| Drug |
metformin/insulin glargine u100 (low dosage) |
1 |
2020 |
| Drug |
metformin/insulin glargine u100 (regular dosage) |
1 |
2020 |
| Drug |
metformin/insulin sc |
1 |
2016 |
| Drug |
metformin/liraglutide |
1 |
2016 |
| Drug |
metformin/secretagogues |
1 |
2006 |
| Drug |
metformin/standard exercise |
1 |
2009 |
| Drug |
metformin/vildagliptin |
1 |
2012 |
| Drug |
metformin/vildagliptin (low dosage) |
1 |
2020 |
| Drug |
metformin/vildagliptin (regular dosage) |
1 |
2020 |
| Drug |
metformin1000mg |
1 |
2012 |
| Drug |
metformin500mg |
1 |
2012 |
| Drug |
metoprolol er |
1 |
2008 |
| Behavioral |
mhealth |
1 |
2020 |
| Behavioral |
mhealth for diabetes adherence support |
1 |
2016 |
| Behavioral |
mi- informed sms program |
1 |
2013 |
| Behavioral |
mi-based health education intervention |
1 |
2017 |
| Other |
microcirculation testing |
1 |
2013 |
| Behavioral |
microclinic |
1 |
2012 |
| Behavioral |
microclinic behavioral health basic program (education-only in classroom setting; no structured social interactions) |
1 |
2013 |
| Behavioral |
microclinic behavioral health full program (education curriculum in classroom setting, |
1 |
2013 |
| Behavioral |
microclinic behavioral health full program (education curriculum in classroom setting,/full social interaction program) |
1 |
2013 |
| Behavioral |
microclinic diabetes education program |
1 |
2012 |
| Behavioral |
microclinic social induction diabetes |
1 |
2014 |
| Behavioral |
microclinic social induction diabetes/obesity program |
1 |
2014 |
| Other |
microfludic noodle |
1 |
2019 |
| Drug |
microgynâ® |
1 |
2011 |
| Drug |
microgynonâ® |
1 |
2016 |
| Device |
microlet 2 lancing device (bayer) |
1 |
2020 |
| Device |
microlet 28g lancets (bayer) |
1 |
2020 |
| Dietary Supplement |
micronutrient |
1 |
2012 |
| Drug |
mifepristone 600 mg daily |
1 |
2017 |
| Other |
mind, exercise, nutrition, do it! |
1 |
2019 |
| Behavioral |
mindfuless |
1 |
2019 |
| Behavioral |
mindfulness-based cognitive therapy mbct |
1 |
2018 |
| Behavioral |
mindfulness-based intervention |
1 |
2019 |
| Behavioral |
mindfulness-based stress reduction |
1 |
2018 |
| Behavioral |
mindfulness informational materials |
1 |
2017 |
| Behavioral |
mindfulness/positive affect skills |
1 |
2012 |
| Dietary Supplement |
mineral supplementation |
1 |
2010 |
| Behavioral |
minimal psychological intervention |
1 |
2015 |
| Dietary Supplement |
mirtoselect |
1 |
2010 |
| Dietary Supplement |
mixed-meal |
1 |
2019 |
| Dietary Supplement |
mixed grain 1 |
1 |
2013 |
| Dietary Supplement |
mixed grain 2 |
1 |
2013 |
| Other |
mixed meal |
1 |
2013 |
| Other |
mixed meal test |
1 |
2013 |
| Other |
mixed meal test (mmt) |
1 |
2014 |
| Other |
mixed oral glucose tolerance test |
1 |
2016 |
| Drug |
mixed protamine zinc recombinant human insulin lispro 25r |
1 |
2010 |
| Drug |
mk-1006 |
1 |
2008 |
| Drug |
mk-1092, 16 nmol |
1 |
2017 |
| Drug |
mk-1092, 16 nmol/kg |
1 |
2017 |
| Drug |
mk-1092, 32 nmol |
1 |
2017 |
| Drug |
mk-1092, 32 nmol/kg |
1 |
2017 |
| Drug |
mk-1092, 4.0 nmol |
1 |
2017 |
| Drug |
mk-1092, 4.0 nmol/kg |
1 |
2017 |
| Drug |
mk-1092, 64 nmol |
1 |
2017 |
| Drug |
mk-1092, 64 nmol/kg |
1 |
2017 |
| Drug |
mk-1092, 8.0 nmol |
1 |
2017 |
| Drug |
mk-1092, 8.0 nmol/kg |
1 |
2017 |
| Drug |
mk-1293 |
1 |
2014 |
| Drug |
mk-3102 |
1 |
2013 |
| Biological |
mk-5160 16 nmol |
1 |
2017 |
| Biological |
mk-5160 16 nmol/kg |
1 |
2017 |
| Biological |
mk-5160 32 nmol |
1 |
2017 |
| Biological |
mk-5160 32 nmol/kg |
1 |
2017 |
| Biological |
mk-5160 64 nmol |
1 |
2017 |
| Biological |
mk-5160 64 nmol/kg |
1 |
2017 |
| Drug |
mk-8245 |
1 |
2009 |
| Drug |
mk-8655 |
1 |
2012 |
| Drug |
mk-8666 |
1 |
2013 |
| Drug |
mk0431, sitagliptin phosphate / duration of treatment: 12 weeks |
1 |
2006 |
| Drug |
mk0431, sitagliptin phosphate / duration of treatment: 21 weeks |
1 |
2007 |
| Drug |
mk0653, ezetimibe |
1 |
2007 |
| Drug |
mk0653, ezetimibe / duration of treatment: 30 weeks |
1 |
2007 |
| Drug |
mk0653a, ezetimibe (/) simvastatin |
1 |
2005 |
| Drug |
mk0653a, ezetimibe (/) simvastatin / duration of treatment: 6 weeks |
1 |
2007 |
| Drug |
mk0893 |
1 |
2009 |
| placebo |
mk0893-matched placebo |
1 |
2009 |
| Drug |
mk0916 |
1 |
2007 |
| Drug |
mk0941 |
1 |
2007 |
| Drug |
mk0954, losartan |
1 |
2006 |
| Drug |
mk0954, losartan / duration of treatment: mean 3.4 years |
1 |
2006 |
| Drug |
mk0954a, losartan potassium ( |
1 |
2007 |
| Drug |
mk0954a, losartan potassium (/) hydrochlorothiazide (hyzaar) / duration of treatment : 8 weeks |
1 |
2007 |
| Drug |
mk1006 |
1 |
2008 |
| Drug |
ml [krystexxa] |
1 |
2019 |
| Drug |
ml [prolia] |
1 |
2018 |
| Drug |
ml pit |
1 |
2019 |
| Drug |
ml subcutaneous solution |
1 |
2018 |
| Biological |
mnc’s transplantation |
1 |
2012 |
| Biological |
mncs |
1 |
2016 |
| Device |
mobigame |
1 |
2016 |
| Behavioral |
mobile |
1 |
2015 |
| Behavioral |
mobile app novame |
1 |
2018 |
| Other |
mobile application-based diabetes education |
1 |
2020 |
| Other |
mobile application for diabetes |
1 |
2018 |
| Behavioral |
mobile application training group. |
1 |
2018 |
| Behavioral |
mobile health care application |
1 |
2014 |
| Other |
mobile health care environment (mhce) |
1 |
2016 |
| Other |
mobile health system |
1 |
2017 |
| Device |
mobile phone |
1 |
2016 |
| Behavioral |
mobile phone short message service |
1 |
2020 |
| Behavioral |
mobile phone text messaging |
1 |
2015 |
| Behavioral |
mobile/connected health |
1 |
2015 |
| Dietary Supplement |
mock |
1 |
2016 |
| Other |
moderate-intensity exercise training (mit) |
1 |
2017 |
| Dietary Supplement |
moderate diet regimen |
1 |
2014 |
| Other |
moderate fiber diets |
1 |
2009 |
| Behavioral |
moderate intensity continuous training |
1 |
2017 |
| Behavioral |
moderate intensity exercise training |
1 |
2011 |
| Other |
modified carbohydrate breakfast |
1 |
2013 |
| Device |
modified dental implant |
1 |
2010 |
| Drug |
modified gip |
1 |
2005 |
| Behavioral |
modified paleolithic diet |
1 |
2012 |
| Behavioral |
modified paleolithic diet/exercise under observation |
1 |
2012 |
| Behavioral |
modified paleolithic diet/general advice on exercise |
1 |
2012 |
| Drug |
momordica charantia |
1 |
2015 |
| Other |
monitoring |
1 |
2018 |
| Other |
monitoring/management |
1 |
2018 |
| Diagnostic Test |
monofilament testing |
1 |
2018 |
| Drug |
monorovaâ® tab |
1 |
2018 |
| Drug |
montelukast 10mg |
1 |
2019 |
| Behavioral |
monthly food vouchers |
1 |
2019 |
| Other |
monthly screening for risk |
1 |
2018 |
| Behavioral |
monthly stock boxes |
1 |
2019 |
| Dietary Supplement |
moringa oleifera tea |
1 |
2017 |
| Dietary Supplement |
morolstever1 |
1 |
2020 |
| Drug |
mosapride citrate |
1 |
2014 |
| Behavioral |
motivation |
1 |
2009 |
| Behavioral |
motivation/behavioral skills |
1 |
2009 |
| Behavioral |
motivational intervention |
1 |
2011 |
| Behavioral |
motivational interviewing (mi)-based patient empowerment program (pep) |
1 |
2019 |
| Behavioral |
motivational interviewing intervention arm |
1 |
2019 |
| Behavioral |
motivational interviewing/cognitive behavioral-based therapy |
1 |
2013 |
| Behavioral |
motivational sessions |
1 |
2014 |
| Drug |
mp-513 high dose |
1 |
2009 |
| Drug |
mp-513 high dose/metformin |
1 |
2009 |
| Drug |
mp-513 low dose |
1 |
2009 |
| Drug |
mp-513 low dose/metformin |
1 |
2009 |
| Drug |
mp-513 lowest dose |
1 |
2009 |
| Drug |
mp-513 lowest dose/metformin |
1 |
2009 |
| Drug |
mp-513 medium dose |
1 |
2009 |
| Drug |
mp-513 medium dose/metformin |
1 |
2009 |
| Other |
mri scans |
1 |
2013 |
| Drug |
msdc-0160 220 mg |
1 |
2008 |
| Drug |
msdc-0160 90 mg |
1 |
2008 |
| Drug |
msdc-0602 100 mg |
1 |
2011 |
| Drug |
msdc-0602 250 mg |
1 |
2011 |
| Other |
mufa diet |
1 |
2017 |
| Drug |
mulberry leaf extract |
1 |
2008 |
| Dietary Supplement |
mulberry leaf extract effect on post prandial blood glucose |
1 |
2011 |
| Behavioral |
multicomponent online program |
1 |
2016 |
| Behavioral |
multidisciplinary team care |
1 |
2006 |
| Behavioral |
multifamily group |
1 |
2017 |
| Behavioral |
multimedia health education |
1 |
2018 |
| Behavioral |
multimodal intervention |
1 |
2019 |
| Drug |
multiple (four weekly) subcutaneous injections (part b) of pb1023 |
1 |
2010 |
| Drug |
multiple (four weekly) subcutaneous injections (part b) of pb1023/placebo (0.9% nacl) |
1 |
2010 |
| Other |
multiple daily insulin injections (control) |
1 |
2019 |
| Dietary Supplement |
mung bean |
1 |
2016 |
| Dietary Supplement |
musashino t2dm diet |
1 |
2015 |
| Diagnostic Test |
muscle biopsy |
1 |
2017 |
| Diagnostic Test |
muscle biopsy/blood test |
1 |
2017 |
| Other |
my diabetes care |
1 |
2019 |
| Behavioral |
my diabetes goal survey |
1 |
2018 |
| Behavioral |
my diabetes goal survey/optional care management |
1 |
2018 |
| Other |
mydosecoach app |
1 |
2018 |
| Drug |
mylan’s insulin glargine |
1 |
2014 |
| Behavioral |
myplan 2.0 |
1 |
2017 |
| Device |
mystar dosecoach |
1 |
2015 |
| Dietary Supplement |
n-3 pufa group |
1 |
2017 |
| Dietary Supplement |
n-3 pufas |
1 |
2011 |
| Drug |
n-acetylcystein(drug) |
1 |
2006 |
| Drug |
n-aceylcysteine |
1 |
2008 |
| Other |
n-hydroxy-nor-l-arginine |
1 |
2016 |
| Drug |
nacl (0,9%) |
1 |
2012 |
| Drug |
naltrexone sr 32 mg |
1 |
2007 |
| Drug |
naltrexone sr 32 mg/bupropion sr 360 mg/ day |
1 |
2007 |
| Dietary Supplement |
nanotechnology structured water ( magnalife) |
1 |
2019 |
| Drug |
nasal glucagon |
1 |
2016 |
| Procedure |
nasojejunal feeding tube |
1 |
2007 |
| Drug |
nasulin |
1 |
2009 |
| Drug |
nateglinide 120 mg |
1 |
2009 |
| Drug |
nateglinide 60 mg |
1 |
2004 |
| Drug |
nateglinide 60 mg / valsartan placebo |
1 |
2004 |
| placebo |
nateglinide placebo |
1 |
2004 |
| Other |
native palm olein (iv56) |
1 |
2013 |
| Other |
naturally-sweetened orange juice |
1 |
2018 |
| Drug |
naveglitazar |
1 |
2003 |
| Drug |
nc-503 (eprodisate disodium) |
1 |
2008 |
| Other |
ncep diet first, then almond diet |
1 |
2012 |
| Device |
ncpap nasal continuous positive airway pressure-sub-therapeutic treatment group |
1 |
2013 |
| Device |
ncpap; nasal continuous positive airway pressure. |
1 |
2013 |
| Drug |
nebivolol |
1 |
2008 |
| Biological |
neo-kidney augment |
1 |
2015 |
| Behavioral |
nes with energy restriction |
1 |
2009 |
| Behavioral |
nes without energy restriction |
1 |
2009 |
| Diagnostic Test |
nesfatin-1 |
1 |
2020 |
| Drug |
neuropeptide y |
1 |
2015 |
| Drug |
neutral protamine hagedorn (nph) |
1 |
2018 |
| Other |
new medicine service |
1 |
2012 |
| Behavioral |
newme) |
1 |
2016 |
| Drug |
nexium |
1 |
2008 |
| Drug |
niacin/laropiprant |
1 |
2014 |
| Drug |
nicotinic acid |
1 |
2018 |
| Drug |
nitazoxanide |
1 |
2013 |
| Drug |
nitroprusside, pentalong, imdur, aicar, isoptin |
1 |
2005 |
| Drug |
nly01 |
1 |
2019 |
| Device |
nmes |
1 |
2017 |
| placebo |
nmes-placebo |
1 |
2017 |
| Drug |
nn1952 |
1 |
2009 |
| Drug |
nn9924 (i.v.) |
1 |
2009 |
| Drug |
nn9924 (oral) |
1 |
2009 |
| Drug |
nn9924 (s.c.) |
1 |
2009 |
| Drug |
nn9925 (i.v.) |
1 |
2010 |
| Drug |
nn9925 (oral) |
1 |
2010 |
| Drug |
nnc 0148-0000-0362 |
1 |
2012 |
| Drug |
nnc 55-0414 |
1 |
2006 |
| Drug |
nnc 90-1170 |
1 |
2001 |
| Drug |
nnc0090-2746 |
1 |
2014 |
| Drug |
nnc0113-0987 |
1 |
2012 |
| Drug |
nnc0113-2023 |
1 |
2018 |
| Drug |
nnc0148-0287 |
1 |
2018 |
| Drug |
nnc0148-0287sema |
1 |
2018 |
| Drug |
nnc0268-0965 |
1 |
2019 |
| Drug |
nnc0472-0147 |
1 |
2020 |
| Drug |
nnc0480-0389 |
1 |
2020 |
| Drug |
nnc9204-1513 |
1 |
2018 |
| Drug |
no aspirin |
1 |
2005 |
| Procedure |
no blood-glucose self-control |
1 |
2008 |
| Other |
no breakfast |
1 |
2011 |
| Other |
no breakfast/beverage only |
1 |
2011 |
| Behavioral |
no information on high risk factor levels but lifestyle advice |
1 |
2014 |
| Behavioral |
no information on high risk factor levels, nor lifestyle advice |
1 |
2014 |
| Other |
no intervention |
1 |
2010 |
| Dietary Supplement |
no peanuts (control) |
1 |
2011 |
| Other |
no raw corn starch |
1 |
2018 |
| Behavioral |
no red meat |
1 |
2017 |
| Other |
no training |
1 |
2018 |
| Dietary Supplement |
non-alcoholic beer |
1 |
2018 |
| Dietary Supplement |
non-glycated beta-lactoglobulins |
1 |
2011 |
| Drug |
non-insulin anti-diabetic treatment |
1 |
2016 |
| Drug |
non-insulin antihyperglycemic drugs |
1 |
2016 |
| Behavioral |
non-sedentary behaviour modelling |
1 |
2019 |
| Dietary Supplement |
non coated sucrose |
1 |
2017 |
| Dietary Supplement |
non coated sucrose/whole milk |
1 |
2017 |
| Behavioral |
nordic walking |
1 |
2010 |
| Behavioral |
normal activity |
1 |
2013 |
| Behavioral |
normal activity/hypercaloric diet |
1 |
2013 |
| Other |
normal follow-up |
1 |
2007 |
| Behavioral |
normal lifestyle intervention |
1 |
2013 |
| Behavioral |
normal meal |
1 |
2015 |
| Behavioral |
normal physical activity |
1 |
2016 |
| Drug |
normal saline 0.9% |
1 |
2008 |
| Behavioral |
normal sleep |
1 |
2015 |
| Behavioral |
normal sleep/ late meal |
1 |
2015 |
| Behavioral |
normal sleep/ normal meal |
1 |
2015 |
| Behavioral |
normal timing of food intake |
1 |
2019 |
| Other |
normo-carbohydrate meal intake |
1 |
2018 |
| Other |
normocaloric diet |
1 |
2015 |
| Other |
north american diet |
1 |
2019 |
| Other |
novartis access |
1 |
2016 |
| Device |
novofineâ® needle 12 mm |
1 |
2009 |
| Device |
novofineâ® needle 4 mm |
1 |
2006 |
| Device |
novofineâ® needle 8 mm |
1 |
2007 |
| Drug |
novolin-r |
1 |
2005 |
| Drug |
novolin 30r;pioglitazone;metformin |
1 |
2017 |
| Drug |
novolinâ® 30r |
1 |
2011 |
| Drug |
novolog |
1 |
2017 |
| Drug |
novolog/novorapid |
1 |
2017 |
| Device |
novopenâ„¢ 4 |
1 |
2007 |
| Device |
novopenâ® 3 |
1 |
2007 |
| Device |
novopenâ®4 |
1 |
2018 |
| Drug |
novorapid/amaryl |
1 |
2005 |
| Drug |
nph |
1 |
2013 |
| Drug |
nph human insulin |
1 |
2008 |
| Drug |
nph insulin (insulin isophane) |
1 |
2010 |
| Drug |
nph insulin / regular insulin |
1 |
2007 |
| Drug |
nph insulin/regular insulin |
1 |
2009 |
| Drug |
nph twice-daily |
1 |
2008 |
| Drug |
nph/reg |
1 |
2013 |
| Drug |
npl insulin |
1 |
2008 |
| Behavioral |
numeracy oriented educational intervention |
1 |
2007 |
| Behavioral |
nurse-led integrative health |
1 |
2017 |
| Behavioral |
nurse-led integrative health/wellness programme |
1 |
2017 |
| Other |
nurse-monitoring for patients with diabetes mellitus type 2 |
1 |
2012 |
| Behavioral |
nurse case management |
1 |
2012 |
| Behavioral |
nurse case manager |
1 |
2001 |
| Behavioral |
nurse case manager/community health worker team |
1 |
2001 |
| Behavioral |
nursing consultation |
1 |
2018 |
| Behavioral |
nursing team on the protocol |
1 |
2010 |
| Drug |
nutriceutical oral capsule, |
1 |
2018 |
| Behavioral |
nutrition education intervention |
1 |
2020 |
| Behavioral |
nutrition education/occupational therapy/yoga |
1 |
2019 |
| Behavioral |
nutrition intervention |
1 |
2012 |
| Other |
nutrition intervention based on my dia-rnp |
1 |
2019 |
| Dietary Supplement |
nutrition program |
1 |
2018 |
| Other |
nutrition/physical activity |
1 |
2012 |
| Behavioral |
nutritional counseling |
1 |
2005 |
| Behavioral |
nutritional counseling/diabetes education |
1 |
2005 |
| Other |
nutritional formula |
1 |
2008 |
| Other |
nutritional ingredient |
1 |
2011 |
| Other |
nutritional product for diabetes (medical food) |
1 |
2008 |
| Behavioral |
nutritional strategy |
1 |
2019 |
| Behavioral |
nutritional therapy |
1 |
2015 |
| Behavioral |
nutritional therapy/education |
1 |
2015 |
| Drug |
oad |
1 |
2007 |
| Drug |
oams |
1 |
2011 |
| Dietary Supplement |
oat beta-glucan as a supplement in type 2 diabetics |
1 |
2019 |
| Dietary Supplement |
oatmeal breakfast |
1 |
2016 |
| Behavioral |
obesity program |
1 |
2014 |
| Procedure |
ogtt |
1 |
2015 |
| Dietary Supplement |
okra seed |
1 |
2019 |
| Drug |
omacor |
1 |
2006 |
| Drug |
omacorâ® (omega-3-acid ethyl esters) |
1 |
2015 |
| Drug |
omarigliptin 25 mg |
1 |
2017 |
| Drug |
omega-3-acids ethylesters 90 4g |
1 |
2014 |
| Drug |
omega-3 fatty acid (fish oil) |
1 |
2012 |
| Drug |
omega-3 fatty acids |
1 |
2005 |
| Drug |
omega-3 polyunsaturated fatty acids (pufa) |
1 |
2003 |
| Dietary Supplement |
omega-3 pufa |
1 |
2014 |
| Dietary Supplement |
omega 3 supplements |
1 |
2011 |
| Procedure |
omentectomy |
1 |
2007 |
| Drug |
omeprazole |
1 |
2019 |
| Procedure |
omt-sham protocol |
1 |
2018 |
| Procedure |
omt protocol |
1 |
2018 |
| Device |
onduo app |
1 |
2019 |
| Behavioral |
one drop | experts on call |
1 |
2018 |
| Behavioral |
one drop | experts on track |
1 |
2018 |
| Behavioral |
one drop | experts revive |
1 |
2018 |
| Behavioral |
one drop experts program |
1 |
2016 |
| Behavioral |
one drop experts program / apple watch |
1 |
2016 |
| Device |
onetouch delicia extra fine 33g lancets (lifescan) |
1 |
2020 |
| Device |
onetouch delicia lancing device (lifescan) |
1 |
2020 |
| Behavioral |
onetouchâ® ultraâ®2 system |
1 |
2006 |
| Behavioral |
online - use of online grocery shopping platform |
1 |
2019 |
| Behavioral |
online diabetes prevention program |
1 |
2015 |
| Dietary Supplement |
onyx sorghum |
1 |
2018 |
| Drug |
opc-262 2.5 mg |
1 |
2009 |
| Drug |
opc-262 5 mg |
1 |
2009 |
| Drug |
open-label glimepiride |
1 |
2013 |
| Procedure |
open duodenojejunal bypass |
1 |
2012 |
| Device |
openflow microperfusion catheter |
1 |
2008 |
| Other |
operative groups based on methodology of problematization |
1 |
2016 |
| Drug |
opk-88003 |
1 |
2018 |
| Other |
optifast |
1 |
2017 |
| Other |
optimal diet |
1 |
2018 |
| Behavioral |
optimal insulin injection |
1 |
2019 |
| Drug |
optimisation of pharmacological treatment |
1 |
2005 |
| Procedure |
optimised treatment |
1 |
2005 |
| Behavioral |
optimizing processes of care |
1 |
2006 |
| Drug |
optimizing therapeutic treatments |
1 |
2006 |
| Behavioral |
optimum lifestyle intervention |
1 |
2013 |
| Behavioral |
optional care management |
1 |
2018 |
| Other |
or behavioral changes |
1 |
2007 |
| Drug |
or glyburide alone. |
1 |
2002 |
| Drug |
or insulin |
1 |
2009 |
| Behavioral |
or involvement of family member |
1 |
2019 |
| Drug |
or metformin hcl alone |
1 |
2002 |
| Drug |
or rosuvastatin |
1 |
2014 |
| Drug |
or sulfonylurea) |
1 |
2013 |
| Drug |
or tzd |
1 |
2008 |
| Drug |
oral administration of ipragliflozin |
1 |
2016 |
| Drug |
oral administration of lobeglitazone |
1 |
2014 |
| Drug |
oral anti-diabetic drug |
1 |
2012 |
| Drug |
oral antidiabetic drug (glimepiride |
1 |
2007 |
| Drug |
oral antidiabetic drug (glimepiride/metformin) |
1 |
2007 |
| Drug |
oral antihyperglycemic medication |
1 |
2014 |
| Drug |
oral antihyperglycemic medications (oam) |
1 |
2013 |
| Drug |
oral antihyperglycemic medications (oams) |
1 |
2013 |
| Drug |
oral contraceptive (brevicon) |
1 |
2010 |
| Other |
oral ethanol, overnight |
1 |
2007 |
| Other |
oral glucoce tolerance test |
1 |
2012 |
| Other |
oral glucose breath test |
1 |
2013 |
| Other |
oral glucose load |
1 |
2015 |
| Other |
oral glucose test (ogtt); isoglycaemic iv. clamp; liquid meal test; gastric emptying rate; prednisolone; paracetamol |
1 |
2008 |
| Procedure |
oral glucose tolerance test 2 days post-partum |
1 |
2013 |
| Behavioral |
oral hygiene instructions |
1 |
2017 |
| Drug |
oral hypoglycemic agents (pre-specified) [metformin, sulfonylurea] |
1 |
2016 |
| Drug |
oral hypoglycemic agents [metformin |
1 |
2016 |
| Drug |
oral hypoglycemic agents [metformin //- sulfonylurea] |
1 |
2016 |
| Drug |
oral insulin |
1 |
2009 |
| Drug |
oral nnc 0113-0987 |
1 |
2011 |
| Drug |
oral vildagliptin |
1 |
2016 |
| Drug |
oral vitamin d |
1 |
2015 |
| Other |
orange juice concentrate |
1 |
2020 |
| Dietary Supplement |
ordinary water |
1 |
2019 |
| Drug |
ormd-0801 |
1 |
2015 |
| Drug |
ormd-0801 (bid) |
1 |
2016 |
| Drug |
ormd-0801 (qd) |
1 |
2016 |
| Drug |
ormd-0801 (tid) |
1 |
2016 |
| Drug |
ormd-0801 dose # 1 |
1 |
2013 |
| Drug |
ormd-0801 dose # 2 |
1 |
2013 |
| Drug |
ortho-cyclen |
1 |
2011 |
| Behavioral |
ot diabetes self-management intervention |
1 |
2019 |
| Drug |
other diabetes medication currently prescribed to participant |
1 |
2008 |
| Dietary Supplement |
other protein sources at breakfast |
1 |
2013 |
| Device |
otm |
1 |
2008 |
| Device |
otm / 33g |
1 |
2008 |
| Device |
otm/28g |
1 |
2008 |
| Device |
otu |
1 |
2008 |
| Device |
otu/28g |
1 |
2008 |
| Device |
overstitch |
1 |
2018 |
| Other |
oxygen |
1 |
2013 |
| Drug |
oxyntomodulin |
1 |
2011 |
| Other |
pa |
1 |
2009 |
| placebo |
pacebo 1 (placebo for amantadine) |
1 |
2011 |
| Diagnostic Test |
paced breathing at 6, 10 |
1 |
2017 |
| Diagnostic Test |
paced breathing at 6, 10/15 breaths per minute |
1 |
2017 |
| Behavioral |
pacific diabetes prevention education |
1 |
2017 |
| Drug |
pantoprazole |
1 |
2012 |
| Device |
paqâ„¢ insulin infusion device |
1 |
2011 |
| Device |
paqâ® insulin delivery device |
1 |
2015 |
| Behavioral |
par |
1 |
2011 |
| Drug |
paracetamol |
1 |
2012 |
| Behavioral |
parent education |
1 |
2018 |
| Drug |
paricalcitol |
1 |
2011 |
| Drug |
part a, reference (d635 10 |
1 |
2019 |
| Drug |
part a, reference (d635 10/500mg, astrazeneca) |
1 |
2019 |
| placebo |
part b placebo |
1 |
2018 |
| Drug |
part b, reference (d635 10 |
1 |
2019 |
| Drug |
part b, reference (d635 10/500mg, astrazeneca) |
1 |
2019 |
| Behavioral |
partners in care with semi-structured support group |
1 |
2013 |
| Other |
passive diffusion |
1 |
2011 |
| Behavioral |
patient-centered counselling |
1 |
2020 |
| Behavioral |
patient-centered counselling/written material |
1 |
2020 |
| Behavioral |
patient-driven sma |
1 |
2018 |
| Other |
patient-facing diabetes dashboard |
1 |
2018 |
| Behavioral |
patient education, self-monitoring of blood glucose |
1 |
2012 |
| Behavioral |
patient education, self-monitoring of blood glucose/remote patient monitoring of blood glucose |
1 |
2012 |
| Other |
patient education/self-management intervention in a low-resource setting on diabetes knowledge/levels of blood glucose control |
1 |
2020 |
| Behavioral |
patient liaison combination |
1 |
2011 |
| Behavioral |
patient self-directed care |
1 |
2014 |
| Drug |
paz320 |
1 |
2013 |
| Drug |
pb-119 |
1 |
2014 |
| Drug |
pb-119 100 î¼g |
1 |
2018 |
| Drug |
pb-119 100 î¼g/ glucophageâ® |
1 |
2018 |
| Drug |
pb-119 150 î¼g |
1 |
2018 |
| Drug |
pb-119 150 î¼g/ glucophageâ® |
1 |
2018 |
| Drug |
pb-119 150ug |
1 |
2018 |
| Drug |
pb-119 200 î¼g |
1 |
2018 |
| Drug |
pb-119 200 î¼g/ glucophageâ® |
1 |
2018 |
| Drug |
pb-119 200ug |
1 |
2018 |
| Drug |
pb-119 75ug |
1 |
2018 |
| placebo |
pb-119 injection placebo |
1 |
2017 |
| placebo |
pb-119 placebo |
1 |
2018 |
| Drug |
pb-119 placebo / glucophageâ® |
1 |
2018 |
| Drug |
pb1023 injection |
1 |
2011 |
| Drug |
pbi4050 |
1 |
2015 |
| Other |
pcd |
1 |
2008 |
| Behavioral |
pda |
1 |
2010 |
| Behavioral |
pda self reporting. |
1 |
2009 |
| Behavioral |
pda/cdsmp |
1 |
2010 |
| Device |
pds290 |
1 |
2018 |
| Device |
pds290 pen-injector |
1 |
2018 |
| Procedure |
pdt |
1 |
2013 |
| Dietary Supplement |
pea protein in enteric coating |
1 |
2017 |
| Dietary Supplement |
pea protein with separate enteric coating materials |
1 |
2017 |
| Dietary Supplement |
peanut butter |
1 |
2009 |
| Dietary Supplement |
peanuts |
1 |
2009 |
| Dietary Supplement |
peanuts/peanut butter |
1 |
2009 |
| Other |
pearl millet couscous - made in senegal |
1 |
2018 |
| Other |
pearl millet couscous - made in usa |
1 |
2018 |
| Other |
pearl millet thick porridge |
1 |
2018 |
| Behavioral |
pedometer intervention |
1 |
2015 |
| Other |
peer-led support group |
1 |
2019 |
| Behavioral |
peer education |
1 |
2010 |
| Behavioral |
peer support dyad intervention |
1 |
2018 |
| Behavioral |
peers supporting health-literacy, self efficacy, advocacy |
1 |
2019 |
| Behavioral |
peers supporting health-literacy, self efficacy, advocacy/adherence |
1 |
2019 |
| Drug |
pegloticase 8 mg |
1 |
2019 |
| Drug |
pegloticase 8 mg/ml [krystexxa] |
1 |
2019 |
| Drug |
pentoxifylline |
1 |
2011 |
| Device |
percutaneous neurostimulation (pens) of dermatome t7 |
1 |
2014 |
| Procedure |
percutaneous renal denervation |
1 |
2012 |
| Procedure |
percutaneous renal denervation/tmns |
1 |
2012 |
| Drug |
perindopril |
1 |
2018 |
| Drug |
perindopril arginine |
1 |
2019 |
| Drug |
perindopril oral tablet |
1 |
2017 |
| Drug |
perindopril/amlodipine |
1 |
2018 |
| Procedure |
periodontal scaling |
1 |
2010 |
| Procedure |
periodontal scaling/root planing |
1 |
2010 |
| Procedure |
periodontal treatment |
1 |
2013 |
| Procedure |
periodontal treatment with hyaluronic acid associated with srp |
1 |
2019 |
| Procedure |
periodontal treatment/pdt |
1 |
2013 |
| Other |
peripheral venous cannulation |
1 |
2017 |
| Behavioral |
person centered, occupation based intervention support with problem solving therapy |
1 |
2018 |
| Behavioral |
personal contact (pc) |
1 |
2003 |
| Device |
personal glucometer |
1 |
2016 |
| Drug |
personalized diet |
1 |
2018 |
| Behavioral |
personalized diet plan |
1 |
2009 |
| Behavioral |
personalized diet plan/pda self reporting. |
1 |
2009 |
| Behavioral |
personalized dietary advice services |
1 |
2015 |
| Device |
personalized glucose predictive |
1 |
2011 |
| Device |
personalized glucose predictive/therapy advisory system (diadvisor) |
1 |
2011 |
| Behavioral |
personalized health planning shared medical appointment |
1 |
2015 |
| Other |
personalized risk communication for people with type 2 diabetes |
1 |
2019 |
| Behavioral |
personalized self-management |
1 |
2000 |
| Radiation |
pet |
1 |
2016 |
| Radiation |
pet/scan |
1 |
2016 |
| Drug |
petroleum jelly |
1 |
2019 |
| Drug |
pex168/placebo |
1 |
2013 |
| Drug |
pf-00734200 10 mg qd |
1 |
2007 |
| Drug |
pf-00734200 2 mg qd |
1 |
2007 |
| Drug |
pf-00734200 30 mg qd |
1 |
2008 |
| Drug |
pf-00734200 5 mg qd |
1 |
2007 |
| Drug |
pf-03882845 |
1 |
2011 |
| Biological |
pf-04603629 |
1 |
2008 |
| Drug |
pf-04620110 |
1 |
2011 |
| Drug |
pf-04634817 |
1 |
2012 |
| Biological |
pf-04856883 |
1 |
2011 |
| Drug |
pf-04937319 - 100mg |
1 |
2011 |
| Drug |
pf-04937319 - 20mg |
1 |
2011 |
| Drug |
pf-04937319 - 3mg |
1 |
2011 |
| Drug |
pf-04937319 - 50mg |
1 |
2011 |
| Drug |
pf-04937319 10 mg |
1 |
2012 |
| Drug |
pf-04937319 100 mg |
1 |
2012 |
| Drug |
pf-04937319 50 mg |
1 |
2012 |
| Drug |
pf-04937319 high dose |
1 |
2014 |
| Drug |
pf-04937319 ir mst |
1 |
2014 |
| Drug |
pf-04937319 low dose |
1 |
2014 |
| Drug |
pf-04937319 mr 1 |
1 |
2014 |
| Drug |
pf-04937319 mr 2 |
1 |
2014 |
| Drug |
pf-04937319 mr 3 |
1 |
2014 |
| Drug |
pf-04937319 once-daily |
1 |
2013 |
| Drug |
pf-04937319 split-dose |
1 |
2013 |
| Drug |
pf-0499132 |
1 |
2011 |
| Drug |
pf-05161704 |
1 |
2010 |
| Drug |
pf-05161704/placebo |
1 |
2010 |
| Biological |
pf-06293620 |
1 |
2014 |
| Drug |
pf-06835919 |
1 |
2019 |
| Drug |
pf-06882961 |
1 |
2018 |
| Drug |
pf-07081532 |
1 |
2020 |
| Procedure |
pharmaceutical care at baseline |
1 |
2006 |
| Procedure |
pharmaceutical care at baseline/follow-up visits over 6 months |
1 |
2006 |
| Other |
pharmaceutical care programe |
1 |
2015 |
| Other |
pharmacist collaboration in diabetes care |
1 |
2007 |
| Behavioral |
pharmacist counseling intervention |
1 |
2020 |
| Other |
pharmacist review of therapy |
1 |
2017 |
| Drug |
pharmacotherapy |
1 |
2018 |
| Other |
pharmacotherapy follow-up care |
1 |
2016 |
| Behavioral |
pharmacy managed diabetes clinic (pmdc) |
1 |
2017 |
| Behavioral |
pheinaction-personalized patient engagement plan |
1 |
2020 |
| Procedure |
phlebotomy |
1 |
2015 |
| Behavioral |
phone call support |
1 |
2008 |
| Drug |
phx1149 |
1 |
2007 |
| Drug |
phx1149t |
1 |
2008 |
| Behavioral |
physical activity (pa) enhancement program with behavioral support |
1 |
2011 |
| Behavioral |
physical activity behavior change (pabc) |
1 |
2016 |
| Behavioral |
physical activity coaching |
1 |
2014 |
| Behavioral |
physical activity counseling |
1 |
2017 |
| Behavioral |
physical activity counseling/fitbit |
1 |
2017 |
| Other |
physical activity counselling via a brochure |
1 |
2016 |
| Behavioral |
physical activity intervention |
1 |
2015 |
| Behavioral |
physical activity referral scheme |
1 |
2018 |
| Behavioral |
physical activity) |
1 |
2007 |
| Behavioral |
physical activity/exercise education/behaviour counseling from a registered kinesiologist/a ymca wellness coach |
1 |
2014 |
| Behavioral |
physical exercise |
1 |
2005 |
| Other |
physical exercise training |
1 |
2010 |
| Behavioral |
physical walking |
1 |
2005 |
| Behavioral |
physician counseling for health behavior change |
1 |
2009 |
| Behavioral |
physician feedback (a) |
1 |
2007 |
| Behavioral |
physician supported care |
1 |
2014 |
| Behavioral |
pilam go4health weight-loss program |
1 |
2014 |
| Dietary Supplement |
pine nut oil |
1 |
2017 |
| Other |
pinto beans |
1 |
2019 |
| Drug |
pio |
1 |
2009 |
| Drug |
pio (pioglitazone) |
1 |
2009 |
| Drug |
pio) as comparator to liraglutide |
1 |
2011 |
| Drug |
pioglitazone - tzd |
1 |
2016 |
| Drug |
pioglitazone (30 mg) |
1 |
2008 |
| Drug |
pioglitazone / alogliptin |
1 |
2018 |
| Drug |
pioglitazone 15 mg |
1 |
2010 |
| Drug |
pioglitazone 15 mg fdc |
1 |
2010 |
| Drug |
pioglitazone 15mg |
1 |
2010 |
| Drug |
pioglitazone 30 mg fdc |
1 |
2010 |
| Drug |
pioglitazone 30 mg q.d |
1 |
2006 |
| Drug |
pioglitazone 30 mg q.d. |
1 |
2006 |
| Drug |
pioglitazone 45 mg |
1 |
2010 |
| Drug |
pioglitazone 45 mg fdc |
1 |
2010 |
| Drug |
pioglitazone 45 mg q.d. |
1 |
2009 |
| Drug |
pioglitazone 45 mg q.d. / sitagliptin 100 mg placebo q.d. |
1 |
2009 |
| Drug |
pioglitazone group |
1 |
2013 |
| Drug |
pioglitazone open label |
1 |
2009 |
| placebo |
pioglitazone placebo |
1 |
2006 |
| Drug |
pioglitazone rescue therapy |
1 |
2010 |
| Drug |
pioglitazone study drug |
1 |
2009 |
| Drug |
pioglitazone/epa |
1 |
2005 |
| Drug |
pioglitazone/exenatide |
1 |
2009 |
| Drug |
pioglitazone/insulin |
1 |
2008 |
| Drug |
pioglitazone/metformin |
1 |
2014 |
| Drug |
pioglitazone/placebo/rosiglitazone |
1 |
2010 |
| Drug |
pioglitazone/rosiglitazone/placebo |
1 |
2010 |
| Other |
pistachio |
1 |
2009 |
| Dietary Supplement |
pistachios |
1 |
2011 |
| Other |
pizza |
1 |
2017 |
| placebo |
placebo-liraglutide |
1 |
2012 |
| placebo |
placebo-matching dapagliflozin |
1 |
2010 |
| placebo |
placebo-metformin |
1 |
2005 |
| placebo |
placebo-metformin. |
1 |
2005 |
| placebo |
placebo-repaglinide |
1 |
2005 |
| placebo |
placebo-repaglinide. |
1 |
2005 |
| placebo |
placebo - capsule |
1 |
2013 |
| placebo |
placebo - exenatide - exenatide |
1 |
2005 |
| placebo |
placebo - solution |
1 |
2013 |
| placebo |
placebo (0.9% nacl) |
1 |
2010 |
| placebo |
placebo (0.9% sodium chloride) |
1 |
2012 |
| placebo |
placebo (calcined magnesia) |
1 |
2018 |
| placebo |
placebo (canagliflozin) |
1 |
2017 |
| placebo |
placebo (captisol â®) |
1 |
2014 |
| placebo |
placebo (captisolâ®) |
1 |
2013 |
| placebo |
placebo (for diazoxide) |
1 |
2018 |
| placebo |
placebo (for liraglutide) |
1 |
2017 |
| placebo |
placebo (for red grape cells (rgc)) |
1 |
2013 |
| placebo |
placebo (for rvx000222) |
1 |
2015 |
| placebo |
placebo (insulin 287) |
1 |
2018 |
| placebo |
placebo (insulin glargine) |
1 |
2018 |
| placebo |
placebo (linagliptin) |
1 |
2008 |
| placebo |
placebo (matching empagliflozin) |
1 |
2015 |
| placebo |
placebo (matching sitagliptin) |
1 |
2008 |
| placebo |
placebo (matching taspoglutide) |
1 |
2008 |
| placebo |
placebo (matching with bms-986036) |
1 |
2014 |
| placebo |
placebo (metformin) |
1 |
2010 |
| placebo |
placebo (mid dose) |
1 |
2010 |
| placebo |
placebo (middle dose) |
1 |
2009 |
| placebo |
placebo (nnc0113-2023) |
1 |
2018 |
| placebo |
placebo (nnc0472-0147) |
1 |
2020 |
| placebo |
placebo (nnc0480-0389) |
1 |
2020 |
| placebo |
placebo (oral semaglutide) |
1 |
2019 |
| placebo |
placebo (oral) |
1 |
2010 |
| placebo |
placebo (sad) |
1 |
2016 |
| placebo |
placebo (saxagliptin) |
1 |
2010 |
| placebo |
placebo (semaglutide 0.5 mg) |
1 |
2017 |
| placebo |
placebo (semaglutide 1.0 mg) |
1 |
2017 |
| placebo |
placebo (subcutaneous) |
1 |
2010 |
| Drug |
placebo / atazanavir |
1 |
2008 |
| Drug |
placebo / duration of treatment: mean 3.4 years |
1 |
2006 |
| Drug |
placebo / insulin |
1 |
2008 |
| Drug |
placebo / metformin |
1 |
2005 |
| Drug |
placebo / pioglitazone (30 mg) |
1 |
2008 |
| Drug |
placebo / rosuvastatin |
1 |
2016 |
| Drug |
placebo / teneli (teneligliptin) / pio (pioglitazone) |
1 |
2009 |
| Drug |
placebo / teneli (teneligliptin) / su (sulfonylurea) |
1 |
2009 |
| Drug |
placebo /metformin |
1 |
2013 |
| placebo |
placebo 0.01 ml |
1 |
2002 |
| placebo |
placebo 0.02 ml |
1 |
2002 |
| placebo |
placebo 0.03 ml |
1 |
2002 |
| placebo |
placebo 0.04 ml |
1 |
2002 |
| placebo |
placebo 0.04 ml once daily |
1 |
2004 |
| placebo |
placebo 0.04 ml twice daily |
1 |
2004 |
| placebo |
placebo 0.08 ml once daily |
1 |
2004 |
| placebo |
placebo 0.5mg |
1 |
2014 |
| Drug |
placebo 0.5mg/d |
1 |
2014 |
| placebo |
placebo 10 mg |
1 |
2013 |
| placebo |
placebo 10mg |
1 |
2016 |
| placebo |
placebo 2 (fo dextromethorphan) |
1 |
2011 |
| placebo |
placebo 5 mg |
1 |
2013 |
| placebo |
placebo 5 mg for saxagliptin |
1 |
2014 |
| placebo |
placebo 500 mg capsule twice daily |
1 |
2005 |
| placebo |
placebo 500 mg for metformin (with titration) |
1 |
2014 |
| placebo |
placebo a tablet |
1 |
2010 |
| placebo |
placebo albiglutide |
1 |
2009 |
| placebo |
placebo as capsules |
1 |
2012 |
| placebo |
placebo as sc injection |
1 |
2012 |
| placebo |
placebo attention control |
1 |
2012 |
| placebo |
placebo bi 10773 high dose |
1 |
2010 |
| placebo |
placebo bi 10773 low dose |
1 |
2010 |
| placebo |
placebo biscuit |
1 |
2014 |
| placebo |
placebo capsules to match egt0001442 |
1 |
2009 |
| placebo |
placebo co-ingestion |
1 |
2011 |
| placebo |
placebo comparator beverage (beet-it stamina shot) |
1 |
2013 |
| Other |
placebo comparator beverage (beet-it stamina shot)/exercise training |
1 |
2013 |
| placebo |
placebo comparator: saline infusion |
1 |
2013 |
| placebo |
placebo control |
1 |
2017 |
| placebo |
placebo control group |
1 |
2011 |
| placebo |
placebo device |
1 |
2019 |
| placebo |
placebo drink |
1 |
2014 |
| placebo |
placebo drug: metformin |
1 |
2007 |
| placebo |
placebo evogliptin |
1 |
2016 |
| placebo |
placebo for 12 weeks as add-on to metformin |
1 |
2017 |
| placebo |
placebo for active |
1 |
2012 |
| placebo |
placebo for bi 44847 |
1 |
2007 |
| placebo |
placebo for comparator |
1 |
2012 |
| placebo |
placebo for ertugliflozin 10 mg |
1 |
2014 |
| placebo |
placebo for ertugliflozin 5 mg |
1 |
2014 |
| placebo |
placebo for fenofibrate |
1 |
2012 |
| placebo |
placebo for gemfibrozil |
1 |
2007 |
| placebo |
placebo for glipizide |
1 |
2007 |
| placebo |
placebo for liraglutide |
1 |
2011 |
| placebo |
placebo for ly2428757 |
1 |
2009 |
| placebo |
placebo for mbx-2044 |
1 |
2007 |
| placebo |
placebo for metformin |
1 |
2008 |
| placebo |
placebo for mitiglinide |
1 |
2007 |
| placebo |
placebo for mk-0893 |
1 |
2008 |
| placebo |
placebo for nasulin |
1 |
2009 |
| placebo |
placebo for oxyntomodulin |
1 |
2011 |
| placebo |
placebo for tt223 |
1 |
2009 |
| placebo |
placebo for up to 28 days |
1 |
2018 |
| placebo |
placebo glimepiride |
1 |
2009 |
| placebo |
placebo group(once daily) |
1 |
2012 |
| placebo |
placebo identical once daily tablet treatment |
1 |
2016 |
| placebo |
placebo identical to bi 10773 high dose |
1 |
2010 |
| placebo |
placebo identical to bi 10773 low dose |
1 |
2010 |
| placebo |
placebo identical to bi 1356 5mg |
1 |
2008 |
| placebo |
placebo identical to bi10773 high dose |
1 |
2010 |
| placebo |
placebo identical to bi10773 low dose |
1 |
2010 |
| placebo |
placebo identical to glimepiride 1mg |
1 |
2008 |
| Drug |
placebo identical to glimepiride 1mg/2mg/3mg/4 mg |
1 |
2008 |
| placebo |
placebo identical to sitagliptin 100mg |
1 |
2010 |
| placebo |
placebo iv |
1 |
2010 |
| placebo |
placebo juice |
1 |
2008 |
| placebo |
placebo lactose powder |
1 |
2009 |
| placebo |
placebo liquid auto-injector |
1 |
2016 |
| placebo |
placebo lyophilized dcc pen injector |
1 |
2016 |
| placebo |
placebo matching dbpr108 tablet(100mg), placebo matching dbpr108 tablet(50mg) |
1 |
2019 |
| placebo |
placebo matching ertugliflozin |
1 |
2015 |
| placebo |
placebo matching metformin |
1 |
2005 |
| placebo |
placebo matching metformin xr |
1 |
2009 |
| placebo |
placebo matching with bms-823778 |
1 |
2012 |
| placebo |
placebo matching with metformin ir |
1 |
2013 |
| placebo |
placebo matching with metformin xr |
1 |
2013 |
| placebo |
placebo matching with sitagliptin |
1 |
2014 |
| placebo |
placebo of anagliptin |
1 |
2012 |
| placebo |
placebo of dlbs3233 |
1 |
2012 |
| placebo |
placebo of mci-196 tablet |
1 |
2007 |
| placebo |
placebo of mp-513 |
1 |
2010 |
| placebo |
placebo of ta-7284 |
1 |
2008 |
| placebo |
placebo once weekly |
1 |
2008 |
| placebo |
placebo oral tablet then dapagliflozin 10mg |
1 |
2017 |
| placebo |
placebo pill |
1 |
2012 |
| placebo |
placebo product |
1 |
2014 |
| placebo |
placebo sc |
1 |
2010 |
| Drug |
placebo solution/lifestyle measures |
1 |
2008 |
| placebo |
placebo standard exercise |
1 |
2009 |
| placebo |
placebo supplements |
1 |
2011 |
| placebo |
placebo tablet of dlbs1033 |
1 |
2013 |
| placebo |
placebo to bi 10773 |
1 |
2007 |
| placebo |
placebo to canakinumab |
1 |
2010 |
| placebo |
placebo to ertuglilflozin 1 |
1 |
2010 |
| Drug |
placebo to ertuglilflozin 1/5 mg |
1 |
2010 |
| placebo |
placebo to ertuglilflozin 25 mg |
1 |
2010 |
| placebo |
placebo to evolocumab |
1 |
2016 |
| placebo |
placebo to gliclazide |
1 |
2012 |
| placebo |
placebo to hctz |
1 |
2010 |
| placebo |
placebo to linagliptin |
1 |
2013 |
| placebo |
placebo to match albiglutide |
1 |
2009 |
| placebo |
placebo to match metformin |
1 |
2012 |
| placebo |
placebo to match pioglitazone |
1 |
2009 |
| placebo |
placebo to match ranolazine |
1 |
2012 |
| placebo |
placebo to match saxagliptin |
1 |
2016 |
| placebo |
placebo to match sitagliptin |
1 |
2016 |
| placebo |
placebo to metformin xr |
1 |
2013 |
| placebo |
placebo to mk-1092 |
1 |
2017 |
| placebo |
placebo to mk-5160 |
1 |
2017 |
| placebo |
placebo to roflumilast |
1 |
2012 |
| Drug |
placebo to sitagliptin / metformin fdc |
1 |
2011 |
| Drug |
placebo to sitagliptin / metformin xr |
1 |
2013 |
| placebo |
placebo to vildagliptin |
1 |
2012 |
| placebo |
placebo topical gel |
1 |
2016 |
| placebo |
placebo with dietician monitoring |
1 |
2015 |
| placebo |
placebo with metformin and |
1 |
2008 |
| Drug |
placebo with metformin and/or tzd |
1 |
2008 |
| placebo |
placebo(gemigliptin) |
1 |
2013 |
| placebo |
placebo(metformin) |
1 |
2013 |
| placebo |
placebo, mk-0431 |
1 |
2011 |
| Drug |
placebo, mk-0431/ono-5435 |
1 |
2011 |
| placebo |
placebo, nicorandil, glimepiride |
1 |
2018 |
| Drug |
placebo/glipizide 5 mg |
1 |
2004 |
| Drug |
placebo/metformin ir |
1 |
2009 |
| Drug |
placebo/pioglitazone/rosiglitazone |
1 |
2010 |
| Drug |
placebo/rosiglitazone/pioglitazone |
1 |
2010 |
| placebo |
placeboa |
1 |
2018 |
| placebo |
placebob |
1 |
2018 |
| Procedure |
placement of nasogastric feeding tube |
1 |
2007 |
| Dietary Supplement |
plant sterols |
1 |
2014 |
| Other |
plates exercises |
1 |
2018 |
| Other |
poc (point of care) |
1 |
2018 |
| Other |
polydextrose |
1 |
2010 |
| Other |
polydextrose/soluble gluco fibre |
1 |
2010 |
| Drug |
polyphenol |
1 |
2011 |
| Procedure |
pool water |
1 |
2012 |
| Other |
population-based physical activity (pa) advice |
1 |
2019 |
| Device |
portable monitoring device |
1 |
2018 |
| Other |
portfolio diet |
1 |
2017 |
| Behavioral |
portion controlled diet |
1 |
2010 |
| Behavioral |
positive affect informational materials |
1 |
2017 |
| Behavioral |
positive affect skills |
1 |
2012 |
| Device |
positive airway pressure therapy |
1 |
2007 |
| Dietary Supplement |
positive control |
1 |
2015 |
| Behavioral |
positive outcomes for women |
1 |
2019 |
| Radiation |
positron emission tomography with the tracer [11c]5-hydroxy-tryptophan |
1 |
2016 |
| Procedure |
post prandial glucoses) |
1 |
2005 |
| Behavioral |
post test measures |
1 |
2016 |
| Behavioral |
postprandial exercise |
1 |
2019 |
| Other |
power resistance training |
1 |
2020 |
| Behavioral |
pp-mi health behavior intervention |
1 |
2016 |
| Behavioral |
ppg training |
1 |
2016 |
| Drug |
pramlintide acetate (symlin) |
1 |
2007 |
| Drug |
prandial insulin |
1 |
2014 |
| Drug |
prandial insulin lispro |
1 |
2010 |
| Drug |
prasugrel. |
1 |
2012 |
| Drug |
pravastatin, simvastatin, atorvastatin, rosuvastatin |
1 |
2014 |
| Behavioral |
pre-coded messages |
1 |
2008 |
| Other |
pre-diabetes screening |
1 |
2010 |
| Device |
pre-filled pen injector |
1 |
2010 |
| Other |
pre-meal |
1 |
2005 |
| Drug |
pre-meal insulin aspart. |
1 |
2009 |
| Behavioral |
pre-medical consultation structured diabetes self-care education programme |
1 |
2019 |
| Dietary Supplement |
pre-operative carbohydrate drink |
1 |
2020 |
| Behavioral |
pre-visit tool |
1 |
2015 |
| Dietary Supplement |
prebiotic fibers: oligofructose |
1 |
2015 |
| Dietary Supplement |
prebiotic fibers: oligofructose/inulin |
1 |
2015 |
| Behavioral |
precede hpe model |
1 |
2011 |
| Behavioral |
predx diabetes risk score |
1 |
2011 |
| Drug |
preexisting metformin |
1 |
2009 |
| Device |
prefilled pen injector |
1 |
2008 |
| Drug |
premeal insulin lispro mixtures |
1 |
2005 |
| Dietary Supplement |
premeal protein enriched bar |
1 |
2018 |
| Behavioral |
premier lifestyle intervention with dash diet |
1 |
2008 |
| Drug |
premixed analogue insulin (70 |
1 |
2016 |
| Drug |
premixed analogue insulin (70/30) |
1 |
2016 |
| Drug |
premixed insulin aspart twice daily (bid) |
1 |
2007 |
| Drug |
preprandial lispro insulin |
1 |
2009 |
| Behavioral |
primary care-occupational therapy |
1 |
2014 |
| Behavioral |
primary care collaboration |
1 |
2010 |
| Dietary Supplement |
primrose oil |
1 |
2015 |
| Behavioral |
print-based physical activity intervention |
1 |
2007 |
| Behavioral |
print educational intervention |
1 |
2005 |
| Behavioral |
print materials, pedometers |
1 |
2005 |
| Behavioral |
print materials, pedometers/logbooks |
1 |
2005 |
| Behavioral |
print materials, pedometers/logbooks, telephone counselling |
1 |
2005 |
| Dietary Supplement |
probiotic |
1 |
2018 |
| Behavioral |
problem-solving training self-study |
1 |
2009 |
| Behavioral |
problem solving skills |
1 |
2005 |
| Behavioral |
problem solving therapy (caps) |
1 |
2008 |
| Drug |
probucol |
1 |
2009 |
| Procedure |
procedure |
1 |
2013 |
| Procedure |
procedure/surgery |
1 |
2013 |
| Other |
processed meat hamburger |
1 |
2015 |
| Behavioral |
program active |
1 |
2017 |
| Behavioral |
program active cbt |
1 |
2017 |
| Behavioral |
program active exercise |
1 |
2017 |
| Behavioral |
program energy |
1 |
2007 |
| Drug |
prolia, 60 mg |
1 |
2018 |
| Drug |
prolia, 60 mg/ml subcutaneous solution |
1 |
2018 |
| Behavioral |
promotion |
1 |
2007 |
| Drug |
propolis |
1 |
2018 |
| Drug |
propranolol hydrochloride (hcl) |
1 |
2009 |
| Procedure |
proprioceptive exercises |
1 |
2017 |
| Drug |
prostaglandin i2 |
1 |
2010 |
| Drug |
protaphane |
1 |
2012 |
| Dietary Supplement |
protein drink |
1 |
2012 |
| Other |
proteus discover |
1 |
2016 |
| Other |
protocol-driven care under jade program |
1 |
2008 |
| Other |
protocolized diuretic therapy |
1 |
2020 |
| Behavioral |
provider-supported integrated care |
1 |
2014 |
| Behavioral |
provider feedback |
1 |
2009 |
| Other |
provider portal “diabetes connected health” tool - deluxe |
1 |
2008 |
| Other |
provider training |
1 |
2009 |
| Drug |
psn821 |
1 |
2011 |
| Behavioral |
psycho-education package |
1 |
2017 |
| Drug |
psyllium powder |
1 |
2018 |
| Procedure |
pulmonary function testing |
1 |
2005 |
| Drug |
pyridoxal-5’-phosphate with |
1 |
2005 |
| Drug |
pyridoxal-5’-phosphate with/without ace inhibitor |
1 |
2005 |
| Dietary Supplement |
pyridoxamine dihydrochloride |
1 |
2018 |
| Other |
qigong therapy |
1 |
2009 |
| Drug |
qr-bromocriptine |
1 |
2011 |
| Dietary Supplement |
quercetin |
1 |
2013 |
| Behavioral |
questionnaire |
1 |
2015 |
| Behavioral |
radio story |
1 |
2014 |
| Drug |
radiolabelled gsk189075 |
1 |
2007 |
| Other |
raisins |
1 |
2012 |
| placebo |
ranolazine placebo |
1 |
2011 |
| Drug |
rapid-acting insulin analogs |
1 |
2015 |
| Drug |
rapid acting insulin (humalogâ® [insulin lispro], novologâ® [insulin aspart], |
1 |
2007 |
| Drug |
rapid acting insulin (humalogâ® [insulin lispro], novologâ® [insulin aspart],/apidraâ® [insulin glulisine]) |
1 |
2007 |
| Other |
ras-antagonist/beta-blocker none/at stable dose |
1 |
2016 |
| Drug |
ras-antagonist/beta-blocker up-to maximal dosages |
1 |
2016 |
| Other |
raspberries |
1 |
2018 |
| Behavioral |
reach-in program, standard of care |
1 |
2008 |
| Behavioral |
reach-out program, nutritional |
1 |
2008 |
| Behavioral |
reach-out program, nutritional/exercise program |
1 |
2008 |
| Behavioral |
ready to act |
1 |
2013 |
| Other |
ready to eat mixed meal 1 |
1 |
2015 |
| Other |
ready to eat mixed meal 2 |
1 |
2015 |
| Other |
ready to eat mixed meal 3 |
1 |
2015 |
| Device |
real-time cgm data |
1 |
2016 |
| Drug |
reandron 1000 |
1 |
2008 |
| Drug |
rebaudioside a |
1 |
2018 |
| Other |
rebound exercise |
1 |
2016 |
| Behavioral |
receiving results via genetic counselor |
1 |
2010 |
| Drug |
recombinant human hyaluronidase ph20 |
1 |
2010 |
| Drug |
recombinant human hyaluronidase ph20 (rhuph20) |
1 |
2009 |
| Dietary Supplement |
red grape cells (rgc) |
1 |
2013 |
| Behavioral |
reducing |
1 |
2018 |
| Behavioral |
reducing/breaking prolonged sitting |
1 |
2018 |
| Dietary Supplement |
reference food format |
1 |
2014 |
| Dietary Supplement |
reference meal |
1 |
2012 |
| Other |
reference product |
1 |
2019 |
| Behavioral |
referral to treatment |
1 |
2013 |
| Other |
refined wheat flour porridge |
1 |
2018 |
| Other |
refined wheat flour porridge,coarse bran |
1 |
2018 |
| Other |
refined wheat flour porridge,fine bran |
1 |
2018 |
| Drug |
reg |
1 |
2013 |
| Other |
regular bake beans in tomato sauce |
1 |
2019 |
| Behavioral |
regular care |
1 |
2015 |
| Behavioral |
regular diabetes patient education |
1 |
2009 |
| Behavioral |
regular health education |
1 |
2018 |
| Drug |
regular) |
1 |
2008 |
| Other |
rehabilitation exercise intervention |
1 |
2011 |
| Procedure |
reiki |
1 |
2001 |
| Behavioral |
relaxation |
1 |
2009 |
| Device |
relion lancing device (relion) |
1 |
2020 |
| Device |
relion ultra-thin |
1 |
2020 |
| Device |
relion ultra-thin/33g lancets (relion) |
1 |
2020 |
| Biological |
remd-477 |
1 |
2015 |
| Behavioral |
reminders, habit-based strategies and |
1 |
2019 |
| Behavioral |
reminders, habit-based strategies and/or involvement of family member |
1 |
2019 |
| Drug |
remogliflozin etabonate (gsk189075) |
1 |
2008 |
| Other |
remote blood glucose monitoring |
1 |
2010 |
| Behavioral |
remote patient monitoring of blood glucose |
1 |
2012 |
| Other |
remote, personalized type 2 diabetes care. |
1 |
2013 |
| Procedure |
removal of omentum |
1 |
2005 |
| Device |
renal denervation |
1 |
2018 |
| Procedure |
renal denervation therapy |
1 |
2013 |
| Drug |
repaglinide/metformin combination, repaglinide, metformin |
1 |
2013 |
| Drug |
rescue |
1 |
2007 |
| Behavioral |
resilience-based diabetes self-management education |
1 |
2020 |
| Behavioral |
resilient, empowered, active living with diabetes |
1 |
2014 |
| Other |
resistance exercise program |
1 |
2019 |
| Behavioral |
resistance exercise training program with rubber bands |
1 |
2011 |
| Other |
resistance training associated with vibration |
1 |
2018 |
| Other |
resistance training associated with vibration sham |
1 |
2018 |
| Other |
resistant starch |
1 |
2014 |
| Procedure |
resistive exercises |
1 |
2017 |
| Device |
resonator device |
1 |
2009 |
| Device |
resperate |
1 |
2009 |
| Other |
rest situation |
1 |
2015 |
| Device |
restorex ptt - 3 months |
1 |
2018 |
| Device |
restorex ptt - 6 months |
1 |
2018 |
| Device |
reusable pen device for insulin injection |
1 |
2003 |
| Drug |
rg1511 |
1 |
2007 |
| Drug |
ribavirin |
1 |
2013 |
| Other |
ricebran soybean milk |
1 |
2018 |
| Other |
rich in mufa diet |
1 |
2009 |
| Other |
rich in mufa diet -pa |
1 |
2009 |
| Other |
rich in mufa diet/pa |
1 |
2009 |
| Drug |
rifampin |
1 |
2017 |
| Drug |
rifaximin 200 mg |
1 |
2018 |
| Drug |
rimonabant |
1 |
2007 |
| Procedure |
risk profile information |
1 |
2012 |
| Behavioral |
risk result |
1 |
2013 |
| Drug |
rivoglitazone |
1 |
2005 |
| Drug |
ro 205-2349 |
1 |
2003 |
| Drug |
ro4876904 |
1 |
2007 |
| Drug |
ro5027838 |
1 |
2009 |
| Drug |
ro5093151 |
1 |
2009 |
| Drug |
ro6799477 |
1 |
2014 |
| Drug |
ro6807952 |
1 |
2011 |
| Drug |
ro6811135 |
1 |
2013 |
| Procedure |
root planning alone |
1 |
2019 |
| Drug |
ropivacaine |
1 |
2012 |
| Drug |
rosiglitazone-metformin |
1 |
2006 |
| Drug |
rosiglitazone-metformin fixed dose combination |
1 |
2006 |
| Drug |
rosiglitazone (avandia) |
1 |
2008 |
| Drug |
rosiglitazone (avandia)/other diabetes medication currently prescribed to participant |
1 |
2008 |
| Drug |
rosiglitazone (brl49653c) |
1 |
2007 |
| Drug |
rosiglitazone 4 mg |
1 |
2006 |
| Drug |
rosiglitazone maleate / metformin 2 miligrams (mg) / 500 mg |
1 |
2010 |
| Drug |
rosiglitazone maleate / metformin 4 miligrams (mg) / 1000 mg |
1 |
2010 |
| Drug |
rosiglitazone maleate/metformin hydrochloride |
1 |
2007 |
| Drug |
rosiglitazone(drug), blood pressure lowering effect |
1 |
2006 |
| Drug |
rosiglitazone(drug), cardiac adverse effects |
1 |
2006 |
| Drug |
rosiglitazone/metformin combination tablet |
1 |
2006 |
| Drug |
rosiglitazone/pioglitazone/placebo |
1 |
2010 |
| Drug |
rosiglitazone/placebo/pioglitazone |
1 |
2010 |
| Drug |
rosuvamibeâ® tab |
1 |
2018 |
| Drug |
rosuvastatin (rosuvastatin calciumâ®, chemipharm co. |
1 |
2018 |
| Drug |
rosuvastatin gel |
1 |
2016 |
| Drug |
rosuvastatin; improvement of lipid profile |
1 |
2005 |
| Drug |
rosuvastatin10 mg tablet |
1 |
2019 |
| Other |
rotating fluids protocol |
1 |
2019 |
| Behavioral |
routine |
1 |
2018 |
| Other |
routine rehabilitation program |
1 |
2019 |
| Other |
routine rehabilitation program / foot exercise training |
1 |
2019 |
| Other |
routine rehabilitation program patient education |
1 |
2019 |
| Drug |
routine treatment |
1 |
2020 |
| Procedure |
roux-en-y bypass gastroplasty |
1 |
2007 |
| Drug |
rta 402 |
1 |
2014 |
| Drug |
ruboxistaurin |
1 |
2007 |
| Other |
running |
1 |
2015 |
| Dietary Supplement |
rutin in combination with vitamin c |
1 |
2018 |
| Drug |
rvx000222 |
1 |
2015 |
| Other |
rye |
1 |
2018 |
| Other |
rye/wheat |
1 |
2018 |
| Other |
rygb |
1 |
2008 |
| Other |
rygb/imm |
1 |
2008 |
| Drug |
s-707106 |
1 |
2010 |
| Drug |
s-707106 dose a |
1 |
2010 |
| Drug |
s-707106 dose b |
1 |
2010 |
| Drug |
s-707106 dose c |
1 |
2010 |
| Dietary Supplement |
safflower oil |
1 |
2010 |
| Other |
sal seed oil |
1 |
2019 |
| Other |
sal seed oleogel |
1 |
2019 |
| Behavioral |
salba diet |
1 |
2006 |
| placebo |
salsalate placebo |
1 |
2008 |
| Other |
sandwich |
1 |
2008 |
| Dietary Supplement |
sanprobi barrier-multispecies probiotic |
1 |
2019 |
| Drug |
sar247799 |
1 |
2018 |
| Drug |
sar342434 |
1 |
2014 |
| Dietary Supplement |
sardine |
1 |
2018 |
| Other |
sardine diet |
1 |
2014 |
| Other |
sasi bypass |
1 |
2016 |
| Drug |
saxaglipitin |
1 |
2010 |
| Drug |
saxagliptin / metformin |
1 |
2005 |
| Drug |
saxagliptin / metformin (fdc tablet) |
1 |
2010 |
| Drug |
saxagliptin / metformin ir (fdc) |
1 |
2009 |
| Drug |
saxagliptin 2.5 mg |
1 |
2015 |
| Drug |
saxagliptin 2.5mg |
1 |
2015 |
| Drug |
saxagliptin 5mg / dapagliflozin 10 mg |
1 |
2018 |
| Drug |
saxagliptin, 2.5 mg |
1 |
2010 |
| Drug |
saxagliptin, 2.5 mg / metformin, 500 mg (fasted state) |
1 |
2010 |
| Drug |
saxagliptin, 2.5 mg / metformin, 500 mg (fed state) |
1 |
2010 |
| Drug |
saxagliptin, 2.5 mg /metformin, 500 mg fdc (fasted state) |
1 |
2010 |
| Drug |
saxagliptin, 2.5 mg /metformin, 500 mg fdc (fed state) |
1 |
2010 |
| Drug |
saxagliptin, 5 mg |
1 |
2008 |
| Drug |
saxagliptin, 5 mg / insulin |
1 |
2008 |
| Drug |
saxagliptin, onglyza |
1 |
2015 |
| Drug |
saxagliptin/dapagliflozin fdc |
1 |
2014 |
| Drug |
saxagliptin/metformin fdc |
1 |
2011 |
| Drug |
saxagliptin/metformin fixed-dose combination (fdc) |
1 |
2011 |
| Drug |
saxagliptin/metformin ir |
1 |
2009 |
| Drug |
saxagliptin/metformin, fasting |
1 |
2009 |
| Drug |
saxagliptin/metformin, fed |
1 |
2009 |
| Drug |
sb-756050 immediate release capsule |
1 |
2008 |
| Drug |
sb-756050 modified release capsule |
1 |
2008 |
| Drug |
sb756050 |
1 |
2008 |
| Device |
scale |
1 |
2018 |
| Procedure |
scaling root planing |
1 |
2017 |
| Procedure |
scaling/root planning alone |
1 |
2019 |
| Radiation |
scan |
1 |
2016 |
| Drug |
sch 497079 |
1 |
2008 |
| Behavioral |
scope-dm |
1 |
2019 |
| Behavioral |
scope-dm with 3 months’ supply of glucometer |
1 |
2019 |
| Behavioral |
scope-dm with 6 months’ supply of glucometer |
1 |
2019 |
| Behavioral |
seated control |
1 |
2018 |
| Drug |
secretagogues |
1 |
2006 |
| Behavioral |
self-hypnosis |
1 |
2016 |
| Device |
self-injector pen device (opticlikâ®) |
1 |
2012 |
| Behavioral |
self-management intervention |
1 |
2013 |
| Other |
self-management intervention in a low-resource setting on diabetes knowledge |
1 |
2020 |
| Behavioral |
self-management support |
1 |
2012 |
| Behavioral |
self-management support education |
1 |
2013 |
| Other |
self-management using booklet for management type 2 dm |
1 |
2013 |
| Other |
self-management using smartphone application for type2 dm |
1 |
2013 |
| Other |
self-monitoring for patients with diabetes mellitus type 2 |
1 |
2012 |
| Other |
self-monitoring for patients with dibetes mellitus |
1 |
2012 |
| Behavioral |
self-monitoring of blood glucose (smbg) |
1 |
2006 |
| Behavioral |
self-regulation theory-based mhealth behavior intervention |
1 |
2017 |
| Behavioral |
self-regulatory approaches |
1 |
2009 |
| Behavioral |
self assessments |
1 |
2016 |
| Drug |
semaglutide 3 mg |
1 |
2018 |
| Drug |
semaglutide 7 mg |
1 |
2018 |
| Drug |
semaglutide b 3 mg |
1 |
2018 |
| Drug |
semaglutide b 7 mg |
1 |
2018 |
| Drug |
semaglutide c 3 mg |
1 |
2018 |
| Drug |
semaglutide c 7 mg |
1 |
2018 |
| Drug |
semaglutide d 3 mg |
1 |
2018 |
| Drug |
semaglutide d 7 mg |
1 |
2018 |
| Drug |
semaglutide pen |
1 |
2018 |
| placebo |
semaglutide placebo 0.5 mg |
1 |
2017 |
| placebo |
semaglutide placebo 1.0 mg |
1 |
2017 |
| Drug |
semaglutide, 0.25 mg |
1 |
2018 |
| Drug |
semaglutide, 0.5 mg/ml |
1 |
2018 |
| Drug |
semaglutide, 1.0 mg/ml |
1 |
2018 |
| Drug |
semaglutide, 1.34 mg |
1 |
2018 |
| Drug |
semaglutide, 1.34 mg/ml |
1 |
2018 |
| Drug |
semaglutide, 2.0 mg |
1 |
2018 |
| Drug |
semaglutide, 2.0 mg/ml |
1 |
2018 |
| Other |
semolina wheat porridge |
1 |
2018 |
| Device |
sensewear pro3â® armband |
1 |
2010 |
| Device |
sensor based glucose monitoring system |
1 |
2014 |
| Drug |
sertraline |
1 |
2019 |
| placebo |
sevelamer placebo |
1 |
2015 |
| Drug |
sglt-2 inhibitors |
1 |
2016 |
| Drug |
sglt2 inhibition |
1 |
2019 |
| Drug |
sglt2 inhibitors |
1 |
2014 |
| Device |
sham- continuous positive airway pressure (sham-cpap) |
1 |
2008 |
| Drug |
sham apdt |
1 |
2011 |
| Device |
sham continuous positive airway pressure |
1 |
2012 |
| Other |
sham control |
1 |
2013 |
| Device |
sham cpap |
1 |
2017 |
| Device |
sham cpap therapy |
1 |
2010 |
| Device |
sham dw1330 device |
1 |
2016 |
| Device |
sham extracorporeal shock wave |
1 |
2020 |
| Procedure |
sham procedure |
1 |
2016 |
| Other |
sham: endoscopy |
1 |
2016 |
| Other |
sham: endoscopy/standard of care |
1 |
2016 |
| Other |
shared care |
1 |
2015 |
| Behavioral |
shared medical visit |
1 |
2016 |
| Behavioral |
shared reward |
1 |
2016 |
| Procedure |
short bpl rygb |
1 |
2019 |
| Drug |
shr117887 |
1 |
2013 |
| Other |
signal |
1 |
2014 |
| Other |
similar brand) |
1 |
2019 |
| Diagnostic Test |
simple fibrosis scores |
1 |
2020 |
| Diagnostic Test |
simple fibrosis scores/electronic reminder messages |
1 |
2020 |
| Drug |
simplified diabetes regimen starting with a fixed dose of human insulin inhalation powder |
1 |
2006 |
| Drug |
simvastatin- slv337 sd beta- slv337 sd alpha - slv337 md beta- slv337 sd beta |
1 |
2009 |
| Drug |
simvastatin- slv337 sd beta- slv337 sd alpha - slv337 md beta- slv337 sd beta/ simvastatin |
1 |
2009 |
| Drug |
simvastatin - slv337 sd alpha - slv337 sd beta - slv337 md beta - slv337 sd beta |
1 |
2009 |
| Drug |
simvastatin - slv337 sd alpha - slv337 sd beta - slv337 md beta - slv337 sd beta/ simvastatin |
1 |
2009 |
| Drug |
simvastatin 20 |
1 |
2011 |
| Drug |
simvastatin 20 mg/placebo |
1 |
2006 |
| Drug |
simvastatin 40 mg fdc |
1 |
2012 |
| placebo |
simvastatin placebo |
1 |
2007 |
| Drug |
simvastatin tablets |
1 |
2008 |
| Biological |
simvastatin/albiglutide |
1 |
2010 |
| Drug |
single dose pb1023 |
1 |
2011 |
| Other |
single leg exercise training |
1 |
2012 |
| Behavioral |
single lifestyle advice |
1 |
2013 |
| Drug |
single subcutaneous dose (part a) of pb1023 |
1 |
2010 |
| Drug |
single subcutaneous dose (part a) of pb1023/placebo (0.9% nacl) |
1 |
2010 |
| Device |
sipore15â„¢ |
1 |
2019 |
| Drug |
sitagliptin - 100mg |
1 |
2011 |
| Drug |
sitagliptin - dpp4i |
1 |
2016 |
| Drug |
sitagliptin (dpp4 inhibitor) |
1 |
2011 |
| Drug |
sitagliptin (januvia) |
1 |
2008 |
| Drug |
sitagliptin / metformin fdc |
1 |
2011 |
| Drug |
sitagliptin / metformin xr fdc |
1 |
2013 |
| placebo |
sitagliptin 100 mg placebo q.d. |
1 |
2009 |
| Drug |
sitagliptin 100 mg q.d./ pioglitazone 45 mg q.d. |
1 |
2009 |
| Drug |
sitagliptin 100 mg q.d./metformin ≥ 1500 mg/day |
1 |
2006 |
| Drug |
sitagliptin 100 mg q.d./pioglitazone 30 mg q.d |
1 |
2006 |
| Drug |
sitagliptin 100 mg/simvastatin 40 mg fdc |
1 |
2012 |
| Drug |
sitagliptin 100mg od |
1 |
2013 |
| Drug |
sitagliptin 100mg qd |
1 |
2012 |
| Drug |
sitagliptin 50 mg |
1 |
2010 |
| placebo |
sitagliptin matched placebo |
1 |
2013 |
| Drug |
sitagliptin once-daily |
1 |
2013 |
| Drug |
sitagliptin phosphate anhydrous formulation |
1 |
2009 |
| Drug |
sitagliptin phosphate/metformin hydrochloride fdc |
1 |
2009 |
| Drug |
sitagliptin tablet |
1 |
2007 |
| Drug |
sitagliptin, mitiglinide |
1 |
2011 |
| Drug |
sitagliptin/acarbose |
1 |
2013 |
| Drug |
sitagliptin/metformin |
1 |
2015 |
| Drug |
sitagliptin/metformin 50 mg/500 mg tablet |
1 |
2010 |
| Drug |
sitagliptin/metformin 50 mg/850 mg tablet |
1 |
2010 |
| Drug |
sitagliptin/metformin fdc |
1 |
2009 |
| Drug |
sitagliptin/metformin xr |
1 |
2012 |
| Drug |
sitaglitpin |
1 |
2015 |
| Drug |
sk-0403 |
1 |
2007 |
| Procedure |
skeletal muscle biopsy |
1 |
2004 |
| Behavioral |
skills training |
1 |
2016 |
| Dietary Supplement |
skim milk |
1 |
2014 |
| Other |
sky |
1 |
2015 |
| Behavioral |
sleep-extend intervention |
1 |
2018 |
| Behavioral |
sleep duration 45 min |
1 |
2016 |
| Behavioral |
sleep duration 90 min |
1 |
2016 |
| Behavioral |
sleep pattern |
1 |
2018 |
| Behavioral |
sleep timing |
1 |
2016 |
| Procedure |
sleeve gastrecomy |
1 |
2012 |
| Drug |
sliding scale regular insulin (ssri) |
1 |
2009 |
| Drug |
slv337 |
1 |
2009 |
| Drug |
slx-4090 |
1 |
2009 |
| Behavioral |
small change intervention |
1 |
2018 |
| Dietary Supplement |
small mixed protein |
1 |
2015 |
| Dietary Supplement |
small mixed protein/lipid meal |
1 |
2015 |
| Behavioral |
small talk big difference delayed access training |
1 |
2017 |
| Behavioral |
small talk big difference immediate access training |
1 |
2017 |
| Device |
smart pillbox |
1 |
2018 |
| Behavioral |
smarthealth diabetes |
1 |
2016 |
| Device |
smartphone |
1 |
2015 |
| Device |
smartphone app |
1 |
2014 |
| Other |
smbg to guide clinical decisions |
1 |
2010 |
| Other |
smbg with knowledge |
1 |
2010 |
| Other |
smbg/cgm |
1 |
2010 |
| Behavioral |
smbg/intensive education |
1 |
2010 |
| Behavioral |
sms messaging |
1 |
2019 |
| Behavioral |
sms text messaging |
1 |
2017 |
| Drug |
smt |
1 |
2008 |
| Drug |
snac |
1 |
2016 |
| Other |
snacks |
1 |
2012 |
| Drug |
soc therapy |
1 |
2007 |
| Other |
soccer |
1 |
2015 |
| Other |
soccer exercise |
1 |
2012 |
| Other |
soccer exercise/continued daily lifestyle |
1 |
2012 |
| Behavioral |
social support |
1 |
2005 |
| Behavioral |
socially-based exercise intervention for older adults |
1 |
2018 |
| Other |
soda water |
1 |
2007 |
| Drug |
sodium-glucose transport-2 (sglt-2) inhibitors |
1 |
2016 |
| Drug |
sodium chloride 0.9% solution |
1 |
2012 |
| Other |
soft beverage |
1 |
2017 |
| Other |
soft beverage/pizza |
1 |
2017 |
| Device |
softclix 28 g lancets (roche) |
1 |
2020 |
| Other |
soluble flaxseed gum fibre |
1 |
2014 |
| Other |
soluble gluco fibre |
1 |
2010 |
| Drug |
soluble human insulin |
1 |
2008 |
| Dietary Supplement |
soy compounds) |
1 |
2008 |
| Dietary Supplement |
soy protein |
1 |
2012 |
| Other |
soybean milk |
1 |
2018 |
| Drug |
sp2086 (100 mg q.d.) |
1 |
2013 |
| Drug |
sp2086 (100 mg q.d.)/metformin |
1 |
2013 |
| Drug |
sp2086(50 mg q.d.) |
1 |
2013 |
| Drug |
sp2086(50 mg q.d.)/metformin |
1 |
2013 |
| Device |
spartz balloon |
1 |
2019 |
| Other |
specialized multidisciplinary diabetes team (smdt) approach |
1 |
2018 |
| Dietary Supplement |
spewhe |
1 |
2019 |
| Other |
spice polyphenols |
1 |
2010 |
| placebo |
spil1033, placebo |
1 |
2011 |
| Drug |
spironolacone 25 mg tablets added to losartan |
1 |
2012 |
| Behavioral |
sport |
1 |
2009 |
| Drug |
spp635 |
1 |
2007 |
| Behavioral |
sprint interval training |
1 |
2015 |
| Behavioral |
square-stepping exercise |
1 |
2014 |
| Drug |
sr exenatide (pt302) |
1 |
2009 |
| Other |
sri-lanka |
1 |
2007 |
| Drug |
srp |
1 |
2016 |
| Drug |
srp/placebo gel |
1 |
2016 |
| Drug |
srp/rosuvastatin gel |
1 |
2016 |
| Drug |
srt2379 |
1 |
2009 |
| Drug |
srt3025 |
1 |
2011 |
| Behavioral |
standard ada recommended diet for type 2 diabetics |
1 |
2005 |
| Other |
standard antenatal care |
1 |
2015 |
| Dietary Supplement |
standard antidiabetic diet |
1 |
2016 |
| Behavioral |
standard behavioral weight change intervention |
1 |
2016 |
| Device |
standard blood glucose monitoring |
1 |
2014 |
| Other |
standard carbohydrate meals |
1 |
2015 |
| Behavioral |
standard care arm) |
1 |
2009 |
| Other |
standard care group |
1 |
2012 |
| Other |
standard control |
1 |
2011 |
| Behavioral |
standard counselling procedure |
1 |
2010 |
| Other |
standard diabetes care at pcp |
1 |
2014 |
| Behavioral |
standard diabetes education |
1 |
2010 |
| Behavioral |
standard diabetes self-management education |
1 |
2020 |
| Behavioral |
standard diabetic diet) |
1 |
2006 |
| Behavioral |
standard diabetologist care |
1 |
2012 |
| Procedure |
standard dmp care |
1 |
2012 |
| Behavioral |
standard dpp |
1 |
2014 |
| Behavioral |
standard education |
1 |
2019 |
| Other |
standard enteral feeding product |
1 |
2007 |
| Drug |
standard exercise |
1 |
2009 |
| Behavioral |
standard exercise program |
1 |
2015 |
| Other |
standard food |
1 |
2010 |
| Other |
standard glycemic care |
1 |
2010 |
| Behavioral |
standard healthy eating advice |
1 |
2019 |
| Behavioral |
standard insulin administration education |
1 |
2019 |
| Procedure |
standard lifestyle advice |
1 |
2013 |
| Other |
standard medical management |
1 |
2018 |
| Behavioral |
standard nutritional education |
1 |
2018 |
| Other |
standard nutritional product (medical food) |
1 |
2008 |
| Behavioral |
standard of care reminders |
1 |
2016 |
| Behavioral |
standard of care reminders/self assessments |
1 |
2016 |
| Behavioral |
standard of diabetes care |
1 |
2019 |
| Behavioral |
standard protein diet |
1 |
2019 |
| Behavioral |
standard risk assessment |
1 |
2013 |
| Behavioral |
standard smoking cessation intervention |
1 |
2011 |
| Procedure |
standardised liquid meal |
1 |
2015 |
| Dietary Supplement |
standardised meals |
1 |
2010 |
| Drug |
standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25oh vitamin d3 |
1 |
2012 |
| Drug |
standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25oh vitamin d3/a statin |
1 |
2012 |
| Other |
standardized diet |
1 |
2013 |
| Other |
standardized risk assessment |
1 |
2009 |
| Behavioral |
standardized sma |
1 |
2018 |
| Other |
starch 1 |
1 |
2019 |
| Other |
starch 2 |
1 |
2019 |
| Other |
starch 3 |
1 |
2019 |
| Other |
starch 4 |
1 |
2019 |
| Device |
starter kit algorithm |
1 |
2017 |
| Behavioral |
static web-based materials |
1 |
2013 |
| Other |
stayers |
1 |
2005 |
| Device |
stem cell educator |
1 |
2011 |
| Combination Product |
stem cell educator therapy |
1 |
2017 |
| Biological |
stem cell harvest |
1 |
2008 |
| Procedure |
stem cells |
1 |
2015 |
| Biological |
stem cells from human exfoliated teeth |
1 |
2018 |
| Behavioral |
step count prescription |
1 |
2011 |
| Device |
step counter |
1 |
2018 |
| Drug |
still water |
1 |
2018 |
| Device |
stimulator |
1 |
2016 |
| Behavioral |
stock boxes |
1 |
2019 |
| Behavioral |
stop smoking |
1 |
2006 |
| Behavioral |
strength exercise |
1 |
2006 |
| Other |
strengthen self-monitoring of blood glucose |
1 |
2018 |
| Other |
strengthening exercises according to circadian rhythym |
1 |
2020 |
| Behavioral |
stress management education |
1 |
2019 |
| Behavioral |
stress management phone application (eco fusion mentally) |
1 |
2016 |
| Other |
stress test |
1 |
2012 |
| Other |
stretching control |
1 |
2015 |
| Other |
strides |
1 |
2013 |
| Dietary Supplement |
stringent diet regimen |
1 |
2014 |
| Biological |
stromal cells (msc) higher dose |
1 |
2019 |
| Biological |
stromal cells (msc) lower dose |
1 |
2019 |
| Behavioral |
structured |
1 |
2018 |
| Combination Product |
structured education |
1 |
2019 |
| Behavioral |
structured exercise training program |
1 |
2010 |
| Behavioral |
structured mnt |
1 |
2015 |
| Behavioral |
structured mnt/weekly support |
1 |
2015 |
| Behavioral |
structured personal care |
1 |
2010 |
| Behavioral |
structured self-management group education during 2 years |
1 |
2011 |
| Other |
structured weight-loss program |
1 |
2016 |
| Behavioral |
structured/exercise |
1 |
2018 |
| Other |
study 2 (48 hours of complete bed rest) |
1 |
2007 |
| Drug |
su |
1 |
2009 |
| Drug |
su (sulfonylurea) |
1 |
2009 |
| Drug |
sub cutaneous liraglutide |
1 |
2016 |
| Diagnostic Test |
subcutaneous administration of recombinant human igf-1 |
1 |
2009 |
| Drug |
subcutaneous injection |
1 |
2008 |
| Device |
subcutaneous insertions of needles |
1 |
2014 |
| Drug |
subcutaneous insulin |
1 |
2011 |
| Device |
subcutaneous insulin delivery:accu-chek rapid-d infusion set |
1 |
2010 |
| Drug |
subetta |
1 |
2013 |
| Procedure |
subgingival scaling |
1 |
2001 |
| Procedure |
subgingival scaling/doxycycline |
1 |
2001 |
| Procedure |
subgingival scaling/metronidazole |
1 |
2001 |
| Other |
subject |
1 |
2008 |
| Other |
subject only portal “diabetes connected health tool” basic |
1 |
2008 |
| Other |
subject/provider portal “diabetes connected health” tool - deluxe |
1 |
2008 |
| Diagnostic Test |
submã¡ximal functional capacity assesment by 6 minutes walk test |
1 |
2019 |
| Other |
suboptimal diet |
1 |
2018 |
| Drug |
substance p, |
1 |
2011 |
| Other |
sucralose |
1 |
2016 |
| Dietary Supplement |
sucrose consumption |
1 |
2009 |
| Dietary Supplement |
sucrose in enteric coating |
1 |
2017 |
| Dietary Supplement |
sucrose with separate enteric coating materials |
1 |
2017 |
| Dietary Supplement |
sucrose/whole milk powder in enteric coating |
1 |
2017 |
| Other |
sugar-sweetened beverage |
1 |
2018 |
| Other |
sugar-sweetened orange-flavoured beverage |
1 |
2020 |
| Other |
sugar 1 |
1 |
2019 |
| Other |
sugar 2 |
1 |
2019 |
| Behavioral |
sugar handshake |
1 |
2019 |
| Other |
sugar pill |
1 |
2011 |
| Drug |
sugar substitute splenda |
1 |
2009 |
| Dietary Supplement |
sugardown |
1 |
2014 |
| Behavioral |
sugary drink warning labels |
1 |
2018 |
| Drug |
sulfonylurea (glimepiride) |
1 |
2013 |
| Drug |
sulfonylurea (su) |
1 |
2013 |
| Drug |
sulfonylurea/pioglitazone |
1 |
2011 |
| Drug |
sulfonylureas |
1 |
2012 |
| Drug |
sulforaphane |
1 |
2016 |
| Drug |
sulphonylruea |
1 |
2010 |
| Drug |
supaglutide |
1 |
2020 |
| Drug |
supaglutide injection |
1 |
2018 |
| Dietary Supplement |
super beets |
1 |
2016 |
| placebo |
super beets placebo |
1 |
2016 |
| Behavioral |
supervised exercise training group |
1 |
2018 |
| Behavioral |
supervised walking |
1 |
2010 |
| Drug |
supplemental insulin aspart |
1 |
2015 |
| Dietary Supplement |
supplementation with vitamin d3 y k2 |
1 |
2019 |
| Other |
support for community health workers |
1 |
2017 |
| Other |
support group |
1 |
2014 |
| Behavioral |
supportive social incentive |
1 |
2016 |
| Behavioral |
supportive therapy |
1 |
2010 |
| Procedure |
supra-gingival scaling |
1 |
2001 |
| Procedure |
supra-gingival scaling/placebo |
1 |
2001 |
| Procedure |
supragingival biofilm control |
1 |
2011 |
| Procedure |
surgical ileal transposition with sleeve |
1 |
2013 |
| Drug |
suvorexant |
1 |
2019 |
| Other |
switchers |
1 |
2005 |
| Drug |
sy-004 |
1 |
2019 |
| placebo |
sy-004 matching placebo |
1 |
2019 |
| Dietary Supplement |
symbiointest |
1 |
2017 |
| Combination Product |
symbiter-omega |
1 |
2019 |
| Dietary Supplement |
symbiter-smectite |
1 |
2020 |
| Drug |
symlin (pramlintide) |
1 |
2009 |
| Drug |
syr-472 |
1 |
2014 |
| Device |
syringe |
1 |
2005 |
| Drug |
systemic doxycycline |
1 |
2011 |
| Drug |
systemic doxycycline/sham apdt |
1 |
2011 |
| Device |
t:slim x2 with control-iq |
1 |
2020 |
| Drug |
t0903131 besylate |
1 |
2009 |
| Drug |
t2-18c3 therapeutic antibody |
1 |
2011 |
| Other |
t2dxcel mobile application |
1 |
2019 |
| Drug |
ta-7284 |
1 |
2008 |
| Drug |
ta-7284-high-middle |
1 |
2009 |
| Drug |
ta-7284-low-middle |
1 |
2009 |
| Drug |
tab. 750mg |
1 |
2015 |
| Drug |
tablet |
1 |
2017 |
| Device |
tablet computer |
1 |
2012 |
| Behavioral |
tablets intervention |
1 |
2014 |
| Drug |
tacrolimus |
1 |
2006 |
| Procedure |
tactile massage |
1 |
2009 |
| Drug |
tagatose |
1 |
2009 |
| Behavioral |
tai chi quan |
1 |
2018 |
| Device |
tailored lighting intervention |
1 |
2018 |
| Behavioral |
tailored telephone intervention of education |
1 |
2005 |
| Behavioral |
tailored web-based walking program |
1 |
2005 |
| Drug |
tak-272 |
1 |
2014 |
| placebo |
tak-272 placebo |
1 |
2014 |
| Drug |
tak-559 |
1 |
2008 |
| Drug |
tak-648 |
1 |
2015 |
| Drug |
tak-875/sitagliptin |
1 |
2011 |
| Drug |
tang-min-ling pills high dosage |
1 |
2010 |
| Drug |
tang-min-ling pills low dosage |
1 |
2010 |
| Device |
tantalus system |
1 |
2011 |
| Behavioral |
tap-hc-dm |
1 |
2015 |
| Other |
targeted self-monitoring of blood glucose (smbg) |
1 |
2009 |
| Behavioral |
task analysis intervention group |
1 |
2019 |
| Drug |
taspoglutide 20mg |
1 |
2007 |
| Drug |
taspoglutide 20mg-30mg |
1 |
2007 |
| Drug |
taspoglutide 20mg-40mg |
1 |
2007 |
| Dietary Supplement |
tauroursodeoxycholic acid |
1 |
2017 |
| Drug |
tc-6987 |
1 |
2011 |
| Drug |
tca ir 40 mg |
1 |
2016 |
| Behavioral |
teaching: individual (5606) |
1 |
2016 |
| Drug |
technetium tc99m sestamibi |
1 |
2005 |
| Other |
technical support for mhealth system |
1 |
2017 |
| Behavioral |
technology-assisted case management |
1 |
2011 |
| Device |
technology-based self-management model |
1 |
2016 |
| Behavioral |
technology intensified |
1 |
2014 |
| Drug |
technosphere |
1 |
2007 |
| Drug |
technosphere inhalation powder |
1 |
2008 |
| Drug |
technosphere insulin inhalation powder |
1 |
2009 |
| Drug |
technosphere insulin/metformin |
1 |
2006 |
| Drug |
technosphere powder |
1 |
2011 |
| Drug |
technosphere/insulin |
1 |
2007 |
| Drug |
technosphereâ® insulin |
1 |
2011 |
| Drug |
technosphereâ® insulin inhalation powder/medtoneâ„¢ inhaler |
1 |
2008 |
| Drug |
tecoma stans |
1 |
2017 |
| Behavioral |
tele-interventions related to diabetes management |
1 |
2020 |
| Behavioral |
tele-interventions related to diabetes management/mental well-being |
1 |
2020 |
| Behavioral |
tele-medical nutrition therapy (tele-mnt) |
1 |
2020 |
| Behavioral |
telecoaching |
1 |
2012 |
| Other |
telehealth training |
1 |
2017 |
| Other |
telehealth training/support for community health workers |
1 |
2017 |
| Other |
telemedicine diabetes intervention |
1 |
2011 |
| Device |
telemedicine system |
1 |
2007 |
| Behavioral |
telemonitoring / self-management support |
1 |
2012 |
| Procedure |
telemonitoring group |
1 |
2011 |
| Procedure |
telemonitoring of patients with diabetes type 2 |
1 |
2011 |
| Procedure |
telemonitoring/telemedicine |
1 |
2011 |
| Behavioral |
telephone intensive lifestyle counselling |
1 |
2016 |
| Behavioral |
telephone intervention group |
1 |
2019 |
| Other |
telephone reinforcement |
1 |
2013 |
| Behavioral |
telephonic intervention to prevent diabetes mellitus, type 2 |
1 |
2012 |
| Drug |
telmisartan/with hydrochlorothiazide (80/12.5 mg) |
1 |
2005 |
| Drug |
teneli / teneli / pio |
1 |
2009 |
| Drug |
teneli / teneli / su |
1 |
2009 |
| Drug |
teneligliptin / sulfonylurea |
1 |
2014 |
| Drug |
teneligliptin 10mg |
1 |
2008 |
| Drug |
teneligliptin 40 mg |
1 |
2008 |
| Drug |
teneligliptin/canagliflozin |
1 |
2014 |
| Drug |
teriparatide |
1 |
2018 |
| Drug |
tesaglitazar |
1 |
2006 |
| Drug |
tesofensine |
1 |
2016 |
| Drug |
tesofensine/metoprolol |
1 |
2016 |
| Other |
test food containing different types of dietary protein |
1 |
2019 |
| Behavioral |
test meals rich in different fatty acids |
1 |
2007 |
| Other |
test soda |
1 |
2014 |
| Drug |
testosterone undecanoate |
1 |
2018 |
| Behavioral |
text message reminders |
1 |
2017 |
| Behavioral |
text messaging |
1 |
2017 |
| Drug |
th9507 |
1 |
2010 |
| Behavioral |
the diabetes treatment satisfaction questionnaire |
1 |
2005 |
| Device |
the diet plate (r) tm portion control plate |
1 |
2005 |
| Device |
the diet plate (r) tm portion control plate/bowl |
1 |
2005 |
| Behavioral |
the ebmeds system |
1 |
2013 |
| Other |
the happy kitchen |
1 |
2019 |
| Device |
the neurotronic arterial ablation catheter |
1 |
2020 |
| Device |
therapeutic cpap |
1 |
2017 |
| Behavioral |
therapeutic education program |
1 |
2018 |
| Device |
therapy advisory system (diadvisor) |
1 |
2011 |
| Behavioral |
therapy regimen |
1 |
2013 |
| Dietary Supplement |
thiamine pyrophosphate |
1 |
2019 |
| Drug |
thiapalmitate tracer |
1 |
2015 |
| Drug |
thiazolidinedione |
1 |
2013 |
| Drug |
thiazolidinedione (pioglitazone) |
1 |
2008 |
| Procedure |
three-monthly haemoglobin a1c |
1 |
2008 |
| Drug |
thyroid hormone |
1 |
2012 |
| Drug |
thyroxine |
1 |
2015 |
| Drug |
ticagrelor 60 mg |
1 |
2013 |
| Other |
tight control: goal glucose 350 mg |
1 |
2015 |
| Other |
tight control: goal glucose 350 mg/dl/lower |
1 |
2015 |
| Behavioral |
time restricted eating as treatment (treat) for diabetes. |
1 |
2019 |
| Behavioral |
time restricted feeding |
1 |
2019 |
| Other |
tinned mackerel fish |
1 |
2016 |
| Other |
tissue control group |
1 |
2008 |
| Drug |
titration |
1 |
2009 |
| Behavioral |
tlc-ped |
1 |
2006 |
| Procedure |
tmns |
1 |
2012 |
| Device |
tnm (thermoneuromodulation device) |
1 |
2014 |
| Drug |
tocilizumab |
1 |
2009 |
| Dietary Supplement |
tocotrienol |
1 |
2013 |
| Drug |
tofogliflozin |
1 |
2015 |
| Drug |
tofogliflozin csg452 |
1 |
2014 |
| Behavioral |
tomando control-nurse |
1 |
2017 |
| Behavioral |
tomando control-promotora |
1 |
2017 |
| Dietary Supplement |
tonalin sg1000t ffa |
1 |
2010 |
| Behavioral |
toning health education program |
1 |
2011 |
| Drug |
topical ca |
1 |
2019 |
| Drug |
torasemide |
1 |
2011 |
| Dietary Supplement |
totum-63 |
1 |
2016 |
| Drug |
tq-f3083 blank analog capsule |
1 |
2019 |
| Drug |
tq-f3083 capsule 10 mg |
1 |
2019 |
| Drug |
tq-f3083 capsule 20 mg |
1 |
2019 |
| Behavioral |
traditional approach |
1 |
2020 |
| Drug |
traditional chinese medicine |
1 |
2013 |
| Other |
traditional cme |
1 |
2012 |
| Behavioral |
traditional diabetes prevention education |
1 |
2017 |
| Behavioral |
traditional exercise |
1 |
2015 |
| Behavioral |
traditional intensity exercise |
1 |
2010 |
| Behavioral |
traditional lecture style health education |
1 |
2019 |
| Behavioral |
traditional mnt |
1 |
2015 |
| Other |
traditional model of care |
1 |
2018 |
| Other |
training - detraining - retraining |
1 |
2012 |
| Behavioral |
training course for practice nurses in autonomy support |
1 |
2010 |
| placebo |
training placebo |
1 |
2015 |
| Other |
training/liraglutide |
1 |
2011 |
| Other |
training/placebo |
1 |
2011 |
| Dietary Supplement |
trans-resveratrol |
1 |
2018 |
| Drug |
trans-resveratrol extract from polygonum cuspidatum |
1 |
2012 |
| Dietary Supplement |
trans fat (soy bean oil) |
1 |
2008 |
| Device |
transcutaneous electrical nerve stimulator (dw1330) |
1 |
2016 |
| Behavioral |
treadmill |
1 |
2009 |
| Procedure |
treated |
1 |
2006 |
| Procedure |
treated/educated by nurses specialized in diabetes. |
1 |
2006 |
| Behavioral |
treatment as usual/occupational therapy |
1 |
2018 |
| Drug |
trelagliptin 100 mg |
1 |
2017 |
| Drug |
trelagliptin 25 mg |
1 |
2015 |
| Drug |
trelagliptin succinate |
1 |
2019 |
| Dietary Supplement |
triacylglycerol oil |
1 |
2013 |
| Behavioral |
trier social stress test (tsst) |
1 |
2007 |
| Drug |
trimetazidine |
1 |
2006 |
| Drug |
triple fcdp - 2.5 mg saxagliptin |
1 |
2017 |
| Drug |
triple fcdp - 2.5 mg saxagliptin / 5 mg dapagliflozin / 1000 mg metformin xr |
1 |
2017 |
| Drug |
triple fcdp - 5 mg saxagliptin |
1 |
2017 |
| Drug |
triple fcdp - 5 mg saxagliptin / 10 mg dapagliflozin / 1000 mg metformin xr |
1 |
2017 |
| Dietary Supplement |
triticale |
1 |
2016 |
| Dietary Supplement |
triticale/mung bean |
1 |
2016 |
| Drug |
tt223 |
1 |
2009 |
| Drug |
tt223 with metformin and |
1 |
2008 |
| Drug |
tt223 with metformin and/or tzd |
1 |
2008 |
| Behavioral |
ttm intervention for insulin initiation |
1 |
2017 |
| Drug |
ttp054 |
1 |
2012 |
| Drug |
ttp273 |
1 |
2016 |
| Drug |
ttp399 400 mg |
1 |
2015 |
| Drug |
ttp399 800 mg |
1 |
2015 |
| Procedure |
type 2 diabetes diagnosis test |
1 |
2014 |
| Behavioral |
type 2 diabetes self-management |
1 |
2016 |
| Drug |
u-500 insulin delivered by omnipod (disposable insulin pump) |
1 |
2008 |
| Drug |
u-500 insulin, 100 syringe units |
1 |
2014 |
| Drug |
u-500 insulin, 200 syringe units |
1 |
2014 |
| Device |
u-health care |
1 |
2013 |
| Device |
u-healthcare service |
1 |
2010 |
| Behavioral |
u-turn |
1 |
2015 |
| Drug |
ubiquinone |
1 |
2013 |
| Biological |
uc-msc |
1 |
2019 |
| Other |
uf meal: usual amount of fiber |
1 |
2014 |
| Device |
ultra-fine 33g lancets (bd) |
1 |
2020 |
| Device |
ultra-fine needle 12.7 mm |
1 |
2007 |
| Dietary Supplement |
ultra glucose control formula |
1 |
2016 |
| Device |
ultrasound vagus nerve stimulation (decima) |
1 |
2019 |
| Behavioral |
ums strategy |
1 |
2017 |
| Drug |
unlabeled ertugliflozin for oral use |
1 |
2015 |
| Behavioral |
unstructured physical activity |
1 |
2014 |
| Behavioral |
unstructured physical activity/exercise education |
1 |
2014 |
| Behavioral |
updated chd risk profiles |
1 |
2005 |
| Drug |
ursodiol |
1 |
2014 |
| Drug |
urtica dioica (tea bag) |
1 |
2007 |
| Behavioral |
use of a pda to assist shared decision making |
1 |
2014 |
| Device |
use of bd nano pen needle |
1 |
2019 |
| Device |
use of few touch application (fta) |
1 |
2011 |
| Device |
use of fta |
1 |
2011 |
| Device |
use of fta/health counseling based on ttm/cbt |
1 |
2011 |
| Device |
use of the c3-cloud it system |
1 |
2019 |
| Behavioral |
usual care - no intervention |
1 |
2017 |
| Behavioral |
usual care (uc) |
1 |
2017 |
| Behavioral |
usual care based on the indonesian guideline |
1 |
2019 |
| Behavioral |
usual care control |
1 |
2015 |
| Behavioral |
usual care exercise referral scheme |
1 |
2018 |
| Other |
usual care for daily insulin treatment |
1 |
2020 |
| Other |
usual care management |
1 |
2019 |
| Other |
usual diabetes care alone |
1 |
2020 |
| Drug |
usual diabetes therapy |
1 |
2006 |
| Drug |
usual diabetes therapy/placebo |
1 |
2006 |
| Other |
usual diet |
1 |
2008 |
| Other |
usual endocrine care. |
1 |
2013 |
| Behavioral |
usual intake |
1 |
2007 |
| Behavioral |
usual medical care |
1 |
2008 |
| Device |
usual self monitoring blood glucose device |
1 |
2018 |
| Behavioral |
usual titration algorithm |
1 |
2011 |
| Device |
v100; disetronic medical system, burgdorf, switzerland |
1 |
2005 |
| Device |
vagal nerve stimulator |
1 |
2009 |
| Drug |
valsartan 160 mg |
1 |
2004 |
| Drug |
valsartan 160 mg / nateglinide 60 mg |
1 |
2004 |
| Drug |
valsartan 160 mg / nateglinide placebo |
1 |
2004 |
| Drug |
valsartan 160mg |
1 |
2015 |
| placebo |
valsartan placebo |
1 |
2004 |
| Drug |
valsartan placebo / nateglinide placebo |
1 |
2004 |
| Drug |
valsartan/hydrochlorothiazide |
1 |
2011 |
| Drug |
valsartan/with hydrochlorothiazide (160/12.5mg) |
1 |
2005 |
| Behavioral |
values-plus-goals intervention |
1 |
2019 |
| Drug |
vardenafil |
1 |
2014 |
| Behavioral |
varying meal nutrition manipulation |
1 |
2005 |
| Biological |
vascularly biological assessment |
1 |
2018 |
| Other |
vegan diet |
1 |
2012 |
| Other |
vegan phase |
1 |
2020 |
| Other |
vegan sandwich |
1 |
2015 |
| Behavioral |
vegeterranean diet (v-med diet) |
1 |
2018 |
| Behavioral |
vemofit |
1 |
2016 |
| Biological |
venous doppler ultrasound |
1 |
2018 |
| Drug |
verapamil |
1 |
2017 |
| Behavioral |
very low caloric diet |
1 |
2011 |
| Behavioral |
very low calorie diet |
1 |
2011 |
| Other |
very low calorie liquid diet |
1 |
2018 |
| Procedure |
very low fat diet |
1 |
2000 |
| Device |
vestal device |
1 |
2019 |
| Device |
vgo |
1 |
2018 |
| Drug |
viajectâ„¢ |
1 |
2007 |
| Device |
vial |
1 |
2005 |
| Device |
vial/syringe |
1 |
2005 |
| Other |
vibration “sham” em dm |
1 |
2019 |
| Other |
vibration “sham” em ndm |
1 |
2019 |
| Drug |
victoza |
1 |
2013 |
| Drug |
victoza (liraglutide) with dietician monitoring |
1 |
2015 |
| Behavioral |
video games |
1 |
2007 |
| Drug |
vildagliptin (galvus) |
1 |
2014 |
| Drug |
vildagliptin (low dosage) |
1 |
2020 |
| Drug |
vildagliptin (regular dosage) |
1 |
2020 |
| Drug |
vildagliptin / acarbose |
1 |
2009 |
| Drug |
vildagliptin 100 mg qd |
1 |
2006 |
| Drug |
vildagliptin 50 mg |
1 |
2012 |
| Drug |
vildagliptin 50 mg bid/metformin 1500mg (galvus/diabex) |
1 |
2009 |
| Drug |
vildagliptin 50 mg oral tablet |
1 |
2018 |
| Drug |
vildagliptin 50 mg qd |
1 |
2009 |
| Drug |
vildagliptin am |
1 |
2006 |
| placebo |
vildagliptin matching placebo |
1 |
2005 |
| placebo |
vildagliptin placebo |
1 |
2005 |
| Drug |
vildagliptin pm |
1 |
2006 |
| Drug |
vildagliptin/ metformin |
1 |
2012 |
| Drug |
vildagliptin/metformin |
1 |
2010 |
| Drug |
vildagliptin/voglibose |
1 |
2011 |
| Dietary Supplement |
vinegar co-ingestion |
1 |
2011 |
| Other |
virta program |
1 |
2015 |
| Behavioral |
virtual diabetes self-care |
1 |
2015 |
| Behavioral |
virtual diabetes self-care/education program |
1 |
2015 |
| Dietary Supplement |
vitamin |
1 |
2010 |
| Drug |
vitamin a |
1 |
2017 |
| Drug |
vitamin a/e |
1 |
2017 |
| Dietary Supplement |
vitamin b12 |
1 |
2016 |
| Dietary Supplement |
vitamin c 500mg daily |
1 |
2009 |
| Dietary Supplement |
vitamin d-calcium yogurt drink |
1 |
2010 |
| Dietary Supplement |
vitamin d (cholecalciferol) |
1 |
2013 |
| Dietary Supplement |
vitamin d fortified yogurt drink |
1 |
2010 |
| Drug |
vitamin d supplementation |
1 |
2012 |
| Dietary Supplement |
vitamin d2 |
1 |
2011 |
| placebo |
vitamin d3-placebo |
1 |
2007 |
| Drug |
vitamin d3 2,000 iu orally once daily |
1 |
2007 |
| Dietary Supplement |
vitamin d3 2000 international units daily |
1 |
2009 |
| placebo |
vitamin d3 placebo |
1 |
2012 |
| Dietary Supplement |
vitamin d3(cholecalciferol) |
1 |
2014 |
| Dietary Supplement |
vitamin d3, cholecalciferol |
1 |
2010 |
| Dietary Supplement |
vitamin d3/calcium |
1 |
2015 |
| Drug |
vitamin e (d-alpha-tocopheryl acetate) |
1 |
2010 |
| Dietary Supplement |
vitamin k |
1 |
2019 |
| Dietary Supplement |
vitamin/mineral supplementation |
1 |
2010 |
| Other |
vo2max test |
1 |
2018 |
| Drug |
voglibose (basen) |
1 |
2009 |
| placebo |
voglibose placebo |
1 |
2008 |
| Behavioral |
voice messages |
1 |
2014 |
| Drug |
volinanserin (m100907) |
1 |
2007 |
| Behavioral |
volitional intervention |
1 |
2011 |
| placebo |
volume-matching placebo |
1 |
2020 |
| Behavioral |
volunteer peer mentor |
1 |
2015 |
| Behavioral |
volunteer peer mentor/behavioral hlth nurse |
1 |
2015 |
| Drug |
vortioxetine |
1 |
2019 |
| Other |
waiting |
1 |
2012 |
| Behavioral |
walk@workapp-diab |
1 |
2018 |
| Behavioral |
walking exercise |
1 |
2013 |
| Behavioral |
walking football exercise program |
1 |
2019 |
| Other |
walking meditation |
1 |
2014 |
| Other |
walking on levelled surface |
1 |
2020 |
| Other |
walking on soft-sand |
1 |
2020 |
| Dietary Supplement |
walnut supplementation |
1 |
2009 |
| Biological |
warfarin/albiglutide |
1 |
2010 |
| Other |
warm water exercise |
1 |
2015 |
| Behavioral |
water at the end of the main meal |
1 |
2015 |
| Behavioral |
water at the end of the main meal/ diet |
1 |
2015 |
| Dietary Supplement |
water before breakfast |
1 |
2012 |
| Dietary Supplement |
water consumption |
1 |
2009 |
| Other |
water intake |
1 |
2019 |
| Other |
wb-010 |
1 |
2019 |
| Behavioral |
wearable watch training group. |
1 |
2018 |
| Behavioral |
web |
1 |
2007 |
| Behavioral |
web-based dm2 information pages |
1 |
2017 |
| Behavioral |
web-based exercise programme |
1 |
2017 |
| Device |
web-based insulin titration |
1 |
2012 |
| Other |
web-based thecnologies |
1 |
2020 |
| Behavioral |
web/dvd knowledge |
1 |
2007 |
| Behavioral |
website |
1 |
2014 |
| Procedure |
weekly blood glucose profile |
1 |
2008 |
| Behavioral |
weekly support |
1 |
2015 |
| Behavioral |
weight loss |
1 |
2008 |
| Behavioral |
weight loss diet |
1 |
2009 |
| Behavioral |
weight loss diet/exercise |
1 |
2009 |
| Dietary Supplement |
weight loss treatment |
1 |
2012 |
| Behavioral |
weight reduction training |
1 |
2016 |
| Behavioral |
weight watchers modified program |
1 |
2012 |
| Drug |
welchol |
1 |
2008 |
| Behavioral |
well-being intervention |
1 |
2018 |
| Behavioral |
well-formulated ketogenic diet (wfkd) |
1 |
2019 |
| Behavioral |
wellbeing) programme |
1 |
2020 |
| Behavioral |
wellness programme |
1 |
2017 |
| Behavioral |
wellness website |
1 |
2016 |
| Dietary Supplement |
whe |
1 |
2019 |
| Other |
wheat |
1 |
2018 |
| Other |
wheat couscous |
1 |
2018 |
| Dietary Supplement |
whey before breakfast |
1 |
2012 |
| Dietary Supplement |
whey hydrolysate |
1 |
2009 |
| Dietary Supplement |
whey isolate |
1 |
2009 |
| Dietary Supplement |
whey protein |
1 |
2013 |
| Dietary Supplement |
whey protein (wpc) at breakfast |
1 |
2013 |
| Dietary Supplement |
whey protein in enteric coating |
1 |
2017 |
| Dietary Supplement |
whey protein with separate enteric coating materials |
1 |
2017 |
| Other |
white bread |
1 |
2020 |
| Other |
whole body vibration em dm |
1 |
2019 |
| Other |
whole body vibration em ndm |
1 |
2019 |
| Other |
whole body vibration exercise |
1 |
2019 |
| Other |
whole cooked beans with rice meals |
1 |
2010 |
| Dietary Supplement |
whole milk |
1 |
2017 |
| Dietary Supplement |
whole milk powder in enteric coating |
1 |
2017 |
| Other |
whole orange juice with skin removed |
1 |
2020 |
| Dietary Supplement |
whole peanuts without skins, peanut butter, |
1 |
2011 |
| Dietary Supplement |
whole peanuts without skins, peanut butter,/no peanuts (control) |
1 |
2011 |
| Dietary Supplement |
whole wheat flour |
1 |
2018 |
| Other |
whole wheat flour porridge |
1 |
2018 |
| Behavioral |
winter swimming |
1 |
2018 |
| Dietary Supplement |
with a comparable energy maltodextrin |
1 |
2019 |
| Dietary Supplement |
with active peptideâ® |
1 |
2019 |
| Drug |
with hydrochlorothiazide (160 |
1 |
2005 |
| Drug |
with hydrochlorothiazide (80 |
1 |
2005 |
| Behavioral |
with rt group |
1 |
2017 |
| Drug |
without ace inhibitor |
1 |
2005 |
| Other |
without pharmaceutical care programe |
1 |
2015 |
| Other |
worksheet to facilitate goal-setting |
1 |
2009 |
| Other |
worksheet to facilitate goal-setting/action plans |
1 |
2009 |
| Behavioral |
workshop |
1 |
2017 |
| Behavioral |
written material |
1 |
2020 |
| Drug |
xen-d0501, 1 mg |
1 |
2017 |
| Drug |
xen-d0501, 1 mg/tablet |
1 |
2017 |
| Drug |
xen-d0501, 2 mg |
1 |
2017 |
| Drug |
xen-d0501, 2 mg/tablet |
1 |
2017 |
| Drug |
xen-d0501, 4 mg |
1 |
2017 |
| Drug |
xen-d0501, 4 mg/tablet |
1 |
2017 |
| Drug |
xen-d0501, 8 mg |
1 |
2017 |
| Drug |
xen-d0501, 8 mg/tablet |
1 |
2017 |
| Drug |
xenical |
1 |
2014 |
| Drug |
xigduo xr |
1 |
2016 |
| Other |
xtendâ® sucromalt |
1 |
2018 |
| Drug |
xuefuzhuyu decoction |
1 |
2017 |
| Drug |
xuefuzhuyu decoction/calcium dobesilate |
1 |
2017 |
| Drug |
xw003 |
1 |
2020 |
| Other |
yellow mustard gum fibre |
1 |
2014 |
| Drug |
yh1 group |
1 |
2016 |
| Drug |
yh14755 |
1 |
2015 |
| Drug |
ym543 |
1 |
2007 |
| Dietary Supplement |
yoghurt |
1 |
2008 |
| Drug |
yohimbine |
1 |
2012 |
| Behavioral |
youth exercise sessions |
1 |
2010 |
| Drug |
zgn-1061 |
1 |
2017 |
| Dietary Supplement |
zinc |
1 |
2011 |
| Drug |
zinc supplement |
1 |
2017 |
| Drug |
zinc supplement/vitamin a/e |
1 |
2017 |
| Dietary Supplement |
zinc supplements |
1 |
2011 |
| Drug |
zyd1 |
1 |
2012 |